US20080077200A1 - Apparatus and method for stimulation of nerves and automated control of surgical instruments - Google Patents

Apparatus and method for stimulation of nerves and automated control of surgical instruments Download PDF

Info

Publication number
US20080077200A1
US20080077200A1 US11/536,642 US53664206A US2008077200A1 US 20080077200 A1 US20080077200 A1 US 20080077200A1 US 53664206 A US53664206 A US 53664206A US 2008077200 A1 US2008077200 A1 US 2008077200A1
Authority
US
United States
Prior art keywords
light
nerve
stimulation
microns
optical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/536,642
Inventor
Mark P. Bendett
James S. Webb
Roy D. Mead
Charles A. Lemaire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lockheed Martin Corp
Lockheed Martin Aculight Corp
Lockheed Martin Sonar Systems Corp
Original Assignee
Aculight Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US11/536,642 priority Critical patent/US20080077200A1/en
Application filed by Aculight Corp filed Critical Aculight Corp
Assigned to ACULIGHT CORPORATION reassignment ACULIGHT CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BENDETT, MARK P., LEMAIRE, CHARLES A., MEAD, ROY D., WEBB, JAMES S.
Priority to US11/948,912 priority patent/US8929973B1/en
Publication of US20080077200A1 publication Critical patent/US20080077200A1/en
Assigned to LOCKHEED MARTIN CORPORATION reassignment LOCKHEED MARTIN CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ACULIGHT CORPORATION
Priority to US13/217,197 priority patent/US8996131B1/en
Priority to US13/234,102 priority patent/US9061135B1/en
Priority to US13/525,270 priority patent/US8956396B1/en
Priority to US13/525,268 priority patent/US8945197B1/en
Priority to US14/295,919 priority patent/US9653872B2/en
Assigned to LOCKHEED MARTIN CORPORATION reassignment LOCKHEED MARTIN CORPORATION CHAIN OF TITLE Assignors: LOCKHEED MARTIN ACULIGHT CORPORATION
Assigned to LOCKHEED MARTIN ACULIGHT CORPORATION reassignment LOCKHEED MARTIN ACULIGHT CORPORATION CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: ACULIGHT CORPORATION
Assigned to LOCKHEED MARTIN SONAR SYSTEMS CORPORATION reassignment LOCKHEED MARTIN SONAR SYSTEMS CORPORATION CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: LORAL SONAR SYSTEMS CORPORATION
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/0622Optical stimulation for exciting neural tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/0618Psychological treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0635Radiation therapy using light characterised by the body area to be irradiated
    • A61N2005/0643Applicators, probes irradiating specific body areas in close proximity
    • A61N2005/0644Handheld applicators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/065Light sources therefor
    • A61N2005/0651Diodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0658Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0659Radiation therapy using light characterised by the wavelength of light used infrared

Definitions

  • the invention relates generally to surgical instruments, and more particularly to methods and apparatus to stimulate a nerve, sense a result of the nerve stimulation, and control a surgical instrument, such as an ablation laser, based on the sensed result; for example controlling the ablation laser to suppress ablation pulses to avoid damaging vital nerves while removing other diseased tissue, or to enable ablation pulses to remove damaged nerve tissue.
  • a surgical instrument such as an ablation laser
  • a nerve can be stimulated in a number of different ways, including electrical, mechanical, thermal, chemical, and now optical.
  • a nerve is a filament of neural tissue composed of cells each having a cell body and one or more axons and dendrites. The axons extend peripherally as either myelinated or unmyelinated fibers.
  • a chain of Schwann cells surrounds each myelinated nerve fiber with a multilayered myelin sheath. Groups of unmyelinated fibers are associated with single Schwann cells. Both types of nerve fibers are bound by endoneurium to form bundles, or fascicles.
  • a perineurial membrane surrounds each fascicle. Groups of fascicles are held together by internal and external epineurium to form the peripheral nerves.
  • the cell body of a motor neuron lies in the anterior horn of the spinal cord, while the cell body of a sensory neuron is located in the dorsal root ganglion, near the cord.
  • Functional magnetic-resonance-imaging (FMRI) systems use extremely strong magnetic fields in generating images of an animal subject (e.g., a human) to discern functions and abnormalities of various portions of the body, and in particular, of the brain (e.g., during various mental activities or thought patterns).
  • the high static magnetic fields (Bo fields) created by an MRI machine create a danger of projectile accidents from any object having magnetic properties that may be near the MRI machine.
  • Using metal probes to deliver electrical stimulation to nerves of a subject poses one such danger. It would be desirable to stimulate a nerve without using metal probes.
  • Mahadevan-Jansen et al. note that traditional methods of stimulation include electrical, mechanical, thermal, and chemical. A neuron will propagate an electrical impulse (a nerve action potential) in response to a stimulus. The most common form of applying such stimulation is to form a transient current or voltage pulse applied through electrodes. Electrical, mechanical, and chemical stimulations have many limitations. Stimulation by such methods typically results in non-specific stimulation of neurons and/or damage to neurons.
  • some conventional optical systems include some magnetic materials, making them unsuitable for use near MRI systems.
  • 110-volt AC (wall power) is used to control and/or drive the laser components, with electrical, cooling-fluid, and/or optical tethers between a delivery head and other portions of the equipment, making such systems clumsy and/or perhaps somewhat dangerous to use if relatively high voltages are present in the hand-held portion.
  • U.S. Pat. No. 5,548,604 issued to Toepel on Aug.
  • Computer hand held medical device laser describes a palm-sized laser device having a hand-held housing containing a solid state crystal lase material rod, a flashlamp (for pulsed pump light) within a reflective light-coupling cavity and a fluid-cooling chamber adapted to receive and exhaust coolant fluid.
  • the invention provides a method and self-powered (e.g., battery-powered) and/or hand-held apparatus for stimulating nerves using either an infra-red (IR) diode laser or light-emitting diode (LED) (e.g., one running at a wavelength of about 1.87 microns) or a diode-pumped solid-state laser (e.g., using a semiconductor laser diode as a pump source of optical radiation and an optically pumped semiconductor or optically pumped rare-earth-doped fiber laser cavity) running at a wavelength of 2.1 microns (e.g., a 785-micron-wavelength laser diode pumping a Tm/Ho solid-state crystal or fiber), or a laser diode operating at a wavelength of between about 1.8 and about 2.2 microns.
  • the invention uses other wavelengths that are efficacious in optical stimulation of animal tissue such as a nerve.
  • the apparatus is at least mostly embedded in a self-contained hand-held form factor such as a light pen, pointer and/or wand that can be manually used to control, direct and/or shutter the light.
  • the hand-held device includes an embedded laser diode used to obtain optical radiation (optionally directed at least in part in an embedded optical fiber) that has a suitable wavelength and optical power sufficient to optically stimulate the nerve.
  • one or more LEDs, one or more diode lasers, or a combination of one or more LEDs and one or more diode lasers is used to obtain the stimulation light.
  • the hand-held device of the present invention includes one or more internal power sources, such as battery cells, to provide self-contained electrical power to the laser diode and/or other internal components.
  • one or more internal power sources such as battery cells
  • at least some of the metal portions of the battery and other internal electrical wiring connections are all or substantially all made of a non-magnetic electrically conductive material such as copper, in order to be usable near MRI equipment.
  • one or more free-space or bulk optical components are used in the hand-held device of the present invention.
  • one or more IR and/or visible lasers are implemented on a semiconductor chip, and one or more such chips are mounted to a housing (such as a metal or plastic “can” having a front lens) such that the combined optical output of the laser(s)/LED(s) starts in close proximity and is immediately collimated as a single beam and focussed by a single train of lenses and other optical components.
  • at least one beamsplitter/beam combiner is used to combine light from two or more sources into a single output beam.
  • the IR nerve-stimulation optical signal is carried in an optical fiber, and, either sharing a single optical fiber or passing in one or more separate fibers next to the optical fiber that carries the IR nerve-stimulation optical signal, the invention also includes a visible-laser or visible-LED signal that illuminates and points out the area (e.g., the nerve) being stimulated.
  • a high-power surgical and/or therapeutic laser signal is added in conjunction with the IR nerve-stimulation signal and/or visible pointer laser.
  • a visible laser is projected to point out to the surgeon where the IR nerve-stimulation laser signal will be applied; the surgeon then activates the IR nerve-stimulation laser signal and observes the response (for example, phantom-limb pain of an amputee); and once the observed response determines the nerve location to be treated, the surgical and/or therapeutic laser signal is applied to that identified location.
  • the IR nerve-stimulation laser signal is pointed to a location that the surgeon wants to cut or ablate (in some embodiments, this point is illuminated by the visible pointer laser beam) but wants to cut only if no nerve is at that point; the surgeon then activates the IR nerve-stimulation laser signal and observes the response (for example, a muscle contraction that can be seen by the surgeon or sensed by a suitable sensor taped or otherwise affixed to the skin); but in this case, the observed response determines that a location to be treated includes a desired nerve, and the surgical and/or therapeutic laser signal is inhibited from being applied to that identified location.
  • the nerve-response sensor generates a signal that inhibits activation of the surgical laser.
  • the present invention with its ability to precisely stimulate a single nerve or a very small area of a brain (optionally with no magnetic material near the subject, who, in some embodiments, may be a human patient requiring medical care) is a gateway technology that opens broad areas of medicine and surgery.
  • an enlarged digital or video image of the surgery site is displayed, and as the surgeon optically stimulates the various nerves or areas, the image is annotated (e.g., color-coded as a map of nerve function) to provide a record of which response was observed for each of the different areas stimulated.
  • the surgeon can input graphical annotation to the computer identifying the extent or the exact area to which treatment is to be permitted, the visible signal (showing where the fiber is pointing) is inputted and compared to the map, such that the controller allows the surgical and/or therapeutic laser signal to be applied only to the identified allowed area.
  • optical stimulation of nerves refers to stimulation caused by impinging light onto nerve tissue, regardless of the wavelength of the light (ultraviolet, visible, or infrared, wherein the term “light” is not necessarily restricted to light in the visible range of 400- to 700-nanometer wavelengths).
  • the nerve being stimulated can be any nerve, such as motor or sensory nerves in the peripheral nervous system, nerve tissue of the central nervous system (nerves within the brain and spinal cord), the cranial nerves (e.g., the optic nerve, the olfactory nerve, the auditory nerve, and the like), optical or auditory nerves, the autonomic nervous system, as well as brain tissue and/or any other neural tissue.
  • the tissue to which optical stimulation is applied need not itself be a “nerve” as conventionally defined, but could include brain tissue that when stimulated by light initiates a response similar to that carried by a nerve, e.g., an action potential that includes electrical and/or chemical components, and which is propagated to a location some distance from the point that was optically stimulated.
  • the term “subject” is an inclusive term that refers to any animal whose nerves may be stimulated by light, as the term light has been defined above; this includes non-mammalian and mammalian species, including humans, and including especially humans who may be patients receiving professional medical care.
  • optical-fiber structure is an inclusive term that includes a single optical fiber as well as a bundle of individual optical fibers, a fused bundle of optical fibers, star couplers, and depending on the context optionally includes ferrules, lenses, and the like used to couple light into and out of the optical fiber structure.
  • the present invention includes at least some of the following in a small hand-held portable device powered by a self-contained energy-storage device (e.g., batteries or other power source, such as capacitors, chemical energy, rotational flywheel energy, spring energy and the like; and/or a self-contained power receiver such as a coil for receiving AC magnetic or RF energy, a photovoltaic cell for receiving optical energy, and the like), one or more light-emitting sources (that emit tissue-stimulation wavelengths) powered by the self-contained energy-storage device, an optional light-beam combiner coupled to combine two or more optical beams into a single optical beam, optics to focus and deliver light to a nerve, a trigger or activation mechanism, a light-emitting-source controller (e.g., in some embodiments, this includes electronics to condition and control electricity to laser diodes), one or more visible-light-emitting sources such as LEDs and/or laser diodes (that emit light used to point at or identify the
  • the sheath includes or incorporates a lens and/or other portions of the optics to focus the light from the light sources to a particular spot size and/or shape.
  • a plurality of different interchangeable sheaths and/or lens tips are provided, each having a different spot size and/or shape, allowing the surgeon or technician to choose the appropriate light pattern, and/or to change the light pattern based on results of the first-tried sheath's light pattern and/or the patient response obtained.
  • the invention provides a method that includes generating a first light beam from a first self-contained-energy-storage-powered (e.g., battery-powered) light-emitting source, generating a second light beam using a self-contained-energy-storage-powered (e.g., battery-powered) second light-emitting source, combining the first and second light beams, focusing the combined first and second laser light beams, and controlling an amplitude and/or timing of the first and/or second light beams.
  • a first self-contained-energy-storage-powered e.g., battery-powered
  • a self-contained-energy-storage-powered e.g., battery-powered
  • the present invention includes an apparatus having a finger-and/or-thumb control that controls a characteristic of light, optics to focus and deliver the light to a nerve, a self-contained-energy-storage-powered (e.g., battery-powered) laser having a wavelength and power capable of efficaciously stimulating a nerve, and a controller operable to drive the laser based on input from the finger/thumb control.
  • this apparatus is used to deliver an efficacious amount of visible and infrared (IR) light so as to target and stimulate nerve tissue.
  • IR infrared
  • a visible laser beam is used to point to and illuminate the area to be stimulated and an IR laser beam is used to stimulate a nerve at that illuminated area.
  • the present invention includes an apparatus having an optical nerve stimulator, an energy-storage-device charger (e.g., battery charger), and a remote wireless controller and/or programmer.
  • an energy-storage-device charger e.g., battery charger
  • the stimulation light is IR (infrared, e.g., about 1.8-micron wavelength), while in other embodiments other IR wavelengths, visible light wavelengths, ultraviolet wavelengths, and/or combinations of a plurality of such wavelengths are used.
  • the invention provides a method that includes charging a battery, (e.g., supplying a charge to a battery from an RF charger), powering a controller with the battery, powering a first light source from the controlled, powering a second light source, emitting light from the first light source, emitting light from the second light source, controlling a characteristic of the light from the first and second light sources using a remote programmer, combining the light from the first and second light sources via a combiner, and projecting the combined light to a nerve fiber.
  • a battery e.g., supplying a charge to a battery from an RF charger
  • FIG. 1A is a block diagram of a battery-operated nerve-stimulation laser handpiece system 100 A.
  • FIG. 1B is a block diagram of a battery-operated nerve-stimulation laser handpiece system 100 B.
  • FIG. 1C is a block diagram of a battery-operated nerve-stimulation laser handpiece system 100 C.
  • FIG. 1D is a block diagram of a battery-operated nerve-stimulation laser 111 .
  • FIG. 1E is a block diagram of a battery-operated nerve-stimulation laser handpiece system 100 E.
  • FIG. 3 is a block diagram of focus-indicating nerve-stimulation laser handpiece system 300 .
  • FIG. 4A is a block diagram of surgery-inhibiting nerve-stimulation system 400 A.
  • FIG. 4B is a block diagram of surgery-inhibiting nerve-stimulation system 400 B.
  • FIG. 5B is a diagram of a first stimulation/surgical pattern at an operation site sight at which a surgery-inhibiting nerve-stimulation system is employed, at a first time subsequent to the initiation of a surgical procedure.
  • FIG. 5C is a diagram of a surgical sight at which a surgery-inhibiting nerve-stimulation system is employed, at a time when the stimulation/surgical pattern shown in FIG. 5B has been completed.
  • FIG. 5D is a diagram of a second stimulation/surgical pattern at an operation site sight at which a surgery-inhibiting nerve-stimulation system is employed, at a second, later time subsequent to the initiation of a surgical procedure, and showing the surgical site at a time when the second stimulation/surgical pattern has been completed.
  • FIG. 5F is a diagram of an operation site sight at which a surgery-inhibiting nerve-stimulation system is employed, when the operation has been completed.
  • CNAP is an abbreviation for compound nerve action potential.
  • CMAP is an abbreviation for compound muscle action potential.
  • target neural tissue is defined as any neural tissue including, but not limited to, peripheral nerves, spinal-cord tissue, and brain tissue of animals, including mammals, and specifically including humans.
  • electrical impulse is defined an electrical current applied to the nerve to initiate an action potential in the neuron.
  • stimulation effect is defined as propagation of an electrical signal within or along neural or muscular tissue.
  • single nerve fiber is defined as a portion of a neuron, namely the axon, which carries action potentials from the cell body to the axon terminal at a synapse, or one or more of the dendrites, which accumulate signals from one or more sources and carry these to the cell body.
  • Many nerve fibers compose a peripheral nerve, such as the sciatic nerve of a leopard frog (Rana Pepiens) or a mammal.
  • CNAP is one form of nerve action potential.
  • substantially similar apparatus and methods are used for optical stimulation of other tissues, such as muscles and/or generating muscle action potentials.
  • CMAP is one form of muscle action potential.
  • a light-delivery handpiece is hand operated to the extent that the location (i.e., on the nerve or neural tissue) to which light is delivered is determined by positioning the handpiece by hand.
  • a light-delivery handpiece is also hand operated in that a control device (such as a button, wheel, trigger, iris, shutter, and the like) is operated by hand to control the type of stimulation light (e.g., pulses, intensity, wavelength, pulse train, and the like) and/or timing of the stimulation light.
  • a spot is generated by passing the light that exits an end of an optical fiber through a lens, holographic imaging pattern, or other imaging apparatus.
  • spots with diameters of 1 micrometer or smaller, and up to 1000 micrometers (which equal one mm) or larger are used; for example, about 5 micrometers, about 10 micrometers, about 15 micrometers, about 20 micrometers, about 25 micrometers, about 30 micrometers, about 35 micrometers, about 40 micrometers, about 45 micrometers, about 50 micrometers, about 55 micrometers, about 60 micrometers, about 65 micrometers, about 70 micrometers, about 75 micrometers, about 80 micrometers, about 85 micrometers, about 90 micrometers, about 95 micrometers, about 100 micrometers, about 110 micrometers, about 120 micrometers, about 130 micrometers, about 140 micrometers, about 150 micrometers, about 160 micrometers, about 170 micrometers, about 180 micrometers, about 190 micrometers, about 200 micrometers, about 210 micrometers, about 220 micrometers, about 230 micrometers, about 240 micrometers, about 250 micrometers, about
  • a laser-diode device (having one or more emitters) outputs light that is used for nerve stimulation, wherein the light has a wavelength of between about 1.5 microns and about 6 microns; in various embodiments, for example, the wavelength is in the far infrared at about 1.5 microns, or about 1.51 microns, about 1.52 microns, about 1.53 microns, about 1.54 microns, about 1.55 microns, about 1.56 microns, about 1.57 microns, about 1.58 microns, about 1.59 microns, about 1.6 microns, about 1.61 microns, about 1.62 microns, about 1.63 microns, about 1.64 microns, about 1.65 microns, about 1.66 microns, about 1.67 microns, about 1.68 microns, about 1.69 microns, about 1.7 microns, about 1.71 microns, about 1.72 microns, about 1.73 microns, about 1.74 microns, about 1.75 microns
  • one or more laser diodes or LEDs that output shorter wavelengths is used as a source of light to stimulate nerves.
  • shorter wavelengths including short IR, visible, and/or ultraviolet light
  • visible wavelengths are important because devices capable of generating a great number of different ones of these shorter wavelengths are becoming more available, and use of visible light makes the location of the stimulation signal readily apparent to the user without the use of separate lasers or LEDs as visible markers.
  • a laser-diode device (having one or more emitters) outputs light that is used for nerve stimulation, wherein the light has a wavelength of between about 1.5 microns and about 0.2 microns.
  • the wavelength is in the infrared spectrum at about 0.7 microns, about 0.71 microns, about 0.72 microns, about 0.73 microns, about 0.74 microns, about 0.75 microns, about 0.76 microns, about 0.77 microns, about 0.78 microns, about 0.79 microns, about 0.8 microns, about 0.81 microns, about 0.82 microns, about 0.83 microns, about 0.84 microns, about 0.85 microns, about 0.86 microns, about 0.87 microns, about 0.88 microns, about 0.89 microns, about 0.9 microns, about 0.91 microns, about 0.92 microns, about 0.93 microns, about 0.94 microns, about 0.95 micron
  • microns about 1.4 microns, about 1.41 microns, about 1.42 microns, about 1.43 microns, about 1 . 44 microns, about 1.45 microns, about 1.46 microns, about 1.47 microns, about 1.48 microns, about 1 . 49 microns, or about 1.5 microns, or, in other embodiments, in ranges between any two of the above values.
  • the wavelength is in the visible spectrum at about 0.4 microns, or about 0.41 microns, about 0.42 microns, about 0.43 microns, about 0.44 microns, about 0.45 microns, about 0.46 microns, about 0.47 microns, about 0.48 microns, about 0.49 microns, about 0.5 microns, about 0.51 microns, about 0.52 microns, about 0.53 microns, about 0.54 microns, about 0.55 microns, about 0.56 microns, about 0.57 microns, about 0.58 microns, about 0.59 microns, about 0.6 microns, about 0.61 microns, about 0.62 microns, about 0.63 microns, about 0.64 microns, about 0.65 microns, about 0.66 microns, about 0.67 microns, about 0.68 microns, about 0.69 microns, or about 0.7 microns, or, in other embodiments, in ranges between any two of the above values.
  • the wavelength is in the ultraviolet spectrum at about 0.1 microns, or about 0.11 microns, about 0.12 microns, about 0.13 microns, about 0.14 microns, about 0.15 microns, about 0.16 microns, about 0.17 microns, about 0.18 microns, about 0.19 microns, about 0.2 microns, about 0.21 microns, about 0.22 microns, about 0.23 microns, about 0.24 microns, about 0.25 microns, about 0.26 microns, about 0.27 microns, about 0.28 microns, about 0.29 microns, about 0.3 microns, about 0.31 microns, about 0.32 microns, about 0.33 microns, about 0.34 microns, about 0.35 microns, about 0.36 microns, about 0.37 microns, about 0.38 microns, about 0.39 microns, or about 0.4 microns, or, in other embodiments, in ranges between any two of the above values.
  • the invention uses a nerve-stimulation signal composed of one or more wavelengths within a range between two numbers selected from the set that includes all of the above listed far-infrared-, visible-, infrared-, or ultraviolet-spectrum wavelengths.
  • different IR wavelengths have different depths of penetration into living tissue (e.g., nerve tissue), and thus one IR nerve-stimulation wavelength is used for penetration to a first depth, and a second IR nerve-stimulation wavelength is used for penetration to a second depth that is different than the first depth.
  • the two or more different wavelengths are passed through a single optical fiber for delivery to the target neural tissue.
  • different IR wavelengths have different absorption ratios or different stimulation results for different tissue types (e.g., for different types of nerves or neural tissue), and thus one IR nerve-stimulation wavelength is used for stimulation of a first type of neural tissue, and a second IR nerve-stimulation wavelength is used for stimulation of a second type of neural tissue that is different than the first type.
  • the two or more different wavelengths are passed through a single optical fiber for delivery to the target-neural-tissue area.
  • the two or more different wavelengths are generated by two or more solid-state light-emitting devices, such as laser diodes, light-emitting diodes, optically pumped fibers, and the like, and are then combined into a single optical fiber.
  • the two or more wavelengths are sent through separate parallel fibers or through different cores in a single fiber.
  • the optical stimulation light is directed to a very small area of neural tissue, for example in order to stimulate a subset of one or more nerves within a nerve bundle (for example, to stimulate a motor nerve (a nerve that conducts signals from the brain to one muscle or a portion of a muscle), or to stimulate a sensory nerve (a nerve that conducts signals to the brain from a small area of touch-sensing nerves), or an auditory nerve for a single audio frequency, or an optical nerve for a small portion of the visual field or color-sensing spectrum).
  • a precision-directed optical signal includes a single optical wavelength; while in other embodiments two or more different IR-stimulation wavelengths are used for stimulating a single nerve or neural tissue area.
  • two or more different wavelengths provide a stronger stimulation to one nerve cell or one portion of tissue
  • two or more different IR-stimulation wavelengths provide different depths of penetration, such that a selected depth or range of depths can be chosen by selecting the wavelength(s) that reach to those depths.
  • a grating e.g., a distributed Bragg reflector having a characteristic grating spacing chosen to eject light from the fiber along the grating length
  • a length e.g., in various embodiments, 0.1 mm, 0.2 mm, 0.3 mm, 0.4 mm, 0.5 mm, 0.6 mm, 0.7 mm, 0.8 mm, 0.9 mm, 1 mm, 2 mm, 3 mm, 4 mm, 5 mm, 6 mm, 7 mm, 8 mm, 9 mm, 10 mm, 11 mm, 12 mm, 13 mm, 14 mm, 15 mm, 16 mm, 17 mm, 18 mm, 19 mm, 20 mm, or longer than 20 mm
  • the delivery end of a fiber in order that the stimulation optical signal is forced to leave the fiber over a length of the grating, in order that the optical signal is directed to neural tissue over that length of grating on the fiber.
  • the dimension along the fiber at its emissive end is called the X-direction.
  • a plurality of optical fibers is disposed such that their ends emit light across a line perpendicular to their length.
  • the dimension perpendicular to the fibers at their emissive end is called the Y-direction.
  • a plurality of fibers, each having a grating on its end are placed side-by-side such that light is emitted to a larger area, wherein light has an extent in the Y-direction due to the side-by-side spacings of the multiple fibers and an extent in the X-direction due to the lengths of the gratings on each fiber.
  • one or more IR stimulation wavelengths are also chosen to be emitted across different extents along a Z-direction, such that a volume of neural tissue having selected extents in the X-direction, Y-direction, and Z-direction is stimulated using the optical stimulation signal.
  • a plurality of optical fibers at the delivery tip of the handheld device of the present invention is used to deliver optical-stimulation pulses to different points along the same nerve fiber or bundle at different times.
  • a first fiber A delivers an optical-stimulation pulse to point X A along a nerve at a time t 0
  • a second fiber B delivers an optical-stimulation pulse to point X B further along the nerve at a later time t 4 .
  • the relative timings of the times of the optical-stimulation pulses at t 0 and t 4 are selected such that the action potential traveling along the nerve is reinforced or strengthened.
  • one nerve is stimulated using different wavelengths applied to different locations along the nerve; for example 1.8-micron-wavelength light can be applied to a first point and 2.2-micron-wavelength light can be applied to a second point. In some embodiments, both the wavelength and the timing of the light stimulation are varied along the nerve.
  • a diode laser is employed for nerve stimulation. This is important because a single-diode laser is a very low-cost source compared to free-electron lasers (FEL), fiber lasers or pumped solid-state lasers and the like. A single emitter is used in some embodiments, but, in other embodiments, may not provide enough power for certain purposes. In other embodiments, a multiple-emitter laser-diode device is used, wherein light from a plurality of emitters is directed to a single nerve. In some embodiments, a combiner is used to combine light from a plurality of emitters into a single fiber.
  • FEL free-electron lasers
  • one or more side-emitting lasers are employed, while in other embodiments surface-emitting lasers are used.
  • a combination of different laser types is used, e.g., based on the need to generate certain combinations of wavelengths or powers.
  • the laser-diode device is coupled to one or more optical fibers that convey the light to the location at the nerve for stimulation.
  • the laser diode itself is positioned at the point of stimulation, eliminating the need for the optical fiber.
  • a WDM (wavelength-division multiplexing) coupler is used to combine two or more wavelengths to be transmitted through a fiber to be ultimately delivered to nerve tissues. Such couplers combine light at differing wavelengths supplied to two or more optical-fiber ports, to produce a single multi-wavelength beam at an additional optical-fiber port.
  • WDM couplers are well known in the field of telecommunication systems; an early example is described in U.S. Pat. No. 4,296,995, with a more recent example described in U.S. Pat. No. 5,796,889.
  • a WDM coupler is used to couple light from the emitters (e.g., laser diodes or LEDs) into an optical-fiber structure.
  • the fiber core's size or sizes small for stimulating smaller nerves it is important to make the fiber core's size or sizes small for stimulating smaller nerves. More to the point, given the small size of some nerve fibers, a fiber core and a laser diameter corresponding to (e.g., equal to or smaller than) the diameter of this nerve fiber need to be provided. In some embodiments, a fiber core much smaller than the nerve fiber is used. For example, in some embodiments, a fiber core having a one-micron (or smaller) diameter is used. In other embodiments, fibers having core diameters of 100 micrometers or larger are used. In some embodiments, the optical fibers are made of a glass such as silica or other suitable material (such as plastic). In some embodiments, the optical-fiber bundle used for imaging the tissue being stimulated and observed is made of plastic and/or glass fibers. In some embodiments, multiple small-core fibers can be used to simulate multiple small nerves simultaneously or independently.
  • a fiber-coupling technique is implemented to increase the brightness of light delivered from the battery-operated handpiece by coupling light from a plurality of laser emitters (e.g., from a laser-diode bar) for biological stimulation (i.e., nerve or tissue stimulation).
  • a plurality of laser emitters e.g., from a laser-diode bar
  • biological stimulation i.e., nerve or tissue stimulation.
  • Many different coupling techniques may be employed to increase the brightness of a laser-diode bar.
  • co- and contra-directional and evanescent coupling are some of the coupling techniques known in the art.
  • a single-emitter laser diode such as an 1850-nm wavelength single emitter available from Princeton Lightwave company, for example laser diode described at www.princetonlightwave.com/content/HP%20Single%20Element%20Laser%20version%202.pdf or other suitable diode is implemented and used to generate laser light of some efficacious wavelength to a particular target nerve or tissue.
  • such single-emitter laser diodes may be side-emitting and/or surface-emitting laser diodes.
  • a visible wavelength with the IR-stimulation light in order to provide a visual cue for directing the IR-stimulation light used for stimulating a nerve or other tissue.
  • Laser light in the IR range e.g., 700 nm-1850 nm or longer
  • this IR optical-stimulation light cannot be easily aimed to a particular target (e.g., a nerve fiber) using the naked eye.
  • visible light i.e., light in the 400 to 700 nm range from a laser diode, L.E.D., or other source
  • visible light is also inserted into the optical fiber or fiber bundle and used to guide movement of the emitting end of the fiber to aim the IR light so as to allow the IR light to be applied in an efficacious manner to, for example, stimulate a nerve fiber.
  • the visible light is passed through one or more fibers or fiber bundles (i.e., this can be using the same fiber(s) as the IR optical-stimulation light, or in other embodiments, using a separate fiber) so as to provide a target spot.
  • IR light is passed through the same one or more fibers to the same point on a nerve fiber that the visible light previously illuminated or currently illuminates.
  • both the IR light and visible light have separate light sources that are coupled into a commonly shared optical-fiber structure, whereas, in other embodiments, a separate optical-fiber structure is used to channel each wavelength of light.
  • an optical-fiber structure is used in which at least some fibers are used to transmit light of one wavelength, while at least some other fibers are used to transmit light of a different wavelength (for example, in some embodiments, different fibers are used to carry the visible light, the IR-stimulation light, and/or the cutting/ablating/cauterizing light, and/or to return the imaging light obtained from the tissue being targeted).
  • still other optical fibers are used to carry control-light signals to and from the handpiece, such that an operator holding the handpiece can selectively command a remote light source to do his/her bidding.
  • these optical-fiber structures are operatively coupled to a glass, ceramic plastic or some other type of ferrule or plug made from a non-magnetic material.
  • the visible laser light is selected from one or more wavelengths empirically selected to selectively show a visible difference in reflected brightness when directed at nerve fibers as compared to blood vessels, muscles, connective and other tissues.
  • a combination of red, green and/or blue laser or LED light is used.
  • green light has been found to be more effective (as an indicator of where the fiber delivery head is pointing) than red or blue light alone.
  • a fiber bundle (with plastic and/or glass fibers) capable of obtaining image information and transmitting optical two-dimensional color imaging to a remote location is used to convey image information from the subject (e.g., someone in an MRI machine) to a remote viewing location.
  • a machine-vision system is used to distinguish color features of tissues (e.g., hue, tint, and/or brightness) and/or shapes of tissues from a digital or video image, and to display an enhanced image (e.g., one using enhanced or false-color image information) derived from the image.
  • tissue e.g., hue, tint, and/or brightness
  • an enhanced image e.g., one using enhanced or false-color image information
  • an IR video imager is used to obtain and display the location of the IR-stimulation signal without the addition of visible-wavelength light.
  • a fiber bundle or other structure capable of obtaining and transmitting optical two-dimensional IR imaging to a remote location is used to convey image information to a remote IR imager.
  • a second, high-power laser signal (called the “surgical signal”) is generated in (e.g., by a supplemental laser diode, or by applying more electrical power to the stimulation laser diode), or coupled through, the handpiece to the stimulation area, wherein the operator can stimulate nerve tissue using a first stimulation-wavelength-and-power optical signal (called the “stimulation signal”) to distinguish tissue that is to be saved from tissue that is to be cut or destroyed, and then use the high-power laser light to cut, ablate, or cauterize the tissue to be destroyed.
  • the “surgical signal” is generated in (e.g., by a supplemental laser diode, or by applying more electrical power to the stimulation laser diode), or coupled through, the handpiece to the stimulation area, wherein the operator can stimulate nerve tissue using a first stimulation-wavelength-and-power optical signal (called the “stimulation signal”) to distinguish tissue that is to be saved from tissue that is to be cut or destroyed, and then use the high-power laser light to cut, ablate, or cauter
  • the optical-stimulation signal is provided by a first laser source (e.g., a laser diode, optically-pumped fiber laser, or the like), and the optical surgical signal is provided by a second laser source of higher intrinsic power or energy, or of a different wavelength more suited for surgical purposes (e.g., another laser diode, optically-pumped fiber laser, or the like).
  • a first laser source e.g., a laser diode, optically-pumped fiber laser, or the like
  • a second laser source of higher intrinsic power or energy e.g., another laser diode, optically-pumped fiber laser, or the like.
  • a single laser source is used for both the optical stimulation signal and the optical surgical signal, wherein a parameter of the signal is changed to achieve one function or the other (e.g., in some embodiments, the optical surgical signal is obtained by shortening the pulse length, for example by Q-switching, in order that a given amount of energy is delivered in a very short time to ablate a small area of tissue, or by lengthening a pulse length having a constant average energy or by increasing the number of pulses sent in a short time period in order that one or more pulses with a given average power integrate over time to heat the tissue being treated).
  • the optical surgical signal is obtained by shortening the pulse length, for example by Q-switching, in order that a given amount of energy is delivered in a very short time to ablate a small area of tissue, or by lengthening a pulse length having a constant average energy or by increasing the number of pulses sent in a short time period in order that one or more pulses with a given average power integrate over time to heat the tissue
  • the targeting of various nerve fibers is performed manually (e.g., by manually moving a handpiece to locate the delivery end of an optical fiber so that light energy may be directed on to the nerve to be stimulated).
  • the pulse shapes of the light generated by or controlled from the device are controlled through the use of a light-pulse device that regulates the light under control of a computer, microprocessor or CPU (e.g., x86 series, Intel 8051 CMOS series utilizing certain computer-executable instructions stored to a computer-readable medium, or under control of a non-computer, non-programmed electronic circuit).
  • a light-pulse device that regulates the light under control of a computer, microprocessor or CPU (e.g., x86 series, Intel 8051 CMOS series utilizing certain computer-executable instructions stored to a computer-readable medium, or under control of a non-computer, non-programmed electronic circuit).
  • a computer-readable medium is defined to be a medium for carrying or having computer-executable instructions or data structures stored thereon.
  • Such computer-readable media may be any available medium that is accessible by a general-purpose or special-purpose computer system.
  • such computer-readable media can include physical storage media such as RAM, ROM, or EPROM, removable media such as CD-ROM or other optical-disk storage, diskettes, magnetic hard-disk storage or other magnetic-storage devices, or any other media which can be used to carry or store desired program code means in the form of computer-executable instructions, computer-readable instructions, and/or data structures and which may be accessed by a general-purpose or special-purpose computer system; this physical storage media may be fixed to the computer system as in the case of EPROM or a magnetic hard drive, or removable as in the case of an EEPROM on a USB-connected device (e.g., flash memory device) or CDROM, DVD, or diskette, or can include network-connected storage (such as a hard drive connected to the internet.
  • a disposable, biologically inert, non-metallic and/or non-magnetic optical tip at the end of the handpiece is provided.
  • this tip is adjustable or interchangeable so as to allow for the spot size to vary depending on type or location of nerve to be stimulated.
  • this tip is configured on a light pen, pointer or similar handheld device so as to allow the user to manually target a particular nerve fiber or series of fibers.
  • this optical tip is encased in or affixed to a disposable plastic sheath (e.g., a sterile sheath that is used once for an operation and then discarded), whereas in other embodiments it is encased in an end of the aforementioned light pen, pointer or similar device.
  • a sterile disposable sheath is applied to the handpiece before each use, and is discarded afterwards.
  • the handpiece, light pen, pointer or the light-delivery device itself is provided in a sterile condition, and is inexpensive enough to be disposable.
  • the optical path is selectively interruptible by a mechanical shutter and/or variable aperture that allows the user to control the passage of laser light (i.e., the visible signal, optical-stimulation signal, optical surgical signal or the like) through the optical tip.
  • the shutter is used to start and stop the light passing through the optical tip.
  • this shutter and/or aperture is made from a non-metallic material such as a plastic, ceramic or similar material.
  • the variable aperture is adjustable to control the amount of light (e.g., the power and/or size of the spot), which, in some embodiments, also includes the start and stop of the light signal to the target tissue.
  • an iris diaphragm is provided to regulate the variable aperture through which light passes.
  • a non-metallic material such as a plastic, ceramic or similar material is used to construct the iris diaphragm.
  • the optical tip is secured to, or with, a ferrule or similar.
  • the flow of stimulation and/or pointer light is controlled via a mechanical linkage incorporated into the above-described handpiece, light pen or pointer.
  • the linkage includes a trigger-like device that, when depressed or otherwise manually controlled, controls the flow of the above-described light.
  • a sterile, disposable covering or sheath constructed from plastic, polymer or some other substance is placed over the above-described handpiece, light pen or pointer. This disposable covering is then discarded after use of the handpiece, light pen or pointer.
  • this disposable covering includes one of a plurality of different beam-shaping optics that allow for different beam characteristics for different applications.
  • IR light in a higher or lower wavelength range may be more or less efficacious.
  • near-IR light e.g., in the 700-1400 nm wavelength range
  • short-wavelength IR light e.g., in the 1400-3000 nm range
  • the efficacy of a particular IR wavelength can be determined through empirical testing and/or modeling.
  • a power controller is implemented that is operable to provide programmable pulse shapes (e.g., pulse width, repetition rate, etc. that can be varied in a programmable manner).
  • a laser light source is operatively coupled to a timer or pulse-regulating device that controls the shape, magnitude, cycles or other features of a light pulse. In some embodiments, this pulse-regulating device is used in conjunction with the above-described shutter, while in other embodiments it is used alone.
  • the pulse-regulating device is a remote control that is used from outside of the magnetic field generated by an MRI device, so as to not present a danger to an individual using an MRI device, while the hand-held device generating the stimulation light includes a receiver to obtain control information from the remote control but is made of materials that are compatible with use in the field of the MIR machine.
  • a thumb/finger control mechanism includes a non-magnetic (e.g., plastic) component mechanism that is optically assessed in order to control the light source to drive a particular pulse shape (e.g., an optical assessment signal (e.g., an unmodulated laser or LED light signal) is sent to the component mechanism that is part of the thumb/finger control mechanism and the state of the component mechanism, which is a function of the position of the thumb/finger control mechanism, changes a characteristic of the light and returns it as an optical control signal).
  • an optical assessment signal e.g., an unmodulated laser or LED light signal
  • pulse shapes can be modified using a thumb/finger control that can modify the pulse width, repetition rate and the like.
  • a knob, toggle or other switch is used that allows a user to modify the pulse width by turning, for example, a knob to a particular position.
  • the use of a knob, toggle or the like to modify the various pulse shapes can be determined through assessing the ergonomic benefits of a particular switch and switch location on the above- described handpiece or light pen.
  • a laser-wavelength-selective device is implemented to couple the visible light and provide power control or laser-safety monitoring or output-power measurement. In some embodiments, this is done with a beamsplitter (e.g., a 10%-90%) to couple 10% of the visible laser signal into the optical beam having the stimulation-wavelength signal.
  • a beamsplitter e.g., a 10%-90%
  • the visible-light pointer includes a point-to-line or point-to-area beam spreader (e.g., a hologram) that generates a centered pattern (e.g., a cross-hair pattern with perpendicular lines that intersect where the stimulation will occur) that shows where the IR nerve-stimulation light will be (or is) directed, while providing better usability for the surgeon or technician by allowing the user to align one of the lines with the nerve.
  • a point-to-line or point-to-area beam spreader e.g., a hologram
  • a centered pattern e.g., a cross-hair pattern with perpendicular lines that intersect where the stimulation will occur
  • the battery can be replaced by another suitable self-contained energy-storage device (e.g., battery-like devices or other power source, such as capacitors, chemical energy, rotational flywheel energy, spring energy and the like that power the laser directly (e.g., chemical lasers) or are used to generate electricity (e.g., flywheel or spring-driven electrical generators); and/or a self-contained power receiver such as a coil for receiving AC magnetic or RF energy, a photovoltaic cell for receiving optical energy, and the like).
  • a self-contained energy-storage device e.g., battery-like devices or other power source, such as capacitors, chemical energy, rotational flywheel energy, spring energy and the like that power the laser directly (e.g., chemical lasers) or are used to generate electricity (e.g., flywheel or spring-driven electrical generators)
  • a self-contained power receiver such as a coil for receiving AC magnetic or RF energy, a photovoltaic cell for receiving optical energy, and the like.
  • laser diodes as the sources of optical radiation (IR or visible) however other embodiments use LEDs or diode-pumped rare-earth-doped optical fiber sources of laser, super-luminescent, or other radiant energy for the stimulation optical beam, the pointer visible beam, or both.
  • the exemplary embodiments shown include some features in some embodiments and not in others. It is to be understood that other embodiments of the present invention use combinations of features selected from the various figures and descriptions to achieve identical or similar operations.
  • trigger 108 A includes a flexible membrane portion of housing 132 that covers an internal switch that is operatively coupled to a laser controller/power controller 152 (alternatively designated light-emitting-source controller 152 ) that together with laser/light-emitting-source assembly 111 form light source 151 .
  • power source 150 also called self-contained energy source 150 , which includes, e.g., batteries, in some embodiments
  • tip 107 , on-off switch 112 A and handpiece housing or handle 132 are grouped together and protected via a disposable replaceable sheath 105 to form handpiece 140 A.
  • tip 107 forms a part of handpiece housing 132 , and these are together inserted into the disposable sheath 105 via an opening 113 , which is then folded over and sealed (e.g., via pressure-sensitive adhesive).
  • tip 107 and its lens 115 form a part of the disposable sheath 105 (this allows the optics to be interchanged with other disposable sheaths 105 having different optics by swapping sheaths, in order to easily obtain the desired optical pattern uniquely suited for nerve, brain or other tissue stimulation and avoiding possible contamination from the lens if the lens were left in place).
  • Such a sheath 105 is pulled over the length of handpiece housing 132 until the light-transmitting optics or lens 115 of the tip 107 is flush or engaged with the opening 124 of housing 132 .
  • the pieces of handpiece 140 A are all manufactured from substantially non-metallic, non-magnetic materials such as plastics, polymers, ceramics or the like.
  • the light pattern desired from the optics is empirically determined by testing various patterns on various tissues and observing the reaction obtained.
  • the sheath 105 provides a clear window that covers tip 107 and its lens 115 .
  • tip 107 and its lens 115 are configured to be an interchangeable optics mechanism (e.g., a threaded or snap-in imaging adaptor configured to be easily swapped), several different ones of which are provided as a kit with handpiece 140 A.
  • an interchangeable optics mechanism e.g., a threaded or snap-in imaging adaptor configured to be easily swapped
  • FIG. 1B is a block diagram of a battery-operated nerve-stimulation laser handpiece system 100 B.
  • reference numbers of elements shown in FIG. 1B refer to like-numbered elements described above for FIG. 1A .
  • handpiece 140 B has few if any switches (such as 112 A and 108 A described for FIG. 1A ), but rather is activated wirelessly by remote-control device 141 . This helps prevent movement of the handpiece when the light is activated (in contrast to the embodiment shown in FIG. 1A , which might move when the user's finger presses on switch 108 A).
  • remote controller 141 includes one or more switches 108 B (e.g., activated by user 89 's foot, or opposite hand, or otherwise (such as a microphone and voice-recognition software on a computer, activated by the user's voice commands)), a controller 104 B that interprets the activation of the one or more switches 108 B and sends commands through wireless transmitter 109 B to wireless receiver/controller 112 B, which then activates the light-emitting functions of light source 151 .
  • switches 108 B e.g., activated by user 89 's foot, or opposite hand, or otherwise (such as a microphone and voice-recognition software on a computer, activated by the user's voice commands)
  • controller 104 B that interprets the activation of the one or more switches 108 B and sends commands through wireless transmitter 109 B to wireless receiver/controller 112 B, which then activates the light-emitting functions of light source 151 .
  • Other aspects of system 100 B are similar to those described
  • FIG. 1C is a block diagram of a battery-operated nerve-stimulation laser handpiece system 100 C.
  • system 100 C uses a battery-operated nerve-stimulation handpiece 140 C.
  • emission of IR and/or visible light from light source 151 is controlled via a foot-trigger 108 C being pressed by the foot of user 89 , which is operatively coupled to switch 112 C via mechanical linkage 106 C that is within cable sheath 109 (e.g., a flexible plastic rod in a flexible plastic tube).
  • handpiece 140 C from tip 107 to cable sheath 109 are together inserted into disposable sheath 105 though opening 113 , which is then closed and sealed to cable sheath 109 (e.g., with a twist-tie or pressure-sensitive adhesive).
  • other options for sheath 105 are as described for FIG. 1A .
  • Other aspects of system 100 C are similar to those described for FIG. 1A .
  • FIG. 1D is a block diagram of a combined light source or laser assembly 111 .
  • light source 111 includes an IR-laser-diode emitter 101 that emits a wavelength of light useful for tissue stimulation and a front lens 104 .
  • Some embodiments further include a visible laser or LED 102 and a beam-combiner optic or optics 103 (for example, a highly reflective mirror 119 and a beam combiner plate 118 , such as a dichroic mirror that is highly reflective of one wavelength (e.g., the visible-light wavelength of emitter 102 ) and highly transmissive of another wavelength (e.g., the stimulation-light wavelength of emitter 101 ).
  • Some embodiments further include a therapeutic (e.g., surgical) beam generated by a high-power laser 117 and combined using a beam-combiner optic or optics 116 (similar to beam combiner 103 , except for the wavelengths for which the dichroic mirror is configured).
  • a therapeutic e.g., surgical
  • a beam-combiner optic or optics 116 similar to beam combiner 103 , except for the wavelengths for which the dichroic mirror is configured.
  • combining the two or more beams into a single beam makes the downstream optics simpler. In other embodiments such as described below for FIG.
  • light source 111 generates two or more beams (e.g., parallel beams, in some embodiments), wherein the handpiece is configured to deliver the light in the separate beams to the desired location using suitable optics (e.g., some embodiments include two or more visible pointer beams that form separate beams that form separated spots, and the optics is arranged to focus the two visible beams into a single spot only when the invisible (IR) stimulation beam is in focus).
  • suitable optics e.g., some embodiments include two or more visible pointer beams that form separate beams that form separated spots, and the optics is arranged to focus the two visible beams into a single spot only when the invisible (IR) stimulation beam is in focus).
  • one or more visible-light sources 102 emit visible indicator light (i.e., light having one or more visible wavelengths suitable for indicating to a user where the stimulation light or therapeutic (e.g., surgical) light will be delivered), which is coupled by light-beam combiner and/or coupler 103 to combine with the optical beam from stimulation-wavelength laser 101 .
  • visible indicator light i.e., light having one or more visible wavelengths suitable for indicating to a user where the stimulation light or therapeutic (e.g., surgical) light will be delivered
  • visible-light sources 102 include one or more visible-light LEDs, incandescent lamps, and/or laser diodes emitting light at one or more different wavelengths (e.g., 0.45-micron blue light (e.g., gallium-indium nitride devices), 0.55-micron green light (e.g., gallium-indium nitride LED or laser-diode devices), 0.63-micron red light (e.g., gallium-arsenide LED or laser-diode devices), or other wavelengths useful for pointing and/or delivering to the user function-state information, such as different colors or pulsing characteristics to indicate which function has been selected) under control of light-emitting-source controller 152 .
  • 0.45-micron blue light e.g., gallium-indium nitride devices
  • 0.55-micron green light e.g., gallium-indium nitride LED or laser-diode devices
  • one or more high-power laser sources 117 emit high-power laser light (or very-short-pulse laser light), which is coupled by light-beam combiner 116 and/or coupler 103 into the output beam
  • high-power laser sources 117 include one or more high-power lasers or laser diodes or optically-pumped-fiber lasers emitting light at one or more different wavelengths (e.g., 1.55 microns, or other wavelengths useful for surgical purposes) under control of light-emitting-source controller 152 .
  • the high-power laser light effects a burning or cutting operation where heat results from the laser interaction with the tissue (i.e., absorbing photon energy from the laser light and converting it to heat).
  • the very-short-pulse laser light (e.g., from one or more femtosecond-pulse lasers that concentrate power into a very short time period, such as are described in U.S. Patent Application Publication US 2004 0243111 A1 by Mark Bendett et al. and U.S. Patent Application Publication US 2004 0243112 A1 by Mark Bendett et al., both of which are incorporated by reference) effects an ablation or tiny explosion that removes tissue with substantially no heating of surrounding or underlying tissue.
  • FIG. 1E is a block diagram of a battery-operated nerve-stimulation laser handpiece system 100 E.
  • system 100 E includes a handpiece 140 E having a programming and/or recharging port 160 (such as a USB port) that is removably connectable to a computer system 174 for recharging power system 150 (e.g., its batteries) and/or for programming the controller of light source 151 .
  • a programming and/or recharging port 160 such as a USB port
  • Such programming includes, in some embodiments, one or more predetermined characteristics of the light output such as the duration (e.g., the number of milliseconds the pulse is active), number (e.g., the number of pulses in one train, or the total number of pulses allowed in any one session), power (e.g., the total number of watts or the watts per area), shape (e.g., rising trapezoid, flat-top, or falling trapezoid or other shape of each pulse), envelope (e.g., the overall shape of the pulse train, for example, rising trapezoid, flat-top, or falling trapezoid or other shape of the envelope of a series of pulses) or like characteristics of the single pulse or pulse train that is initiated by user activation of trigger 108 A (which, in some embodiments, includes one or more internal separately activateable switches).
  • the duration e.g., the number of milliseconds the pulse is active
  • number e.g., the number of pulses in one train, or
  • FIG. 1F is a block functional diagram of battery-operated nerve-stimulation laser handpiece system 100 E as shown in FIG. 1E described above.
  • Box 108 F shows various input indications received from a user-manipulating trigger 108 A of FIG. 1E described above.
  • an array of one or more buttons and/or a rotateable thumbwheel are activated by the user to initiate one or more functions (e.g., turning on the pointer laser, the nerve-activation laser, or the therapeutic laser, or changing their function).
  • a single click on a button will cause one function to be performed, while two clicks in short succession produce a different function.
  • the USB interface 160 allows the program in programmable controller 177 to be changed, and/or provides a charging mechanism for batteries 150 , which are later used to power programmable controller 177 for functionality and power controller 159 that is used to drive the laser and/or LED light source(s) (e.g., 101 and 102 ).
  • a display 117 is provided (e.g., and LCD screen or one or more LEDs of one or more colors) that displays text and/or graphics to show the activation state of the lasers, and their characteristics such as power, pulse length, repetition rate and the like.
  • FIG. 1G is a block diagram of battery-operated nerve-stimulation laser handpiece system 100 G having a mister 195 and/or focus plate 194 .
  • Handpiece 140 G is similar to handpiece 140 C of FIG. 1C , but with the addition of a spring-loaded-tip light controller 167 .
  • focus plate 194 provides a predetermined optical distance between handpiece 140 G and the nerve 69 that is being stimulated.
  • focus plate 194 includes wetter 195 having a squeeze bulb 193 containing a sterile saline solution and/or index-of-refraction-matching liquid that is applied by squeezing drops through nozzle 196 , either directly onto nerve 69 in tissue 68 , and/or under (i.e., providing a clean gap-free interface between plate 194 and nerve 69 ) and/or on top of, focus plate 194 (i.e., providing a clean gap-free interface between plate 194 and handpiece 140 G).
  • lens 115 is mounted on a spring-loaded selector-activation rod 167 , such that when the tip of handpiece 140 G is pressed onto a nerve or onto focus plate 194 , the visible pointer-light source and/or the stimulation-light source is activated and pointer and/or stimulation light is emitted.
  • selector buttons 127 and 117 are omitted, such that the handpiece 140 G is selectively activated only when tip 167 is pressed against the subject or other object.
  • one or more of the activation signals to the various light sources is activated by switches 117 and/or 127 , and/or by a remote activation switch as described elsewhere herein.
  • a mechanical shutter replaces selector 161 , and is activated (e.g., opened) to allow light to be emitted only when the tip 167 is pressed (in some embodiments, other activation signals are also required, but the light is not emitted until the tip is also pressed). In some embodiments, such a spring-loaded tip helps to ensure that the correct focal distance is obtained before the laser is activated.
  • focus plate 194 (made of glass, plastic, or other material transparent to the light wavelengths of interest) is of a thickness such that when lens 115 is pressed on one face of focus plate 194 with stimulation light being emitted, and the other face of focus plate 194 is pressed onto nerve 69 , the light is focussed to a spot size that is desired. In some embodiments, use of focus plate 194 also keeps the nerve moist and alive by preventing evaporation.
  • wetter 195 can be used to apply a moistening liquid or gel onto nerve 69 or onto the nerve-side face and/or outside face of focus plate 194 (besides keeping the nerve moist and alive, this provides an index-of-refraction matching, which reduces reflections; drying can cause tissue damage and changes the reflectivity to the stimulation light signal).
  • a pump laser diode emits pump light at about 960-micron wavelength
  • the doping species of the fiber is chosen (using a table of such elements that are well known to persons of skill in the art) to obtain a wavelength suitable for nerve or other tissue stimulation.
  • controller and laser device 158 includes electronics and light emitters.
  • one or more of the light emitters operate with visible wavelengths for pointer use, and one or more light emitters in wavelengths suitable for pumping the fiber emitters 159 (i.e., the pump lasers emit a wavelength suitable for pumping the fiber laser segment(s) 159 ).
  • fiber emitters 159 include feedback devices such as mirrors, gratings or the like, and operate as lasers.
  • the fibers serve as superluminescent emitters, wherein spontaneous emission of the fibers is amplified in the fibers.
  • Other aspects of system 100 H are as described in the above figure descriptions.
  • FIG. 2 is a block circuit diagram of battery-operated nerve-stimulation laser handpiece system 200 .
  • power source 150 is connected to circuit 210 , which provides drive current to stimulation-wavelength laser 101 .
  • circuit 210 includes a one-shot circuit 283 that outputs macro pulse envelope waveform 284 of a suitable shape (flat, rising, or falling or other shape), repetition and duration, which signal is then optionally modulated with micro-pulse modulator 285 to obtain a suitable train of one or more shorter-duration pulses, such as waveform 286 or 287 , and laser diode 101 outputs stimulation light having a corresponding amplitude light output (some embodiments switch the order of components, placing the micro-pulse circuit 283 first and use the one-shot 283 as an envelope modulator, other embodiments use other orders of components or substitute circuit functions (e.g., software or microcode control of a power transistor driven by a microcontroller)).
  • circuit 210 is simply a direct drive of
  • FIG. 3 is a block diagram of focus-indicating nerve-stimulation laser handpiece system 300 .
  • one, two, or more visible laser diodes 102 are arranged around (e.g., in some embodiments, one on either side and parallel with) the beam of the tissue-stimulating laser diode 101 .
  • a single lens 115 or a series of two or more lenses e.g., 104 , 114 , and 115 ) are used to collimate and focus the nerve-stimulation beam to a point, or a suitable shape of a desired size.
  • This optical path causes the two pointer beams (e.g., a red pointer beam from the top laser 102 and a blue beam from the bottom laser 102 ) to cross at the optimal focus depth to obtain the desired focus of the non-visible IR nerve-stimulation beam. If the lens 115 at the tip of the handpiece 140 is too close, the blue-beam's spot will be below the red-beam's spot, or if the lens 115 at the tip of the handpiece 140 is too far from the nerve, the blue-beam's spot will be above the red-beam's spot. When at the correct focus, the red spot and blue spot will coincide—be on top of one other.
  • the two pointer beams e.g., a red pointer beam from the top laser 102 and a blue beam from the bottom laser 102
  • somewhat longer pulses and/or higher laser powers are used, and some heating and/or cauterization results.
  • a pulse train or series of such pulses are successively directed at a point, along a line or within an area, the tissue at that point, along that line or within that area is removed to a given depth. Further repetitions of pulses at the point, line, or area remove tissue to successively greater depths.
  • the tissue-removing laser pulses act as an optical scalpel.
  • the surgical or therapeutic operation be suppressed (inhibited or sufficiently reduced) to avoid damaging a nerve (e.g., to avoid damaging a facial nerve during an operation to remove a tumor).
  • “suppressed” includes both “inhibited” (meaning substantially stopped altogether) and “reduced” (meaning that the depth and/or lateral extent is reduced but not entirely inhibited).
  • Various embodiments of the present invention address these issues by sensing a result of stimulating a nerve (either a nerve action potential along the nerve at a short distance from the stimulation, or some other result such as a muscle twitch, or the like, caused by the nerve stimulation; still other embodiments directly stimulate a non-nerve tissue such as a muscle and sense that result), and then enabling the surgical operation (if it is desired to remove the tissue that reacted to the stimulation) or suppressing the surgical operation (if it is desired to preserve the tissue that reacted to the stimulation).
  • the present invention provides an optical-electrical mechanism to stop the surgical laser pulses and/or reduce their power when the stimulation laser(s) and nerve sensor(s) detect a nerve, in order to preserve the nerve (if possible) while still removing other tissue as needed.
  • the surgery is performed by a mechanical scalpel (e.g., one that is robotically assisted or controlled, and the optical nerve stimulation and sensing is used to control movement and/or cutting of the mechanical scalpel to prevent or minimize nerve damage.
  • a local anesthetic and/or analgesic 404 can be administered “upstream” (e.g., between the surgical site and the brain) along a sensory nerve to prevent pain and discomfort during the operation, while the nerve stimulation and sensing of the present invention is still functional to locate and preserve the nerve at the site of the operation.
  • the nerve simulation and sensing and the control of the optical scalpel is performed in “real time” in that the surgeon activates the cutting function and the stimulation/sensing functions, and manually moves the optical scalpel along a line, with a visible pointer laser indicating the location of where both stimulation and cutting would occur.
  • the sensing apparatus e.g., a hook probe attached along the nerve
  • the stimulation and sensing functions are used alone to determine a suitable location (e.g., perhaps at the junction of the ophthalmic, maxillary and mandibular branches of the trigeminal sensory nerve of the face) on the patient for placing each of one or more sensing probes. After the sensing probes are in place, the cutting function can be activated, and the sensing of nerve response would inhibit the cutting function to protect the sensed nerve. In some embodiments, a combination of “upstream” sensing-nerve sensors and “downstream” motor-nerve sensors are used to protect both types of nerves within the surgical area. In some embodiments, one or more stimulation pulses are alternated with one or more cutting pulses, such that the stimulation and sensing is done immediately before cutting is attempted, and if a nerve response is sensed, the cutting operation is suppressed.
  • a suitable location e.g., perhaps at the junction of the ophthalmic, maxillary and mandibular branches of the trigeminal sensory nerve of the face
  • the cutting function
  • “suppressed” includes both “inhibited” (meaning substantially stopped altogether) and “reduced” (meaning that the depth and/or lateral extent is reduced but not entirely inhibited).
  • the response is either all (an action potential is triggered since the stimulation reached a threshold) or nothing (either no stimulation or a failed initiation where threshold is not reached and no action potential is propagated), while if an entire nerve bundle is stimulated, the signal strength can vary between a weak signal and a strong signal depending on the number of neurons that reached threshold.
  • any sensed reaction to nerve stimulation will inhibit or very strongly reduce the cutting depth (and/or lateral extent).
  • a strong sensed reaction to nerve stimulation will inhibit or strongly reduce the cutting depth (and/or lateral extent of the tissue removal), while weaker sensed reaction to nerve stimulation will reduce the cutting depth based on the strength of the sensed signal, providing a variable cutting based on how far from the nerve the cutting will occur or how large is the nerve bundle (e.g., sometimes allowing cutting or damage to small nerves while preventing damage to larger nerves).
  • the surgical area is defined by a mask or marked boundary outside of which the cutting function is inhibited.
  • the area to be treated is delineated by a marked line or shading (e.g., ink or a fluorescent dye) that indicates where cutting is permitted, and only when the visible pointer beam is projected on the allowed area is the cutting beam activated, but when the pointer is outside the allowed area, the cutting is inhibited.
  • a marked line or shading e.g., ink or a fluorescent dye
  • these functions are temporally separated, such that the sensing function is used first to create a map of the nerve locations, and later the inhibition functions are controlled by that map.
  • the optical stimulation and the sensing are used to locate points along the various nerves within the planned surgical area.
  • these nerves are delineated by marked lines or shading (e.g., ink or a fluorescent dye) that indicate where cutting is or is not permitted.
  • one or more video cameras are connected to a computer and used to provide the location of the pointer laser when a response is sensed, and these locations are recorded into the computer's memory (e.g., optionally using fiducial marks or facial features as references for the map), and a computer-generated light map defining the nerve locations is projected (e.g., by a computer-projector display) onto the patient's tissue (e.g., the face).
  • This map is then used to guide the cutting operation, both showing the surgeon where the nerves are located and/or as cut-inhibiting references that are sensed by the computer's video camera(s) such that when the pointer laser is on or next to a previously located nerve (as indicated by the proximity of the laser-pointer light to the projected nerve location), the cutting function is inhibited.
  • FIG. 4A is a block diagram of surgery-inhibiting nerve-stimulation system 400 A.
  • system 400 A stimulates a tissue of patient 88 using an optical signal 401 focussed to a suitably small tissue area and a suitable tissue depth. If a sensory nerve 87 (and/or a motor nerve) is stimulated by the optical stimulation signal 401 (e.g., a laser signal pulse having an IR wavelength of about 1 .
  • the optical stimulation signal 401 e.g., a laser signal pulse having an IR wavelength of about 1 .
  • an action potential e.g., a CNAP
  • nerve stimulation is sensed (e.g., by the nerve's electrical signal sensed by a needle-sized hook probe or other suitable probe along the stimulated nerve a short distance away (e.g., towards the brain if the nerve is a sensory nerve, or towards the muscle if the nerve is a motor nerve), or by a mechanical sensor such as a small piezo sensor or strain gauge that outputs an electrical signal if the muscle twitches due to the nerve being stimulated) and if sense signal 402 indicates the nerve was stimulated, then surgical or therapeutic operation 403 is suppressed (inhibited or sufficiently reduced) to avoid damaging the stimulated nerve 87 .
  • an action potential e.g., a CNAP
  • the stimulation signal is formed and/or focussed onto the patient's tissue to a stimulation spot diameter of 0.1 mm or smaller to a spot diameter of 2 mm or larger, although various embodiments use spot diameters of about 0.1 mm, about 0.2 mm, about 0.3 mm, about 0.4 mm, about 0.5 mm, about 0.6 mm, about 0.7 mm, about 0.8 mm, about 0.9 mm, about 1.0 mm, about 1.1 mm, about 1.2 mm, about 1.3 mm, about 1.4 mm, about 1.5 mm, about 1.6 mm, about 1.7 mm, about 1.8 mm, about 1.9 mm, about 2.0 mm, about 2.2 mm, about 2.4 mm, about 2.6 mm, about 2.8 mm, about 3.0 mm, about 3.2 mm, about 3.4 mm, about 3.6 mm, about 3.8 mm, about 4.0 mm, about 4.2 mm, about 4.4 mm, about 5.6 mm, about
  • system 400 A includes a stimulation unit 410 that outputs an optical signal that is effective at stimulating a nerve 87 of patient 88 .
  • stimulation unit 410 includes block 412 (e.g., a trigger such as 108 A of FIG. 1A described above) that activates an optical stimulation source, block 414 (e.g., an IR laser diode such as device 151 of FIG. 1A described above) that generates an optical stimulation signal, and unit 416 (such as an optical fiber and/or lens system that directs and/or focuses optical signal 401 onto a particular location with desired characteristics (such as size, power, shape, and the like) to stimulate nerve 87 ).
  • block 412 e.g., a trigger such as 108 A of FIG. 1A described above
  • block 414 e.g., an IR laser diode such as device 151 of FIG. 1A described above
  • unit 416 such as an optical fiber and/or lens system that directs and/or focuses optical signal 401 onto a particular location with desired
  • a suitable probe (such as a needle hook adapted to attach to an empirically determined location on nerve 87 to detect whether an action potential has been triggered) generates a relatively small signal that is amplified and/or conditioned by block 422 (e.g., a sensitive low-current differential operational amplifier circuit) and block 424 (e.g., an analog and/or digital logic circuit that examines the output signal from block 422 in relationship to the stimulation trigger from block 412 to determine whether to reduce or inhibit the surgical signal and/or by how much to reduce the cutting signal) that generates control signal 425 .
  • control signal 425 controls one or more aspects of block 430 , which is what generates and/or controls the surgical optical pulses 403 .
  • stimulation optical signals 401 and/or surgical optical signals 403 also include a visible pointer signal to show the user where the stimulation and/or surgery is taking or is soon to be taking place, and optionally the stimulation signal, the visible pointer, and the cutting optical signal are all generated from a single unit (e.g., an optical unit such as unit 111 of FIG. 1D ) and/or are all combined and delivered through a single output lens and/or optical fiber.
  • a visible pointer signal to show the user where the stimulation and/or surgery is taking or is soon to be taking place
  • the stimulation signal, the visible pointer, and the cutting optical signal are all generated from a single unit (e.g., an optical unit such as unit 111 of FIG. 1D ) and/or are all combined and delivered through a single output lens and/or optical fiber.
  • block 430 is implemented as a separate laser and controller (e.g., such as a LASIK opthalmic surgical optical source (Laser-Assisted In Situ Keratomileusis, using an excimer laser)) whose output is controlled and/or inhibited by control signal 425 , and delivered by an optical fiber or combined into a single optical fiber with the stimulation signal 401 for delivery and placement onto the surgical site on patient 88 .
  • a separate laser and controller e.g., such as a LASIK opthalmic surgical optical source (Laser-Assisted In Situ Keratomileusis, using an excimer laser)
  • a single hand-held self-powered (e.g., via internal batteries or other power source 150 , as shown in the figures above) stimulation and surgical laser handpiece is implemented and the cutting operation is controlled and/or inhibited by control signal 425 generated by an integrated or by a separate sensing and inhibition unit 420 (e.g., in some embodiments, system 400 A is implemented and contained in a single handpiece such as 140 E of FIG. 1E described above).
  • sensing, inhibition and/or control functions of sensing and inhibition unit 420 are used in combination with or integrated into any of the nerve-simulation systems described herein or described in U.S. patent application Ser. No. 11/420,729 filed on May 26, 2006 entitled “APPARATUS AND METHOD FOR OPTICAL STIMULATION OF NERVES AND OTHER ANIMAL TISSUE” (which is incorporated herein by reference).
  • FIG. 4B is a block diagram of surgery-inhibiting optical-signal nerve-stimulation system 400 B.
  • the sensing, inhibition and/or control functions of sensing and inhibition unit 420 are used in combination with or integrated into a conventional electrical nerve stimulation unit 460 such as a conventional electrical-based electromyography (EMG) machine as is commonly used for nerve-conduction studies.
  • EMG electromyography
  • block 462 e.g., a trigger corresponding to block 412 of FIG. 4A described above
  • block 464 e.g., corresponding to block 414 of FIG.
  • unit 466 such as a wire or needle along a side of the optical fiber, or an electrical conductor or sheath on the optical fiber that directs and/or focuses optical signal 403 onto a particular location with desired electrical characteristics (such as voltage, current, temporal shape, and the like) to stimulate nerve 87 ), wherein an electrical signal 406 is delivered by the electrical conductor (e.g., wire) to stimulate tissue next to the delivery end of the optical fiber that delivers optical surgical laser pulses 403 , and the sensing and inhibition unit 420 , when a nerve signal is sensed (a nerve signal initiated by electrical stimulation from the needle above), inhibits or reduces the power to the optical pulses 403 used for cutting/ablation.
  • a nerve signal e.g., nerve signal initiated by electrical stimulation from the needle above
  • FIG. 4C is a block diagram of surgery-inhibiting optical-signal nerve-stimulation system 400 C.
  • system 400 C is the same as system 400 A of FIG. 4A described above, but with the addition of a camera and projector mapping system 440 that detects the locations of one or more nerves, optionally projects a map of the located nerves, and suppresses output from the cutting laser when in the vicinity of the detected and mapped nerves.
  • camera and projector mapping system 440 includes a camera 442 that gathers light 441 from the patient 88 and forms a digital image 443 .
  • fiducial marks 84 are placed on the patient 88 and are detected on digital image 443 by image processor 444 (e.g., a combination of hardware and software, in some embodiments).
  • image processor 444 e.g., a combination of hardware and software, in some embodiments.
  • the location 85 of the visible pointer laser (part of signal 401 ) from optical pointer/optical stimulation unit 410 is also located by image processor 444 from image 443 .
  • a map 445 of the location(s) of nerve(s) on the patient is generated by image processor 444 .
  • map 445 is also projected onto patient 88 as a projected pattern 447 from projector 446 that is visible as projected map 448 of the one or more nerves.
  • the map that results can be used a short time later (e.g., a matter of seconds or minutes later, or even hours later) in combination with the detected location cutting signal 403 (either by camera 442 being sensitive to the wavelength of the cutting signal 403 , or by including a visible laser signal that is coincident with cutting signal 403 and which is thus detectable by camera 442 ) to activate the inhibiting/control circuit 426 (similar in output to circuit 424 described above for FIG. 4A ), which then suppresses the cutting portion of signal 403 .
  • System 400 C can be used to map the location of the nerves at a speed compatible with the nerve reaction and conduction times, and the map 445 can then be used to suppress (inhibit or reduce, as desired) the cutting beam. Note that in some embodiments, the map 445 need not be projected onto the patient (i.e., projector 446 can be omitted), but its data on the nerve locations can still be used to inhibit cutting in the locations of the mapped nerves.
  • FIG. 4D is a block diagram of surgery-inhibiting nerve-stimulation system 400 D.
  • System 400 D is similar to system 400 A described above for FIG. 4A , except that the handheld self-contained stimulation unit 140 B (such as unit 140 B of FIG. 1B described above) is physically separate from handheld self-contained surgical unit 480 B (similar to unit 140 B of FIG. 1B described above, except that a surgical-ablation laser (one that outputs femtosecond-type pulses capable of ablating very small pieces of tissue) replaces the stimulation laser).
  • a wireless transceiver-controller 109 B e.g., part of a unit such as unit 141 of FIG.
  • the differential sensing amplifiers (op amps) 422 detect a nerve-action-potential caused reaction (e.g., a nerve twitch sensed by skin-mounted motion sensors (as are well known in the art) or galvanic skin response sensors (e.g., such as are used in polygraph truth detectors, also well known in the art)), the resulting signal to response-sensing, surgery-inhibiting logic 424 sends a control signal 425 to wireless transceiver-controller 409 B, which transmits an inhibit signal via its wireless linkage to handpiece 480 B, and the cutting signal is reduced and/or inhibited based on the sensed signal.
  • a nerve-action-potential caused reaction e.g., a nerve twitch sensed by skin-mounted motion sensors (as are well known in the art) or galvanic skin response sensors (e.g., such as are used in polygraph truth detectors, also well known in the art)
  • both handpieces 140 B and 480 B are combined into a single handpiece having a combination of some or all of the above- described functions.
  • the wireless transceiver-controller 409 B and/or wireless transceiver-controller 109 B also have trigger signal inputs so a user can use a remote control (such as one or more foot-activated switches to activate their respective functions.
  • FIG. 5A is a perspective cut-away diagram of a surgery-inhibiting nerve-stimulation system 500 at the initiation of a surgical procedure.
  • hand-held laser stimulation/surgical device 540 includes a plurality of light-emitting functions including emitting an optical nerve-stimulation signal, a visible optical pointer signal, and/or an optical surgical ablation signal, and also includes a surgical suppression function as described above for FIGS. 4A-4D .
  • hand-held laser stimulation/surgical device 540 is scanned back and forth (e.g., in a raster pattern) and projects optical stimulation light onto the skin of patient 88 , with any nerve- reaction signal (i.e., as a result of the optical stimulation) that is detected sending a signal along wire 402 to inhibit the surgical function of stimulation/surgical device 540 . If no nerve-reaction signal is detected, the surgical function of laser stimulation/surgical device 540 is activated, with a resulting surgical operation being performed (e.g., ablation of the thin layer of tissue that has been stimulated with no ensuing nerve-reaction signal being detected).
  • the nerve-stimulation signal is one or more pulses that are projected, and if no suppression signal is generated, one or more ablation light-signal pulses are emitted, and the process of this sentence is iteratively repeated as the handpiece is moved across the tissue surface.
  • the stimulation function of laser stimulation/surgical device 540 penetrates about 0.6 mm, and is not sufficiently intense to stimulate nerve 87 that lies below that depth in patient 88 's tissue.
  • laser stimulation/surgical device 540 is configured to be moved back and forth across patient 88 's skin manually. In other embodiments, laser stimulation/surgical device 540 is moved back and forth across patient 88 's skin automatically (e.g., being controlled by a programmed computer-control system).
  • the surgeon marks the patient's skin (e.g., with a pen line 544 on the patient's skin or with white tape that masks the area outside line 544 , or the like) to delineate the area where surgery is allowed, and surgery-area boundary marking 544 is used as a predetermined boundary marking that limits the travel excursion of laser stimulation/surgical device 540 (or inhibits its surgical light output) in computer-controlled embodiments.
  • Surgery-area boundary marking 544 may also be a predetermined boundary marking that serves as a guide to limit the manual travel excursion of laser stimulation/surgical device 540 (or inhibits its surgical light output) in manually controlled embodiments.
  • FIG. 5B is a diagram of a first stimulation/surgical pattern 542 at an operation site sight at which a surgery-inhibiting nerve-stimulation system is employed, at a first time subsequent to the initiation of a surgical procedure.
  • Laser stimulation/surgical device 540 passes back and forth across patient 88 's skin, along pattern 542 that is limited by surgery-boundary marking 544 .
  • the surgical light output from handpiece 540 ablates to a small depth on each pass, and deeper tissue removal is accomplished by repeated passes. Since no nerve stimulation was detected in this embodiment so far (since the nerves are located deeper than the stimulation penetration), the cutting/tissue ablation signal is not inhibited (note the continuous dark lines for pattern 542 ), and a uniform tissue removal is accomplished within boundary 544 .
  • FIG. 5C is a diagram of a surgical sight at which a surgery-inhibiting nerve-stimulation system is employed, at a time when the stimulation/surgical pattern shown in FIG. 5B has been completed. Tissue has been surgically removed by laser stimulation/surgical device 540 to a shallow depth 546 and to lateral boundary 544 .
  • FIG. 5D is a diagram of a second stimulation/surgical pattern at an operation site sight at which a surgery-inhibiting nerve-stimulation system is employed, at a second, later time subsequent to the initiation of a surgical procedure, and showing the surgical site at a time when the second stimulation/surgical pattern has been completed.
  • Manual or computer-controlled passing of laser stimulation/surgical device 540 across patient 88 's body within boundary 544 ablates-away further tissue to a depth 547 where no nerve has been stimulated.
  • the stimulation function of laser stimulation/surgical device 540 has resulted in stimulation of a nerve and a nerve reaction has been detected (e.g., by hook probe 402 , in some embodiments) as the stimulation signal hits and triggers a nerve response with a resulting action-potential signal being detected and directed along wire 402 (see FIG. 5A )
  • the surgical function of laser stimulation/surgical device 540 is suppressed (note the light dotted lines above the nerves where ablation is suppressed, but the dark lines in other areas where ablation is not suppressed), resulting in non-ablation of nerve 87 ; the top of non-ablated nerve 87 is at depth 541 .
  • FIG. 5E is a diagram of a third stimulation/surgical pattern at an operation site sight at which a surgery-inhibiting nerve-stimulation system is employed, at a third, later time subsequent to initiation of a surgical procedure, and showing the surgical site at a time when the third stimulation/surgical pattern has been completed.
  • nerve 87 is again not ablated by laser stimulation/ surgical device 540 —the nerve having been stimulated by the stimulation function, with a signal resulting from detection of a nerve reaction passing up wire 402 and inhibiting the surgical function.
  • the top of non-ablated nerve 87 remains at depth 541 .
  • FIG. 5F is a diagram of an operation site sight at which a surgery-inhibiting nerve-stimulation system is employed, when the operation has been completed.
  • Non-nerve tissue has been ablated or otherwise surgically removed to a depth 549 within boundary 544 .
  • nerve 87 has not been ablated by laser stimulation/surgical device 540 —the nerve having been stimulated by the stimulation function, with a signal resulting from detection of a nerve reaction passing up wire 402 and inhibiting the surgical function.
  • the top of non-ablated nerve 87 remains at depth 541 . In this way, unwanted tissue (e.g., a tumor) can be removed while preserving at least some of the nerves passing through the surgical site.
  • unwanted tissue e.g., a tumor
  • an imaging optics turret (such as described in U.S. patent application Ser. No. 11/420,729 filed on May 26, 2006 entitled “APPARATUS AND METHOD FOR OPTICAL STIMULATION OF NERVES AND OTHER ANIMAL TISSUE” which is incorporated herein by reference) is provided at the operative end of handpiece 140 (with any letter suffix following the “140”) of the present invention, such that different optical patterns, spot sizes, and/or focal lengths can be provided by selecting one of a plurality of different lenses or holographic imagers (e.g., a turret that can be rotated to select one imaging optical element of the plurality of imaging optics).
  • a zoom-type lens is provided such that spot size and/or shape and focal length can be independently changed.
  • a plurality of manually or foot-activateable trigger buttons and corresponding wireless connections, mechanical linkages, electrical connections, or other connectivities are provided to select and/or activate one or more of a plurality of different functions of the handpiece, as described below.
  • a voice-activated switch or other activation means is used instead of or in addition to manually activated or foot-activated buttons.
  • the mechanical linkage(s) and trigger(s) are omitted and replaced with a non-magnetic optical-fiber-connected controller-selector that is manually operable to select and/or activate one or more functions.
  • a foot-operated control is used instead.
  • buttons are provided: a first button that when pushed a first time starts a series of one or more optical pulses, which series of one or more optical pulses optionally can automatically stop after a period of time determined by the function selected, or optionally can stop only after the user presses this first button a second time; a second button that, when pressed, advances a function-selecting state machine to the next one of a plurality of different optical-stimulation functions (e.g., no stimulation function is selected, or selecting the duration, intensity, pulse rate, pulse shape, pulse-train shape or pattern, and/or wavelength(s), and the like, for the IR stimulation light), wherein these functions are activated and/or deactivated by pressing the first button; and a third button that, when pressed, advances a state machine to the next one of a plurality of different optical-surgery functions (e.g., no surgical function is selected,
  • a single actuation/control button 108 is used both to select a stimulation function (e.g., by successive single long-duration presses of button 108 to select different functions as shown, e.g., in FIG. 1F ) and to control triggering or timing of the stimulation light (e.g., by a quick double-click of button 108 ).
  • the color of the visible light being sent down the optical fiber changes to a different color (e.g., hue, saturation, and/or intensity) and/or pulse (brightness pulsations) pattern, wherein the visible light color and/or pulsing of the light intensity is indicative of the function selected, thus providing instant feedback to the user concerning which function is currently active.
  • a steady light of one of a plurality of different colors indicates that a stimulation function has been selected, wherein the color indicates which of the stimulation functions has been selected; whereas a quickly pulsating light of one of a plurality of different colors (also different than the stimulation-indicating colors) indicates that a surgery function has been selected, wherein the color of the pulsing light indicates which of the surgery functions has been selected.
  • audio feedback is also provided as the selection buttons cycle through the menus of functions available (such as a synthesized or recorded voice or a set of distinctive tones that announces which function has been selected).
  • handpiece 140 is controlled using a manually controlled selector implementing a finger or thumb control (such as described in copending U.S. patent application Ser. No. 11/420,729 (Attorney Docket 5032.009US1) filed on May 26, 2006 entitled “APPARATUS AND METHOD FOR OPTICAL STIMULATION OF NERVES AND OTHER ANIMAL TISSUE”, incorporated herein by reference) for local mechanical control of the stimulation light.
  • a shutter is operated by button (in other embodiments, a user-controlled variable iris is provided instead of or in addition to shutter).
  • a turret having a plurality of different lenses e.g., having different focal lengths, spot sizes, and/or cylinder/astigmatism (to focus to a long narrow spot or line on the nerve), neutral-density filters, holographic imagers or other optics
  • a turret having a plurality of different lenses e.g., having different focal lengths, spot sizes, and/or cylinder/astigmatism (to focus to a long narrow spot or line on the nerve), neutral-density filters, holographic imagers or other optics
  • a thin transparent membrane such as plastic surgical tape or sterilized Saran WrapTM
  • a thin transparent membrane is placed over and/or in contact with the nerve to keep it from drying out (again, drying can cause tissue dama ge and changes the reflectivity to the stimulation light signal).
  • Some embodiments of the invention use a method of stimulating and/or treating nerves that includes covering the nerve with a transparent material (which is either flexible membrane or rigid substrate, or a combination of the two, depending on the embodiment), and delivering an efficacious amount of light through the transparent material.
  • the transparent material is configured to prevent drying.
  • the transparent material is configured to ensure a proper focus of the light.
  • the material is partially transparent, in order to reduce the intensity of the delivered light signal by a predetermined amount. In other embodiments, the material is substantially fully transparent, in order to deliver a maximum amount of light.
  • the pattern and speed of scanning is predetermined by a computer program, while in other embodiments the pattern is manually controlled by operator 89 .
  • the computer program controls the emission of stimulation laser light in some type of spatial and/or temporal pattern based upon an algorithm (e.g., a programmed binary search, sequential search, or the like) so as to determine which stimulation area delivered an efficacious dose of IR light to the nerve of interest.
  • the actual reaction or response of nerve tissue to IR-light stimulation would, in some embodiments, be determined through empirical observation (muscle twitches), subject reporting (of a touch sensation, taste sensation, or other sensation).
  • the user changes the position and/or function (e.g., changing the pulse length or intensity) of the handpiece based on the response.
  • the response is detected by the stimulation system, and the function of the stimulation system automatically adjusts the stimulation based on the response feedback (e.g., in some embodiments, a stimulation signal is repeated until the response is detected, and then the stimulation stops and/or an audio or visual indication of the response is output by the stimulation system).
  • the manipulation of the array head itself is facilitated, in, at least one embodiment, through the use of an ergonomically designed handle, which is covered by a replaceable, disposable, sterile sheath, and by the feedback to the user provided by having visible light delivered to the area that would be stimulated by the IR stimulation signal and/or the other audio and/or visual indications.
  • a high-power laser is also coupled to the optical fiber (or carried in its own separate fiber), in order to provide a capability for cutting or ablating tissue (e.g., nerve or brain tissue that has been located and identified by the light stimulation signals).
  • tissue e.g., nerve or brain tissue that has been located and identified by the light stimulation signals.
  • This allows the surgeon to stimulate a brain area (or other nerve tissue) to more precisely locate specific regions that are to be saved versus other areas that are to be cut, cauterized or ablated.
  • a surgeon wanting to excise a tumor or an epileptic focus can better locate and identify, e.g., borders of a lesion and surrounding functional portions of the brain using the optical-fiber-delivered optical stimulation according to the present invention, and then use the optical-fiber-delivered cutting or ablating function.
  • the “launch end” on an optical fiber is not limited to just the fiber's first end, but can also be the point or length along the fiber to which light from a source (such as a laser diode) is coupled to insert the light into the fiber, and the “delivery end” is not limited to just the fiber's second end, but can also be the point or length along the fiber from which light from the fiber is ejected to illuminate and/or stimulate a nerve or neural tissue.
  • action potentials are all-or-none, binary occurrences and therefore are not reinforceable—once an action potential is triggered, it goes to the end of the axon and causes neurotransmitter release into the synaptic cleft. However, if a nerve is cut or damaged by disease, it may be desirable to start an action potential and then restart the action potential beyond the damaged area.
  • a set of machine control instructions (programmable control code to adjust, time, or otherwise control pulse shape, timing, intensity, and the like) is stored on computer-readable medium (for example, a compact FLASH memory fob, diskette, CDROM, or network connection (e.g., the internet)), which is connectable to control one or more operations or functions of the light-emitting-source controller.
  • computer-readable medium for example, a compact FLASH memory fob, diskette, CDROM, or network connection (e.g., the internet)
  • one or more of the items labeled herein as “plastic” are implemented using some other non-magnetic material such as ceramic or structured carbon nanotubes, or the like.
  • one or more of the items labeled herein as “laser diodes” are implemented instead as light-emitting diodes (LEDs) or as optically-pumped solid-state optical amplifiers (e.g., semiconductor laser-like devices that are pumped optically).
  • a kit containing various components is included, this kit containing a first light-emitting source, a second light-emitting source, a light-beam combiner, a mechanical linkage with a trigger mechanism a light-emitting-source controller, and a disposable sheath. Also contained in this kit are the various materials needed to assemble the apparatus.
  • a single pulse of light is emitted based on a manual user input (such as the press of a button or the rolling of a wheel) that is coupled mechanically, electrically or optically to the light-emitting-source controller (e.g., a unit that applies electrical power to a laser diode).
  • a manual user input such as the press of a button or the rolling of a wheel
  • the light-emitting-source controller e.g., a unit that applies electrical power to a laser diode
  • a pulse train of light is emitted based on a manual user input (such as the press of a button or the rolling of a wheel) that is coupled mechanically, electrically or optically to the light-emitting-source controller (e.g., a unit that applies electrical power to a laser diode).
  • a manual user input such as the press of a button or the rolling of a wheel
  • the light-emitting-source controller e.g., a unit that applies electrical power to a laser diode
  • a shaped, non-square pulse of light is emitted based on a manual user input (such as the press of a button or the rolling of a wheel) that is coupled mechanically, electrically or optically to the light-emitting-source controller (e.g., a unit that applies electrical power to a laser diode).
  • a manual user input such as the press of a button or the rolling of a wheel
  • the light-emitting-source controller e.g., a unit that applies electrical power to a laser diode
  • a shaped pulse train of light is emitted based on a manual user input (such as the press of a button or the rolling of a wheel) that is coupled mechanically, electrically or optically to the light-emitting-source controller (e.g., a unit that applies electrical power to a laser diode).
  • a manual user input such as the press of a button or the rolling of a wheel
  • the light-emitting-source controller e.g., a unit that applies electrical power to a laser diode
  • Some embodiments of the present invention include an implantable apparatus that has an optical-light stimulator operable to generate a light signal that will stimulate a nerve, a first optical fiber operatively coupled to receive light from the stimulator and deliver the light to the nerve, a power source operatively coupled to power the stimulator, and a receiver configured to receive programming commands from a wireless remote programmer, in order to selectively control operation of the stimulator based on a set of data that was wirelessly received.
  • the apparatus is configured to be implanted in the body of a mammal.
  • the power source is a battery.
  • the stimulator further includes an RF recharger operable to receive RF energy and recharge the battery.
  • the stimulator further includes a first light-emitting source and a second light-emitting source operatively coupled to be controlled by the stimulator.
  • the stimulator further includes an optical combiner operatively coupled to combine light from the first light-emitting source and the second light-emitting source into an optical fiber.
  • Some embodiments of the present invention include a method that includes charging a battery using RF energy, powering a controller from the battery, remotely programming the controller, selectively emitting light from a first light source under control of the controller, selectively emitting light from a second light source under control of the controller, combining the light from the first and second light sources, and transmitting the combined light to a nerve.
  • the selectively emitting light from the first light source includes emitting IR laser light from a laser diode. In some embodiments, the selectively emitting light from the second light source includes emitting visible light.
  • kits that includes a first light-emitting source, a second light-emitting source, a light-beam combiner, a mechanical linkage with a trigger mechanism a light-emitting-source controller, and a disposable sheath.
  • Some embodiments of the present invention include an apparatus that includes an optical fiber, an optical-fiber holder operable to optically couple the optical fiber to a nerve, and an optical sensor operable to distinguish nerve tissue from other tissue based on a sensed optical color.
  • Some embodiments further include one or more additional optical fibers, wherein an illumination light is delivered to the nerve tissue using one or more of the plurality of optical fibers and the sensed optical color is sensed through one or more of the optical fibers.
  • Some embodiments of the present invention include a method that includes generating light from a first laser-diode device, the light having a wavelength between about 1.8 microns and about 2.2 microns, and stimulating a nerve with the light.
  • the light from the first laser-diode device is in a range of between about 1.80 microns and about 1.85 microns, or in a range of between about 1.81 microns and about 1.86 microns, or in a range of between about 1.82 microns and about 1.87 microns, or in a range of between about 1.83 microns and about 1.88 microns, or in a range of between about 1.84 microns and about 1.89 microns, or in a range of between about 1.85 microns and about 1.90 microns, or in a range of between about 1.86 microns and about 1.91 microns, or in a range of between about 1.87 microns and about 1.92 microns, or in a range of between about 1.88 micron
  • Some embodiments of the method further include conveying the light from the laser-diode device to the nerve using an optical fiber.
  • the laser-diode device includes a plurality of emitters, and the method further includes combining the light from at least two of the plurality of emitters into the optical fiber.
  • Some embodiments of the method further include affixing the optical fiber to a frame fixed in positional relationship relative to a patient. Some embodiments of the method further include remotely controlling a positioning of the light relative to the nerve.
  • Some embodiments of the present invention include an apparatus that includes a first disposable sheath that includes a first optical system configured to focus light into a first predetermined pattern that is efficacious to optically stimulate a nerve.
  • kits that further includes a second disposable sheath that includes a second optical system configured to focus light into a second predetermined pattern, different than the first, which is efficacious to optically stimulate a nerve.
  • Some embodiments of the present invention include an apparatus that includes a first light-emitting source operative to emit an optical signal at a first wavelength that is capable of directly stimulating a nerve of a patient; an optical-fiber structure having a first end and a second end; a light-beam coupler that is configured to direct light from the first light-emitting source into the first end of the optical-fiber structure; a light-emitting-source controller operatively coupled to the first light-emitting source and the second light-emitting source to selectively control light output thereof; and a light-delivery unit operatively coupled to the second end of the optical-fiber structure, wherein the light-delivery unit, the optical-fiber structure or both the light-delivery unit and the optical-fiber structure are configured to direct the optical signal onto neural tissue.
  • the first light-emitting source emits infrared (IR) light from a laser diode.
  • IR infrared
  • Some embodiments further include a second light-emitting source operative to emit an optical signal at a second wavelength that is capable of directly stimulating a nerve, wherein the second wavelength is different than the first wavelength and has a different penetration depth into a given tissue, and wherein light at the first wavelength is applied to achieve a first tissue-penetration depth, and light at the second wavelength is applied to achieve a second tissue-penetration depth.
  • a second light-emitting source operative to emit an optical signal at a second wavelength that is capable of directly stimulating a nerve, wherein the second wavelength is different than the first wavelength and has a different penetration depth into a given tissue, and wherein light at the first wavelength is applied to achieve a first tissue-penetration depth, and light at the second wavelength is applied to achieve a second tissue-penetration depth.
  • Some embodiments further include a second light-emitting source operative to emit an optical signal at a second wavelength that is capable of directly stimulating a nerve, wherein the second wavelength is different than the first wavelength and has a different penetration depth into a given tissue, and variable amounts of the first and second different wavelengths are applied simultaneously to achieve a tissue-penetration depth that is variable based on the intensities of the first and second wavelengths of light.
  • the light-delivery unit includes a handpiece configured to be held by hand during delivery of the nerve stimulation, and the apparatus further includes a disposable sheath configured to cover at least a portion of the handpiece to provide a sterile covering.
  • Some embodiments further include a user-operable control mechanism operatively coupled to the controller to control a function of the controller, the control mechanism being configured to be operated in conjunction with the handpiece.
  • the user-operable control mechanism is mounted on the handpiece, and configured to be hand operated by a user.
  • the user-operable control mechanism is mechanically linked to the light-emitting-source controller.
  • Some embodiments of the present invention include a method that includes obtaining, from a first laser diode, a first laser beam having a first wavelength that is capable of directly stimulating neural tissue; transmitting the first laser beam in an optical-fiber structure; imaging the first laser beam from the optical-fiber structure onto a location on the neural tissue for stimulation of the neural tissue; and obtaining user input and based on the user input, controlling the first laser beam.
  • the first laser beam has an infrared (IR) wavelength.
  • Some embodiments of the method further include obtaining a second laser beam having a second wavelength that is capable of directly stimulating a nerve, wherein the second wavelength is different than the first wavelength and has a different penetration depth into a given tissue; transmitting the second laser beam in the optical-fiber structure; applying light at the first wavelength to achieve a first tissue-penetration depth; and applying light at the second wavelength to achieve a second tissue-penetration depth.
  • Some embodiments further include obtaining a second laser beam having a second wavelength that is capable of directly stimulating a nerve, wherein the second wavelength is different than the first wavelength and has a different penetration depth into a given tissue; transmitting the second laser beam in the optical-fiber structure; and applying variable amounts of the first and second different wavelengths simultaneously to achieve a tissue-penetration depth that is variable based on the intensities of the first and second wavelengths of light.
  • Some embodiments further include obtaining a third light beam having a visible-light wavelength; transmitting the third light beam in the optical-fiber structure; and imaging the third light beam from the optical-fiber structure as an indication of where the first laser beam is directed.
  • Some embodiments further include providing a handpiece for manually directing the location of the imaged stimulation light; and covering at least a portion of the handpiece with a sterile cover.
  • the obtaining user input includes coupling a control mechanism to a laser controller to control a function of the controller, wherein the control mechanism is configured to be operated in conjunction with the handpiece.
  • control mechanism is mounted on the handpiece, and the obtaining user input includes coupling a manual operation of the control mechanism by a user to control the first laser beam.
  • Some embodiments further include providing a handpiece for manually directing the location of the imaged stimulation light, wherein the obtaining user input includes coupling a user-operated control mechanism to a laser controller to control a function of the controller, wherein the control mechanism is separate from the handpiece and is configured to be operated such that operation of the control mechanism is independent of movement of the handpiece.
  • Some embodiments further include providing a light-delivery unit for directing the location of the imaged stimulation light, wherein the light-delivery unit includes a frame configured to be affixed to the patient, and a moveable light-delivery head connected to the frame; and positioning the light-delivery head to deliver light to one of a plurality of locations on the patient.
  • the light-delivery unit includes a frame configured to be affixed to the patient, and a moveable light-delivery head connected to the frame; and positioning the light-delivery head to deliver light to one of a plurality of locations on the patient.
  • Some embodiments of the present invention include an apparatus that includes means for generating a first laser beam having a first wavelength that is capable of directly stimulating neural tissue of a patient, wherein light of the first wavelength has a first tissue-penetration profile; means for transmitting the first laser beam; means for imaging the transmitted first laser beam onto a location on the neural tissue for stimulation of the neural tissue; and means for obtaining user input and based on the user input, controlling the first laser beam.
  • the means for generating the first laser beam includes a laser diode and means for controlling electrical power to the laser diode to control timing and intensity of the first laser beam.
  • Some embodiments further include means for visibly indicating a location on the patient at which nerve stimulation is to be obtained by application of the first laser beam.
  • Some embodiments further include means for generating a second laser beam having a second wavelength that is capable of directly stimulating neural tissue of a patient, wherein light of the second wavelength has a second tissue-penetration profile different than the first tissue-penetration profile, and wherein the means for generating the second laser beam is optically coupled to the means for imaging.
  • Some embodiments further include means for generating a third laser beam that is capable of optically cutting tissue, wherein the means for generating the third laser beam is optically coupled to the means for imaging.
  • the apparatus is made of materials compatible with use within a magnetic field of an operating magnetic resonance machine.
  • Some embodiments further include the optical fiber.
  • Some embodiments include combinations of elements from different ones of the above-described Figures and specifications.
  • Some embodiments of the invention include a computer-readable medium that has instructions stored thereon for causing a suitably programmed information processor to perform methods that include one or more of the functions or subfunctions described herein.
  • Some embodiments of the present invention include an apparatus that includes a first light-emitting source operative to emit an optical signal at a first wavelength that is capable of directly stimulating muscle tissue of a subject; an optical-fiber structure having a first end and a second end; a light-beam coupler that is configured to direct light from the first light-emitting source into the first end of the optical fiber structure; a light-emitting-source controller operatively coupled to the first light-emitting source to selectively control light output thereof, and a light-delivery unit operatively coupled to the second end of the optical-fiber structure, wherein the light-delivery unit, the optical fiber structure or both the light-delivery unit and the optical-fiber structure are configured to direct the optical signal onto muscle tissue.
  • the first light-emitting source emits infrared (IR) light from a laser diode.
  • Some embodiments of the muscle stimulator further include a second light-emitting source operative to emit an optical signal at a second wavelength that is capable of directly stimulating muscle tissue, wherein the second wavelength is different than the first wavelength and has a different penetration depth into a given tissue, and wherein light at the first wavelength is applied to achieve a first tissue-penetration depth, and light at the second wavelength is applied to achieve a second tissue-penetration depth.
  • a second light-emitting source operative to emit an optical signal at a second wavelength that is capable of directly stimulating muscle tissue, wherein the second wavelength is different than the first wavelength and has a different penetration depth into a given tissue, and wherein light at the first wavelength is applied to achieve a first tissue-penetration depth, and light at the second wavelength is applied to achieve a second tissue-penetration depth.
  • Some embodiments of the muscle stimulator further include a second light-emitting source operative to emit an optical signal at a second wavelength that is capable of directly stimulating muscle tissue, wherein the first wavelength is different than the second wavelength and has a different penetration depth into a given tissue, and variable amounts of the first and second different wavelengths are applied simultaneously to achieve a tissue-penetration depth that is variable based on the intensities of the first and second wavelengths of light.
  • a second light-emitting source operative to emit an optical signal at a second wavelength that is capable of directly stimulating muscle tissue, wherein the first wavelength is different than the second wavelength and has a different penetration depth into a given tissue, and variable amounts of the first and second different wavelengths are applied simultaneously to achieve a tissue-penetration depth that is variable based on the intensities of the first and second wavelengths of light.
  • Some embodiments of the muscle stimulator further include a third light-emitting source, wherein the third light-emitting source emits visible light, and wherein the light-beam combiner is operatively coupled to direct light from the third light-emitting source into the optical-fiber structure.
  • the light-delivery unit includes a handpiece configured to be held by hand during delivery of the muscle tissue stimulation, and the apparatus further includes a disposable sheath configured to cover at least a portion of the handpiece to provide a sterile covering.
  • Some embodiments of the muscle stimulator further include a user-operable control mechanism operatively coupled to the controller to control a function of the controller, the control mechanism being configured to be operated in conjunction with the handpiece.
  • the user-operable control mechanism is mounted on the handpiece, and configured to be hand operated by a user.
  • the user-operable control mechanism is mechanically linked to the light-emitting-source controller.
  • the light-delivery unit includes a frame configured to be affixed to the subject, and a moveable light-delivery head connected to the frame and configured to be changeably positioned to deliver light to one of a plurality of locations on the subject.
  • Another aspect of some embodiments of the invention include a method that includes obtaining, from a first laser diode, a first laser beam having a first wavelength that is capable of directly optically stimulating an action potential in a tissue of an animal; transmitting the first laser beam in an optical-fiber structure; applying the first laser beam from the optical-fiber structure onto a location on the tissue for stimulation of the tissue; and obtaining user input and based on the user input, controlling the first laser beam.
  • the first laser beam has an infrared (IR) wavelength.
  • the tissue is muscle tissue
  • the action potential is a muscle action potential
  • the tissue is neural tissue
  • the action potential is a nerve action potential
  • Some embodiments further include obtaining a second laser beam having a second wavelength that is capable of directly stimulating muscle tissue, wherein the second wavelength is different than the first wavelength and has a different penetration depth into a given tissue; transmitting the second laser beam in the optical-fiber structure; applying light at the first wavelength to achieve a first tissue-penetration depth; and applying light at the second wavelength to achieve a second tissue-penetration depth.
  • Some embodiments further include obtaining a second laser beam having a second wavelength that is capable of directly stimulating muscle tissue, wherein the second wavelength is different than the first wavelength and has a different penetration depth into a given tissue; transmitting the second laser beam in the optical-fiber structure; and applying variable amounts of the first and second different wavelengths simultaneously to achieve a tissue-penetration depth that is variable based on the intensities of the first and second wavelengths of light.
  • Some embodiments further include obtaining a third light beam having a visible-light wavelength; transmitting the third light beam in the optical-fiber structure; and imaging the third light beam from the optical-fiber structure as an indication of where the first laser beam is directed.
  • Some embodiments further include providing a handpiece for manually directing the location of the imaged stimulation light; and covering at least a portion of the handpiece with a sterile cover.
  • the obtaining user input includes coupling a control mechanism to a laser controller controlling the first laser diode in order to control a function of the controller, wherein the control mechanism is configured to be operated in conjunction with the handpiece.
  • control mechanism is mounted on the handpiece, and the obtaining user input includes coupling a manual operation of the control mechanism by a user to control the first laser beam.
  • Some embodiments further include providing a handpiece for manually directing the location of imaged stimulation light, wherein the obtaining user input includes coupling a user-operated control mechanism to a laser controller to control a function of the controller, wherein the control mechanism is separate from the handpiece and is configured to be operated such that operation of the control mechanism is independent of movement of the handpiece.
  • Some embodiments further include providing a light-delivery unit for directing the location of the imaged stimulation light, wherein the light-delivery unit includes a frame configured to be affixed to the subject, and a moveable light-delivery head connected to the frame; and positioning the light-delivery head to deliver light to one of a plurality of locations on the subject.
  • the light-delivery unit includes a frame configured to be affixed to the subject, and a moveable light-delivery head connected to the frame; and positioning the light-delivery head to deliver light to one of a plurality of locations on the subject.
  • Some embodiments of the present invention include an apparatus that includes means for generating a first laser beam having a first wavelength that is capable of directly stimulating an action potential in muscle tissue of a subject, wherein light of the first wavelength has a first tissue-penetration profile; means for transmitting the first laser beam; means for imaging the transmitted first laser beam onto a location on the muscle tissue for stimulation of the action potential in the muscle tissue; and means for obtaining user input and based on the user input, controlling the first laser beam.
  • the means for generating the first laser beam includes a laser diode and means for controlling electrical power to the laser diode to control timing and intensity of the first laser beam.
  • Some embodiments further include means for visibly indicating a location on the subject to which optical muscle stimulation is to be obtained by application of the first laser beam.
  • Some embodiments further include means for generating a second laser beam having a second wavelength that is capable of directly stimulating muscle tissue of a subject, wherein light of the second wavelength has a second tissue-penetration profile different than the first tissue-penetration profile, and wherein the means for generating the second laser beam is optically coupled to the means for imaging.
  • Some embodiments further include means for generating a third laser beam that is capable of optically cutting tissue, wherein the means for generating the third laser beam is optically coupled to the means for imaging.
  • the means are compatible with use within a magnetic field of an operating magnetic resonance imaging (MRI) apparatus.
  • MRI magnetic resonance imaging
  • Some embodiments of the present invention include an apparatus that includes an elongated endoscope structure having an image-obtaining end configured to be inserted into a small opening in a subject to enable viewing of an interior tissue of the subject; a first laser diode operable to output a laser beam having a first wavelength, and that is capable of directly stimulating muscle tissue of a subject, wherein light of the first wavelength has a first tissue-penetration profile; a fiber holder operable to hold an optical fiber, the optical fiber having a first end configured to be optically coupled to receive the laser beam from the first laser diode and configured to deliver the laser beam to a second end to stimulate neural tissue of the viewed interior tissue of the subject; and a user-input interface operable to obtain user input and based on the user input, to control application of the first laser beam.
  • Some embodiments further include the optical fiber.
  • the fiber holder is further configured to implant and release the optical fiber in the subject.
  • a high-power diode laser array is used for one or more of the light sources used in the above-described embodiments.
  • some embodiments use high-power MQW (multiple quantum well) multiple-emitter laser arrays available from Princeton Lightwave Inc., 2555 Route 130 South Suite 1, Cranbury, N.J. 08512, whose laser arrays output laser light with up to 30 watts or more power at 1.45 to 1.55 microns and up to 12 watts or more power at 1.85 microns.
  • the present invention uses lasers such as described in “218 W quasi-CW operation of 1.83 microns (i.e., micrometers) two-dimensional laser diode array” by M.
  • the present invention uses light sources such as described in U.S. Pat. Nos. 6,639,930 titled “Multi-level closed loop resonators and method for fabricating same” which issued 2003 Oct. 28; U.S. Pat. No. 6,556,611 titled “Wide stripe distributed Bragg reflector lasers with improved angular and spectral characteristics” which issued 2003 Apr. 29; U.S. Pat. No. 6,459,715 titled “Master-oscillator grating coupled power amplifier with angled amplifier section” which issued 2002 Oct.

Abstract

A hand-held self-contained nerve-stimulation device and method using light to provide a source of precise stimulation on one or more nerve fibers. In some embodiments, this simulation is provided through a device and method wherein a laser- or LED-light source is mounted to the handpiece. Light is passed from the light source through optical tip to simulate nerves. In some embodiments, the device is constructed from non-magnetic material such as glass, plastic or ceramics. In some embodiments, the light emanating from the optical tip can be controlled manually or automatically. In some embodiments, the handpiece contains a self-contained power source, such as batteries. In some embodiments, the handpiece is at least in part, activated by remote control in order to prevent moving the handpiece during activation. Some embodiments include a unit operable to sense a response of nerve stimulation and to suppress a laser-ablation surgery operation.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application claims benefit of U.S. Provisional Patent Application No. 60/826,538 (Attorney Docket 5020.001PV1) filed on Sep. 21, 2006, titled “MINIATURE APPARATUS AND METHOD FOR OPTICAL STIMULATION OF NERVES AND OTHER ANIMAL TISSUE,” which is incorporated herein by reference in its entirety. This application is also related to U.S. patent application Ser. No. 11/420,729 (Attorney Docket 5032.009US1) filed on May 26, 2006 entitled “APPARATUS AND METHOD FOR OPTICAL STIMULATION OF NERVES AND OTHER ANIMAL TISSUE” and to U.S. patent application Ser. No. 11/___,___ (Attorney Docket 5032.020US1) filed on even date herewith entitled “APPARATUS AND METHOD FOR STIMULATION OF NERVES AND AUTOMATED CONTROL OF SURGICAL INSTRUMENTS,” which are each incorporated herein by reference in their entirety.
  • FIELD OF THE INVENTION
  • The invention relates generally to surgical instruments, and more particularly to methods and apparatus to stimulate a nerve, sense a result of the nerve stimulation, and control a surgical instrument, such as an ablation laser, based on the sensed result; for example controlling the ablation laser to suppress ablation pulses to avoid damaging vital nerves while removing other diseased tissue, or to enable ablation pulses to remove damaged nerve tissue.
  • BACKGROUND OF THE INVENTION
  • A nerve can be stimulated in a number of different ways, including electrical, mechanical, thermal, chemical, and now optical. A nerve is a filament of neural tissue composed of cells each having a cell body and one or more axons and dendrites. The axons extend peripherally as either myelinated or unmyelinated fibers. A chain of Schwann cells surrounds each myelinated nerve fiber with a multilayered myelin sheath. Groups of unmyelinated fibers are associated with single Schwann cells. Both types of nerve fibers are bound by endoneurium to form bundles, or fascicles. A perineurial membrane surrounds each fascicle. Groups of fascicles are held together by internal and external epineurium to form the peripheral nerves. The cell body of a motor neuron lies in the anterior horn of the spinal cord, while the cell body of a sensory neuron is located in the dorsal root ganglion, near the cord. (Christine Cheng; See Nerve Compression Syndromes of the Upper Limb, by Martin Dunitz, published by Taylor & Francis Group, 2002.)
  • Functional magnetic-resonance-imaging (FMRI) systems use extremely strong magnetic fields in generating images of an animal subject (e.g., a human) to discern functions and abnormalities of various portions of the body, and in particular, of the brain (e.g., during various mental activities or thought patterns). The high static magnetic fields (Bo fields) created by an MRI machine create a danger of projectile accidents from any object having magnetic properties that may be near the MRI machine. Using metal probes to deliver electrical stimulation to nerves of a subject poses one such danger. It would be desirable to stimulate a nerve without using metal probes.
  • Further, it is desirable to cause a controlled stimulation of individual nerves. U.S. Pat. No. 6,921,413 issued to Mahadevan-Jansen et al. on Jul. 26, 2005, and titled “Methods and Devices for Optical Stimulation of Neural Tissues,” is incorporated herein by reference. Mahadevan-Jansen et al. note that traditional methods of stimulation include electrical, mechanical, thermal, and chemical. A neuron will propagate an electrical impulse (a nerve action potential) in response to a stimulus. The most common form of applying such stimulation is to form a transient current or voltage pulse applied through electrodes. Electrical, mechanical, and chemical stimulations have many limitations. Stimulation by such methods typically results in non-specific stimulation of neurons and/or damage to neurons. Difficulty exists in recording electrical activity from the neuron due to an electrical artifact created by the stimulus. To stimulate only one or a few neurons, fragile microelectrodes need to be fashioned and carefully inserted into the tissue to be stimulated. Such techniques do not easily lend themselves to implantable electrodes for long-term use in stimulation of neural tissue. Mahadevan-Jansen et al. describe the use of low-power light from a free-electron laser (FEL) for optically stimulating selected individual nerve cells in vivo, while at the same time not stimulating neighboring cells with the laser light. Unfortunately, FELs are expensive, large, awkward and unwieldy.
  • Further, some conventional optical systems include some magnetic materials, making them unsuitable for use near MRI systems.
  • In other conventional neural-stimulation systems, 110-volt AC (wall power) is used to control and/or drive the laser components, with electrical, cooling-fluid, and/or optical tethers between a delivery head and other portions of the equipment, making such systems clumsy and/or perhaps somewhat dangerous to use if relatively high voltages are present in the hand-held portion. For example, U.S. Pat. No. 5,548,604 issued to Toepel on Aug. 20, 1996 entitled “Compact hand held medical device laser” describes a palm-sized laser device having a hand-held housing containing a solid state crystal lase material rod, a flashlamp (for pulsed pump light) within a reflective light-coupling cavity and a fluid-cooling chamber adapted to receive and exhaust coolant fluid.
  • In view of shortcomings in such conventional devices, there is a need for devices and methods that can provide inexpensive, compact, optionally non-magnetic, optionally having non-wall-powered power supplies, and/or easy-to-use interfaces and form factors for optical stimulation of nerves.
  • BRIEF SUMMARY OF THE INVENTION
  • In some embodiments, the invention provides a method and self-powered (e.g., battery-powered) and/or hand-held apparatus for stimulating nerves using either an infra-red (IR) diode laser or light-emitting diode (LED) (e.g., one running at a wavelength of about 1.87 microns) or a diode-pumped solid-state laser (e.g., using a semiconductor laser diode as a pump source of optical radiation and an optically pumped semiconductor or optically pumped rare-earth-doped fiber laser cavity) running at a wavelength of 2.1 microns (e.g., a 785-micron-wavelength laser diode pumping a Tm/Ho solid-state crystal or fiber), or a laser diode operating at a wavelength of between about 1.8 and about 2.2 microns. In other embodiments, the invention uses other wavelengths that are efficacious in optical stimulation of animal tissue such as a nerve.
  • In some embodiments, the apparatus is at least mostly embedded in a self-contained hand-held form factor such as a light pen, pointer and/or wand that can be manually used to control, direct and/or shutter the light. In some embodiments, the hand-held device includes an embedded laser diode used to obtain optical radiation (optionally directed at least in part in an embedded optical fiber) that has a suitable wavelength and optical power sufficient to optically stimulate the nerve. In other embodiments, one or more LEDs, one or more diode lasers, or a combination of one or more LEDs and one or more diode lasers is used to obtain the stimulation light.
  • In some embodiments, the hand-held device of the present invention includes one or more internal power sources, such as battery cells, to provide self-contained electrical power to the laser diode and/or other internal components. In some embodiments, at least some of the metal portions of the battery and other internal electrical wiring connections are all or substantially all made of a non-magnetic electrically conductive material such as copper, in order to be usable near MRI equipment.
  • In some embodiments, one or more free-space or bulk optical components (such as air gaps, lenses, prisms and the like, in contrast to enclosing the entire optical path in optical fibers) are used in the hand-held device of the present invention. In some embodiments, one or more IR and/or visible lasers are implemented on a semiconductor chip, and one or more such chips are mounted to a housing (such as a metal or plastic “can” having a front lens) such that the combined optical output of the laser(s)/LED(s) starts in close proximity and is immediately collimated as a single beam and focussed by a single train of lenses and other optical components. In other embodiments, at least one beamsplitter/beam combiner is used to combine light from two or more sources into a single output beam.
  • In other embodiments, the IR nerve-stimulation optical signal is carried in an optical fiber, and, either sharing a single optical fiber or passing in one or more separate fibers next to the optical fiber that carries the IR nerve-stimulation optical signal, the invention also includes a visible-laser or visible-LED signal that illuminates and points out the area (e.g., the nerve) being stimulated. In still other embodiments, a high-power surgical and/or therapeutic laser signal is added in conjunction with the IR nerve-stimulation signal and/or visible pointer laser. For example, in some embodiments, a visible laser is projected to point out to the surgeon where the IR nerve-stimulation laser signal will be applied; the surgeon then activates the IR nerve-stimulation laser signal and observes the response (for example, phantom-limb pain of an amputee); and once the observed response determines the nerve location to be treated, the surgical and/or therapeutic laser signal is applied to that identified location. In other embodiments, for example to avoid accidentally cutting a facial nerve during surgery, the IR nerve-stimulation laser signal is pointed to a location that the surgeon wants to cut or ablate (in some embodiments, this point is illuminated by the visible pointer laser beam) but wants to cut only if no nerve is at that point; the surgeon then activates the IR nerve-stimulation laser signal and observes the response (for example, a muscle contraction that can be seen by the surgeon or sensed by a suitable sensor taped or otherwise affixed to the skin); but in this case, the observed response determines that a location to be treated includes a desired nerve, and the surgical and/or therapeutic laser signal is inhibited from being applied to that identified location. In some embodiments, the nerve-response sensor generates a signal that inhibits activation of the surgical laser.
  • The present invention, with its ability to precisely stimulate a single nerve or a very small area of a brain (optionally with no magnetic material near the subject, who, in some embodiments, may be a human patient requiring medical care) is a gateway technology that opens broad areas of medicine and surgery. In some embodiments, an enlarged digital or video image of the surgery site is displayed, and as the surgeon optically stimulates the various nerves or areas, the image is annotated (e.g., color-coded as a map of nerve function) to provide a record of which response was observed for each of the different areas stimulated. In some embodiments, once the annotated map is sufficiently complete, the surgeon can input graphical annotation to the computer identifying the extent or the exact area to which treatment is to be permitted, the visible signal (showing where the fiber is pointing) is inputted and compared to the map, such that the controller allows the surgical and/or therapeutic laser signal to be applied only to the identified allowed area.
  • As used herein, “optical stimulation of nerves” refers to stimulation caused by impinging light onto nerve tissue, regardless of the wavelength of the light (ultraviolet, visible, or infrared, wherein the term “light” is not necessarily restricted to light in the visible range of 400- to 700-nanometer wavelengths). The nerve being stimulated can be any nerve, such as motor or sensory nerves in the peripheral nervous system, nerve tissue of the central nervous system (nerves within the brain and spinal cord), the cranial nerves (e.g., the optic nerve, the olfactory nerve, the auditory nerve, and the like), optical or auditory nerves, the autonomic nervous system, as well as brain tissue and/or any other neural tissue. Thus, the tissue to which optical stimulation is applied need not itself be a “nerve” as conventionally defined, but could include brain tissue that when stimulated by light initiates a response similar to that carried by a nerve, e.g., an action potential that includes electrical and/or chemical components, and which is propagated to a location some distance from the point that was optically stimulated. As used herein, the term “subject” is an inclusive term that refers to any animal whose nerves may be stimulated by light, as the term light has been defined above; this includes non-mammalian and mammalian species, including humans, and including especially humans who may be patients receiving professional medical care. As used herein, the term “optical-fiber structure” is an inclusive term that includes a single optical fiber as well as a bundle of individual optical fibers, a fused bundle of optical fibers, star couplers, and depending on the context optionally includes ferrules, lenses, and the like used to couple light into and out of the optical fiber structure.
  • In some embodiments, the present invention includes at least some of the following in a small hand-held portable device powered by a self-contained energy-storage device (e.g., batteries or other power source, such as capacitors, chemical energy, rotational flywheel energy, spring energy and the like; and/or a self-contained power receiver such as a coil for receiving AC magnetic or RF energy, a photovoltaic cell for receiving optical energy, and the like), one or more light-emitting sources (that emit tissue-stimulation wavelengths) powered by the self-contained energy-storage device, an optional light-beam combiner coupled to combine two or more optical beams into a single optical beam, optics to focus and deliver light to a nerve, a trigger or activation mechanism, a light-emitting-source controller (e.g., in some embodiments, this includes electronics to condition and control electricity to laser diodes), one or more visible-light-emitting sources such as LEDs and/or laser diodes (that emit light used to point at or identify the tissue area being (or to be) stimulated and a disposable sheath. In some embodiments, the sheath includes or incorporates a lens and/or other portions of the optics to focus the light from the light sources to a particular spot size and/or shape. In some embodiments, a plurality of different interchangeable sheaths and/or lens tips are provided, each having a different spot size and/or shape, allowing the surgeon or technician to choose the appropriate light pattern, and/or to change the light pattern based on results of the first-tried sheath's light pattern and/or the patient response obtained.
  • In some embodiments, the invention provides a method that includes generating a first light beam from a first self-contained-energy-storage-powered (e.g., battery-powered) light-emitting source, generating a second light beam using a self-contained-energy-storage-powered (e.g., battery-powered) second light-emitting source, combining the first and second light beams, focusing the combined first and second laser light beams, and controlling an amplitude and/or timing of the first and/or second light beams.
  • In some embodiments, the present invention includes an apparatus having a finger-and/or-thumb control that controls a characteristic of light, optics to focus and deliver the light to a nerve, a self-contained-energy-storage-powered (e.g., battery-powered) laser having a wavelength and power capable of efficaciously stimulating a nerve, and a controller operable to drive the laser based on input from the finger/thumb control. In some embodiments, this apparatus is used to deliver an efficacious amount of visible and infrared (IR) light so as to target and stimulate nerve tissue. In some embodiments, a visible laser beam is used to point to and illuminate the area to be stimulated and an IR laser beam is used to stimulate a nerve at that illuminated area.
  • In some embodiments, the present invention includes an apparatus having an optical nerve stimulator, an energy-storage-device charger (e.g., battery charger), and a remote wireless controller and/or programmer.
  • In some embodiments, the stimulation light is IR (infrared, e.g., about 1.8-micron wavelength), while in other embodiments other IR wavelengths, visible light wavelengths, ultraviolet wavelengths, and/or combinations of a plurality of such wavelengths are used.
  • In some embodiments, the invention provides a method that includes charging a battery, (e.g., supplying a charge to a battery from an RF charger), powering a controller with the battery, powering a first light source from the controlled, powering a second light source, emitting light from the first light source, emitting light from the second light source, controlling a characteristic of the light from the first and second light sources using a remote programmer, combining the light from the first and second light sources via a combiner, and projecting the combined light to a nerve fiber.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1A is a block diagram of a battery-operated nerve-stimulation laser handpiece system 100A.
  • FIG. 1B is a block diagram of a battery-operated nerve-stimulation laser handpiece system 100B.
  • FIG. 1C is a block diagram of a battery-operated nerve-stimulation laser handpiece system 100C.
  • FIG. 1D is a block diagram of a battery-operated nerve-stimulation laser 111.
  • FIG. 1E is a block diagram of a battery-operated nerve-stimulation laser handpiece system 100E.
  • FIG. 1F is a block functional diagram of battery-operated nerve-stimulation laser handpiece system 100E.
  • FIG. 1G is a block diagram of battery-operated nerve-stimulation laser handpiece system 100G.
  • FIG. 1H is a block diagram of battery-operated diode-laser-pumped rare-earth-doped fiber emitter nerve-stimulation handpiece system 100H.
  • FIG. 2 is a block circuit diagram of battery-operated nerve-stimulation laser handpiece system 200.
  • FIG. 3 is a block diagram of focus-indicating nerve-stimulation laser handpiece system 300.
  • FIG. 4A is a block diagram of surgery-inhibiting nerve-stimulation system 400A.
  • FIG. 4B is a block diagram of surgery-inhibiting nerve-stimulation system 400B.
  • FIG. 4C is a block diagram of surgery-inhibiting nerve-stimulation system 400C.
  • FIG. 5A is a perspective cut-away diagram of a surgery-inhibiting nerve-stimulation system at the initiation of a surgical procedure.
  • FIG. 5B is a diagram of a first stimulation/surgical pattern at an operation site sight at which a surgery-inhibiting nerve-stimulation system is employed, at a first time subsequent to the initiation of a surgical procedure.
  • FIG. 5C is a diagram of a surgical sight at which a surgery-inhibiting nerve-stimulation system is employed, at a time when the stimulation/surgical pattern shown in FIG. 5B has been completed.
  • FIG. 5D is a diagram of a second stimulation/surgical pattern at an operation site sight at which a surgery-inhibiting nerve-stimulation system is employed, at a second, later time subsequent to the initiation of a surgical procedure, and showing the surgical site at a time when the second stimulation/surgical pattern has been completed.
  • FIG. 5E is a diagram of a third stimulation/surgical pattern at an operation site sight at which a surgery-inhibiting nerve-stimulation system is employed, at a third, later time subsequent to the initiation of a surgical procedure, and showing the surgical site at a time when the third stimulation/surgical pattern has been completed.
  • FIG. 5F is a diagram of an operation site sight at which a surgery-inhibiting nerve-stimulation system is employed, when the operation has been completed.
  • DETAILED DESCRIPTION OF THE INVENTION
  • Although the following detailed description contains many specifics for the purpose of illustration, a person of ordinary skill in the art will appreciate that many variations and alterations to the following details are within the scope of the invention. Very narrow and specific examples are used to illustrate particular embodiments; however the invention described in the claims is not intended to be limited to only these examples, but rather includes the full scope of the attached claims. Accordingly, the following preferred embodiments of the invention are set forth without any loss of generality to, and without imposing limitations upon the claimed invention.
  • In the following detailed description of the preferred embodiments, reference is made to the accompanying drawings that form a part hereof, and in which are shown by way of illustration specific embodiments in which the invention may be practiced. It is understood that other embodiments may be utilized and structural changes may be made without departing from the scope of the present invention.
  • The leading digit(s) of reference numbers appearing in the Figures generally corresponds to the Figure number in which that component is first introduced, such that the same reference number is used throughout to refer to an identical component that appears in multiple Figures. Signals and connections may be referred to by the same reference number or label, and the actual meaning will be clear from its use in the context of the description.
  • CNAP is an abbreviation for compound nerve action potential. CMAP is an abbreviation for compound muscle action potential. As used herein “target neural tissue” is defined as any neural tissue including, but not limited to, peripheral nerves, spinal-cord tissue, and brain tissue of animals, including mammals, and specifically including humans. As used herein “electrical impulse” is defined an electrical current applied to the nerve to initiate an action potential in the neuron. As used herein “stimulation effect” is defined as propagation of an electrical signal within or along neural or muscular tissue. As used herein “single nerve fiber” is defined as a portion of a neuron, namely the axon, which carries action potentials from the cell body to the axon terminal at a synapse, or one or more of the dendrites, which accumulate signals from one or more sources and carry these to the cell body. Many nerve fibers compose a peripheral nerve, such as the sciatic nerve of a leopard frog (Rana Pepiens) or a mammal.
  • For ease of explanation and conciseness, the present invention is described as embodiments of an apparatus and method for optically stimulating nerves and/or generating nerve action potentials. CNAP is one form of nerve action potential. In other embodiments of the invention, substantially similar apparatus and methods are used for optical stimulation of other tissues, such as muscles and/or generating muscle action potentials. CMAP is one form of muscle action potential.
  • As used herein “hand operated” means operated by some portion of a user's hand or hands, including by one or more of the fingers, thumb, wrist and palm of the hand, or of both hands. In some embodiments, a light-delivery handpiece is hand operated to the extent that the location (i.e., on the nerve or neural tissue) to which light is delivered is determined by positioning the handpiece by hand. In some embodiments, a light-delivery handpiece is also hand operated in that a control device (such as a button, wheel, trigger, iris, shutter, and the like) is operated by hand to control the type of stimulation light (e.g., pulses, intensity, wavelength, pulse train, and the like) and/or timing of the stimulation light.
  • As used herein “one micron” (a unit generally used when referring to wavelength) is defined as 1.0 micrometer (a unit generally used for circle diameter and other such measurements). As used herein “a spot size of d1 micrometers to d2 micrometers,” where d1 and d2 are numbers, is synonymous with “an area of a circle or other shape with a diameter in a range of from d1 micrometers to d2 micrometers,” as is known to people skilled in the art. For example, a spot size in a range of 200 micrometers to 600 micrometers is synonymous with an area (e.g., of a circle) with a diameter in a range of from 200 micrometers to 600 micrometers, corresponding to an area with a size in a range of about 31,416 square micrometers to about 282,743 square micrometers, using the formula of Area=¼pD2. In some embodiments, a spot is generated by passing the light that exits an end of an optical fiber through a lens, holographic imaging pattern, or other imaging apparatus.
  • In other embodiments, spots with diameters of 1 micrometer or smaller, and up to 1000 micrometers (which equal one mm) or larger are used; for example, about 5 micrometers, about 10 micrometers, about 15 micrometers, about 20 micrometers, about 25 micrometers, about 30 micrometers, about 35 micrometers, about 40 micrometers, about 45 micrometers, about 50 micrometers, about 55 micrometers, about 60 micrometers, about 65 micrometers, about 70 micrometers, about 75 micrometers, about 80 micrometers, about 85 micrometers, about 90 micrometers, about 95 micrometers, about 100 micrometers, about 110 micrometers, about 120 micrometers, about 130 micrometers, about 140 micrometers, about 150 micrometers, about 160 micrometers, about 170 micrometers, about 180 micrometers, about 190 micrometers, about 200 micrometers, about 210 micrometers, about 220 micrometers, about 230 micrometers, about 240 micrometers, about 250 micrometers, about 260 micrometers, about 270 micrometers, about 280 micrometers, about 290 micrometers, about 300 micrometers, about 310 micrometers, about 320 micrometers, about 330 micrometers, about 340 micrometers, about 350 micrometers, about 360 micrometers, about 370 micrometers, about 380 micrometers, about 390 micrometers, about 400 micrometers, about 410 micrometers, about 420 micrometers, about 430 micrometers, about 440 micrometers, about 450 micrometers, about 460 micrometers, about 470 micrometers, about 480 micrometers, about 490 micrometers, about 500 micrometers, about 510 micrometers, about 520 micrometers, about 530 micrometers, about 540 micrometers, about 550 micrometers, about 560 micrometers, about 570 micrometers, about 580 micrometers, about 590 micrometers, about 600 micrometers, about 610 micrometers, about 620 micrometers, about 630 micrometers, about 640 micrometers, about 650 micrometers, about 660 micrometers, about 670 micrometers, about 680 micrometers, about 690 micrometers, about 700 micrometers, about 750 micrometers, about 800 micrometers, about 850 micrometers, about 900 micrometers, about 950 micrometers, about 1000 micrometers, about 1.1 millimeters, about 1.2 millimeters, about 1.3 millimeters, about 1.4 millimeters, about 1.5 millimeters, about 1.6 millimeters, about 1.7 millimeters, about 1.8 millimeters, about 1.9 millimeters, about 2 millimeters, about 3 millimeters, about 4 millimeters, about 5 millimeters, or more than about 5 millimeters, or, in other embodiments, in ranges between any two of the above values.
  • In some embodiments, a laser diode emitting light with a 1.87-micron wavelength stimulates nerves. This wavelength is important because devices capable of generating this wavelength are more available than longer mid-IR wavelengths. In some embodiments, laser-diode light of a 2.1-micron wavelength is used for nerve stimulation. Laser diodes that emit 2.1-micron-wavelength light are currently in research and would most likely work as well as other wavelengths, since this wavelength, when generated by a lamp -pumped solid-state laser, has been shown to be effective in stimulating nerves. In some embodiments, a laser-diode device (having one or more emitters) outputs light that is used for nerve stimulation, wherein the light has a wavelength of between about 1.5 microns and about 6 microns; in various embodiments, for example, the wavelength is in the far infrared at about 1.5 microns, or about 1.51 microns, about 1.52 microns, about 1.53 microns, about 1.54 microns, about 1.55 microns, about 1.56 microns, about 1.57 microns, about 1.58 microns, about 1.59 microns, about 1.6 microns, about 1.61 microns, about 1.62 microns, about 1.63 microns, about 1.64 microns, about 1.65 microns, about 1.66 microns, about 1.67 microns, about 1.68 microns, about 1.69 microns, about 1.7 microns, about 1.71 microns, about 1.72 microns, about 1.73 microns, about 1.74 microns, about 1.75 microns, about 1.76 microns, about 1.77 microns, about 1.78 microns, about 1.79 microns, about 1.8 microns, about 1.81 microns, about 1.82 microns, about 1.83 microns, about 1.84 microns, about 1.85 microns, about 1.86 microns, about 1.87 microns, about 1.88 microns, about 1.89 microns, about 1.9 microns, about 1.91 microns, about 1.92 microns, about 1.93 microns, about 1.94 microns, about 1.95 microns, about 1.96 microns, about 1.97 microns, about 1.98 microns, about 1.99 microns, about 2.0 microns, about 2.01 microns, about 2.02 microns, about 2.03 microns, about 2.04 microns, about 2.05 microns, about 2.06 microns, about 2.07 microns, about 2.08 microns, about 2.09 microns, about 2.1 microns, about 2.11 microns, about 2.12 microns, about 2.13 microns, about 2.14 microns, about 2.15 microns, about 2.16 microns, about 2.17 microns, about 2.18 microns, about 2.19 microns, about 2.2 microns, about 2.21 microns, about 2.22 microns, about 2.23 microns, about 2.24 microns, about 2.25 microns, about 2.26 microns, about 2.27 microns, about 2.28 microns, about 2.29 microns, about 2.3 microns, about 2.31 microns, about 2.32 microns, about 2.33 microns, about 2.34 microns, about 2.35 microns, about 2.36 microns, about 2.37 microns, about 2.38 microns, about 2.39 microns, about 2.4 microns, about 2.5 microns, about 2.6 microns, about 2.7 microns, about 2.8 microns, about 2.9 microns, about 3 microns, about 3.1 microns, about 3.2 microns, about 3.3 microns, about 3.4 microns, about 3.5 microns, about 3.6 microns, about 3.7 microns, about 3.8 microns, about 3.9 microns, about 4 microns, about 4.1 microns, about 4.2 microns, about 4.3 microns, about 4.4 microns, about 4.5 microns, about 4.6 microns, about 4.7 microns, about 4.8 microns, about 4.9 microns, about 5 microns, about 5.1 microns, about 5.2 microns, about 5.3 microns, about 5.4 microns, about 5.5 microns, about 5.6 microns, about 5.7 microns, about 5.8 microns, about 5.9 microns, or about 6.0 microns, or, in other embodiments, in ranges between any two of the above values. In other embodiments, an LED having output wavelengths centered in one of these ranges is used as a source of light to stimulate nerves.
  • In still other embodiments, one or more laser diodes or LEDs that output shorter wavelengths (including short IR, visible, and/or ultraviolet light) is used as a source of light to stimulate nerves. In particular, visible wavelengths are important because devices capable of generating a great number of different ones of these shorter wavelengths are becoming more available, and use of visible light makes the location of the stimulation signal readily apparent to the user without the use of separate lasers or LEDs as visible markers. On the other hand, longer IR laser wavelengths tend to be more eye-safe (since the liquids and structures in the front of the eye absorb or block longer IR wavelengths), while shorter laser wavelengths can present an eye hazard with respect to which, precautionary protective measures must be taken Further, different wavelengths have different penetration depths into various tissues, so a selected penetration depth can be achieved by changing wavelength without changing optical power, or by a combination of a selected wavelength and a selected power. In some embodiments, a laser diode having an output wavelength of about 0.95 microns (in the infrared) is used for nerve stimulation. In some embodiments, a laser-diode device (having one or more emitters) outputs light that is used for nerve stimulation, wherein the light has a wavelength of between about 1.5 microns and about 0.2 microns. In various embodiments, for example, the wavelength is in the infrared spectrum at about 0.7 microns, about 0.71 microns, about 0.72 microns, about 0.73 microns, about 0.74 microns, about 0.75 microns, about 0.76 microns, about 0.77 microns, about 0.78 microns, about 0.79 microns, about 0.8 microns, about 0.81 microns, about 0.82 microns, about 0.83 microns, about 0.84 microns, about 0.85 microns, about 0.86 microns, about 0.87 microns, about 0.88 microns, about 0.89 microns, about 0.9 microns, about 0.91 microns, about 0.92 microns, about 0.93 microns, about 0.94 microns, about 0.95 microns, about 0.96 microns, about 0.97 microns, about 0.98 microns, about 0.99 microns, about 1.0 microns, or about 1.01 microns, about 1.02 microns, about 1.03 microns, about 1.04 microns, about 1.05 microns, about 1.06 microns, about 1.07 microns, about 1.08 microns, about 1.09 microns, about 1.1 microns, about 1.11 microns, about 1.12 microns, about 1.13 microns, about 1.14 microns, about 1.15 microns, about 1.16 microns, about 1.17 microns, about 1.18 microns, about 1.19 microns, about 1.2 microns, about 1.21 microns, about 1.22 microns, about 1.23 microns, about 1.24 microns, about 1.25 microns, about 1.26 microns, about 1.27 microns, about 1.28 microns, about 1.29 microns, about 1.3 microns, about 1.31 microns, about 1.32 microns, about 1.33 microns, about 1.34 microns, about 1.35 microns, about 1.36 microns, about 1.37 microns, about 1.38 microns, about 1.39 microns, about 1.4 microns, about 1.41 microns, about 1.42 microns, about 1.43 microns, about 1.44 microns, about 1.45 microns, about 1.46 microns, about 1.47 microns, about 1.48 microns, about 1.49 microns, or about 1.5 microns, or, in other embodiments, in ranges between any two of the above values.
  • In various other embodiments, for example, the wavelength is in the visible spectrum at about 0.4 microns, or about 0.41 microns, about 0.42 microns, about 0.43 microns, about 0.44 microns, about 0.45 microns, about 0.46 microns, about 0.47 microns, about 0.48 microns, about 0.49 microns, about 0.5 microns, about 0.51 microns, about 0.52 microns, about 0.53 microns, about 0.54 microns, about 0.55 microns, about 0.56 microns, about 0.57 microns, about 0.58 microns, about 0.59 microns, about 0.6 microns, about 0.61 microns, about 0.62 microns, about 0.63 microns, about 0.64 microns, about 0.65 microns, about 0.66 microns, about 0.67 microns, about 0.68 microns, about 0.69 microns, or about 0.7 microns, or, in other embodiments, in ranges between any two of the above values.
  • In various other embodiments, for example, the wavelength is in the ultraviolet spectrum at about 0.1 microns, or about 0.11 microns, about 0.12 microns, about 0.13 microns, about 0.14 microns, about 0.15 microns, about 0.16 microns, about 0.17 microns, about 0.18 microns, about 0.19 microns, about 0.2 microns, about 0.21 microns, about 0.22 microns, about 0.23 microns, about 0.24 microns, about 0.25 microns, about 0.26 microns, about 0.27 microns, about 0.28 microns, about 0.29 microns, about 0.3 microns, about 0.31 microns, about 0.32 microns, about 0.33 microns, about 0.34 microns, about 0.35 microns, about 0.36 microns, about 0.37 microns, about 0.38 microns, about 0.39 microns, or about 0.4 microns, or, in other embodiments, in ranges between any two of the above values.
  • In some embodiments, the invention uses a nerve-stimulation signal composed of one or more wavelengths within a range between two numbers selected from the set that includes all of the above listed far-infrared-, visible-, infrared-, or ultraviolet-spectrum wavelengths.
  • In some embodiments, two or more different wavelengths are used in combination for nerve stimulation. In some embodiments, the different wavelengths have different penetration depths into a given tissue, so in some embodiments, the present invention applies light at a first wavelength from a first laser to achieve a first tissue-penetration depth, but applies light at a second wavelength from a second laser to achieve a second tissue-penetration depth. In some embodiments, a variable amount of each of the two or more different wavelengths is applied simultaneously to achieve a tissue-penetration depth that is variable based on the amounts (intensities) of the first and second light wavelengths. In some embodiments, the two or more different wavelengths are used in combination in cases where the simultaneous combination of two or more different wavelengths achieves higher stimulation results when applied to a specific type of neural tissue than is achieved by the application of either wavelength alone. In some embodiments, the two or more different wavelengths are passed through a single optical fiber for delivery to the target neural tissue.
  • In other embodiments, different IR wavelengths have different depths of penetration into living tissue (e.g., nerve tissue), and thus one IR nerve-stimulation wavelength is used for penetration to a first depth, and a second IR nerve-stimulation wavelength is used for penetration to a second depth that is different than the first depth. In some embodiments, the two or more different wavelengths are passed through a single optical fiber for delivery to the target neural tissue.
  • In still other embodiments, different IR wavelengths have different absorption ratios or different stimulation results for different tissue types (e.g., for different types of nerves or neural tissue), and thus one IR nerve-stimulation wavelength is used for stimulation of a first type of neural tissue, and a second IR nerve-stimulation wavelength is used for stimulation of a second type of neural tissue that is different than the first type. In some embodiments, the two or more different wavelengths are passed through a single optical fiber for delivery to the target-neural-tissue area.
  • In some embodiments, the two or more different wavelengths are generated by two or more solid-state light-emitting devices, such as laser diodes, light-emitting diodes, optically pumped fibers, and the like, and are then combined into a single optical fiber. In other embodiments, the two or more wavelengths are sent through separate parallel fibers or through different cores in a single fiber.
  • In some embodiments, the optical stimulation light is directed to a very small area of neural tissue, for example in order to stimulate a subset of one or more nerves within a nerve bundle (for example, to stimulate a motor nerve (a nerve that conducts signals from the brain to one muscle or a portion of a muscle), or to stimulate a sensory nerve (a nerve that conducts signals to the brain from a small area of touch-sensing nerves), or an auditory nerve for a single audio frequency, or an optical nerve for a small portion of the visual field or color-sensing spectrum). In some embodiments, such a precision-directed optical signal includes a single optical wavelength; while in other embodiments two or more different IR-stimulation wavelengths are used for stimulating a single nerve or neural tissue area. In some embodiments, two or more different wavelengths provide a stronger stimulation to one nerve cell or one portion of tissue, while in other embodiments two or more different IR-stimulation wavelengths provide different depths of penetration, such that a selected depth or range of depths can be chosen by selecting the wavelength(s) that reach to those depths.
  • In some embodiments, the optical stimulation light is directed to a larger area of neural tissue, for example in order to stimulate a larger number of nerves or brain cells. It has been found that in some embodiments, the optical stimulation of a single brain cell or a small number of brain cells is ineffective in initiating a neural response, while the optical stimulation of a larger number of brain cells is effective. In some embodiments, delivery of this larger-area optical signal includes a single optical wavelength, while, in other embodiments, two or more different wavelengths are used. In some embodiments, an optical lens, holographic imager, or other imaging device is used to direct light from an optical source (such as a battery-operated laser and/or LED) to the larger area that is to be stimulated. In some embodiments, a grating (e.g., a distributed Bragg reflector having a characteristic grating spacing chosen to eject light from the fiber along the grating length) is imposed along a length (e.g., in various embodiments, 0.1 mm, 0.2 mm, 0.3 mm, 0.4 mm, 0.5 mm, 0.6 mm, 0.7 mm, 0.8 mm, 0.9 mm, 1 mm, 2 mm, 3 mm, 4 mm, 5 mm, 6 mm, 7 mm, 8 mm, 9 mm, 10 mm, 11 mm, 12 mm, 13 mm, 14 mm, 15 mm, 16 mm, 17 mm, 18 mm, 19 mm, 20 mm, or longer than 20 mm) of the delivery end of a fiber in order that the stimulation optical signal is forced to leave the fiber over a length of the grating, in order that the optical signal is directed to neural tissue over that length of grating on the fiber. For discussion purposes, the dimension along the fiber at its emissive end is called the X-direction. In some embodiments, a plurality of optical fibers is disposed such that their ends emit light across a line perpendicular to their length. For discussion purposes, the dimension perpendicular to the fibers at their emissive end is called the Y-direction. In some embodiments, a plurality of fibers, each having a grating on its end, are placed side-by-side such that light is emitted to a larger area, wherein light has an extent in the Y-direction due to the side-by-side spacings of the multiple fibers and an extent in the X-direction due to the lengths of the gratings on each fiber. In some embodiments, one or more IR stimulation wavelengths are also chosen to be emitted across different extents along a Z-direction, such that a volume of neural tissue having selected extents in the X-direction, Y-direction, and Z-direction is stimulated using the optical stimulation signal.
  • In some embodiments, a plurality of optical fibers at the delivery tip of the handheld device of the present invention is used to deliver optical-stimulation pulses to different points along the same nerve fiber or bundle at different times. For example, in some embodiments, a first fiber A delivers an optical-stimulation pulse to point XA along a nerve at a time t0, then later a second fiber B delivers an optical-stimulation pulse to point XB further along the nerve at a later time t4. In some embodiments, the relative timings of the times of the optical-stimulation pulses at t0 and t4 are selected such that the action potential traveling along the nerve is reinforced or strengthened.
  • In some embodiments, one nerve is stimulated using different wavelengths applied to different locations along the nerve; for example 1.8-micron-wavelength light can be applied to a first point and 2.2-micron-wavelength light can be applied to a second point. In some embodiments, both the wavelength and the timing of the light stimulation are varied along the nerve.
  • In some embodiments, a diode laser is employed for nerve stimulation. This is important because a single-diode laser is a very low-cost source compared to free-electron lasers (FEL), fiber lasers or pumped solid-state lasers and the like. A single emitter is used in some embodiments, but, in other embodiments, may not provide enough power for certain purposes. In other embodiments, a multiple-emitter laser-diode device is used, wherein light from a plurality of emitters is directed to a single nerve. In some embodiments, a combiner is used to combine light from a plurality of emitters into a single fiber. In some embodiments, one or more side-emitting lasers are employed, while in other embodiments surface-emitting lasers are used. In some embodiments, a combination of different laser types is used, e.g., based on the need to generate certain combinations of wavelengths or powers.
  • In some embodiments, the laser-diode device is coupled to one or more optical fibers that convey the light to the location at the nerve for stimulation. In other embodiments, the laser diode itself is positioned at the point of stimulation, eliminating the need for the optical fiber.
  • In some embodiments, a WDM (wavelength-division multiplexing) coupler is used to combine two or more wavelengths to be transmitted through a fiber to be ultimately delivered to nerve tissues. Such couplers combine light at differing wavelengths supplied to two or more optical-fiber ports, to produce a single multi-wavelength beam at an additional optical-fiber port. WDM couplers are well known in the field of telecommunication systems; an early example is described in U.S. Pat. No. 4,296,995, with a more recent example described in U.S. Pat. No. 5,796,889. In some instances of each of the embodiments described herein, a WDM coupler is used to couple light from the emitters (e.g., laser diodes or LEDs) into an optical-fiber structure.
  • In at least one embodiment, it is important to make the fiber core's size or sizes small for stimulating smaller nerves. More to the point, given the small size of some nerve fibers, a fiber core and a laser diameter corresponding to (e.g., equal to or smaller than) the diameter of this nerve fiber need to be provided. In some embodiments, a fiber core much smaller than the nerve fiber is used. For example, in some embodiments, a fiber core having a one-micron (or smaller) diameter is used. In other embodiments, fibers having core diameters of 100 micrometers or larger are used. In some embodiments, the optical fibers are made of a glass such as silica or other suitable material (such as plastic). In some embodiments, the optical-fiber bundle used for imaging the tissue being stimulated and observed is made of plastic and/or glass fibers. In some embodiments, multiple small-core fibers can be used to simulate multiple small nerves simultaneously or independently.
  • In at least one embodiment, a fiber-coupling technique is implemented to increase the brightness of light delivered from the battery-operated handpiece by coupling light from a plurality of laser emitters (e.g., from a laser-diode bar) for biological stimulation (i.e., nerve or tissue stimulation). Many different coupling techniques may be employed to increase the brightness of a laser-diode bar. For example, co- and contra-directional and evanescent coupling are some of the coupling techniques known in the art.
  • In some embodiments, a single-emitter laser diode (such as an 1850-nm wavelength single emitter available from Princeton Lightwave company, for example laser diode described at www.princetonlightwave.com/content/HP%20Single%20Element%20Laser%20version%202.pdf or other suitable diode is implemented and used to generate laser light of some efficacious wavelength to a particular target nerve or tissue. As described elsewhere herein, such single-emitter laser diodes may be side-emitting and/or surface-emitting laser diodes.
  • In some embodiments, there is a combining and co-alignment of a visible wavelength with the IR-stimulation light in order to provide a visual cue for directing the IR-stimulation light used for stimulating a nerve or other tissue. Laser light in the IR range (e.g., 700 nm-1850 nm or longer) is not visible to the human eye. Due to this fact, as a practical matter, this IR optical-stimulation light cannot be easily aimed to a particular target (e.g., a nerve fiber) using the naked eye. In some embodiments, visible light (i.e., light in the 400 to 700 nm range from a laser diode, L.E.D., or other source) is also inserted into the optical fiber or fiber bundle and used to guide movement of the emitting end of the fiber to aim the IR light so as to allow the IR light to be applied in an efficacious manner to, for example, stimulate a nerve fiber. In some embodiments, the visible light is passed through one or more fibers or fiber bundles (i.e., this can be using the same fiber(s) as the IR optical-stimulation light, or in other embodiments, using a separate fiber) so as to provide a target spot.
  • Next (or simultaneously), IR light is passed through the same one or more fibers to the same point on a nerve fiber that the visible light previously illuminated or currently illuminates. In some embodiments, both the IR light and visible light have separate light sources that are coupled into a commonly shared optical-fiber structure, whereas, in other embodiments, a separate optical-fiber structure is used to channel each wavelength of light. In some embodiments, an optical-fiber structure is used in which at least some fibers are used to transmit light of one wavelength, while at least some other fibers are used to transmit light of a different wavelength (for example, in some embodiments, different fibers are used to carry the visible light, the IR-stimulation light, and/or the cutting/ablating/cauterizing light, and/or to return the imaging light obtained from the tissue being targeted). In some embodiments, still other optical fibers are used to carry control-light signals to and from the handpiece, such that an operator holding the handpiece can selectively command a remote light source to do his/her bidding. As described below, in some embodiments, these optical-fiber structures are operatively coupled to a glass, ceramic plastic or some other type of ferrule or plug made from a non-magnetic material.
  • In some embodiments, the visible laser light is selected from one or more wavelengths empirically selected to selectively show a visible difference in reflected brightness when directed at nerve fibers as compared to blood vessels, muscles, connective and other tissues. For example, in some embodiments, a combination of red, green and/or blue laser or LED light is used. In some embodiments, green light has been found to be more effective (as an indicator of where the fiber delivery head is pointing) than red or blue light alone. In some embodiments, a fiber bundle (with plastic and/or glass fibers) capable of obtaining image information and transmitting optical two-dimensional color imaging to a remote location is used to convey image information from the subject (e.g., someone in an MRI machine) to a remote viewing location. In some embodiments, a machine-vision system is used to distinguish color features of tissues (e.g., hue, tint, and/or brightness) and/or shapes of tissues from a digital or video image, and to display an enhanced image (e.g., one using enhanced or false-color image information) derived from the image.
  • In some embodiments, an IR video imager is used to obtain and display the location of the IR-stimulation signal without the addition of visible-wavelength light. In some embodiments, a fiber bundle or other structure capable of obtaining and transmitting optical two-dimensional IR imaging to a remote location is used to convey image information to a remote IR imager.
  • In some embodiments, a second, high-power laser signal (called the “surgical signal”) is generated in (e.g., by a supplemental laser diode, or by applying more electrical power to the stimulation laser diode), or coupled through, the handpiece to the stimulation area, wherein the operator can stimulate nerve tissue using a first stimulation-wavelength-and-power optical signal (called the “stimulation signal”) to distinguish tissue that is to be saved from tissue that is to be cut or destroyed, and then use the high-power laser light to cut, ablate, or cauterize the tissue to be destroyed. In some such embodiments, the optical-stimulation signal is provided by a first laser source (e.g., a laser diode, optically-pumped fiber laser, or the like), and the optical surgical signal is provided by a second laser source of higher intrinsic power or energy, or of a different wavelength more suited for surgical purposes (e.g., another laser diode, optically-pumped fiber laser, or the like). In other embodiments, a single laser source is used for both the optical stimulation signal and the optical surgical signal, wherein a parameter of the signal is changed to achieve one function or the other (e.g., in some embodiments, the optical surgical signal is obtained by shortening the pulse length, for example by Q-switching, in order that a given amount of energy is delivered in a very short time to ablate a small area of tissue, or by lengthening a pulse length having a constant average energy or by increasing the number of pulses sent in a short time period in order that one or more pulses with a given average power integrate over time to heat the tissue being treated).
  • In some embodiments, the targeting of various nerve fibers is performed manually (e.g., by manually moving a handpiece to locate the delivery end of an optical fiber so that light energy may be directed on to the nerve to be stimulated).
  • In some embodiments, as is disclosed below, the pulse shapes of the light generated by or controlled from the device are controlled through the use of a light-pulse device that regulates the light under control of a computer, microprocessor or CPU (e.g., x86 series, Intel 8051 CMOS series utilizing certain computer-executable instructions stored to a computer-readable medium, or under control of a non-computer, non-programmed electronic circuit).
  • A computer-readable medium is defined to be a medium for carrying or having computer-executable instructions or data structures stored thereon. Such computer-readable media may be any available medium that is accessible by a general-purpose or special-purpose computer system. By way of example, and not limitation, such computer-readable media can include physical storage media such as RAM, ROM, or EPROM, removable media such as CD-ROM or other optical-disk storage, diskettes, magnetic hard-disk storage or other magnetic-storage devices, or any other media which can be used to carry or store desired program code means in the form of computer-executable instructions, computer-readable instructions, and/or data structures and which may be accessed by a general-purpose or special-purpose computer system; this physical storage media may be fixed to the computer system as in the case of EPROM or a magnetic hard drive, or removable as in the case of an EEPROM on a USB-connected device (e.g., flash memory device) or CDROM, DVD, or diskette, or can include network-connected storage (such as a hard drive connected to the internet.
  • In some embodiments, various methods, systems, apparatus or the like are employed to guide the IR light to its target nerve fiber. In some embodiments, a disposable, biologically inert, non-metallic and/or non-magnetic optical tip at the end of the handpiece is provided. In some embodiments, this tip is adjustable or interchangeable so as to allow for the spot size to vary depending on type or location of nerve to be stimulated. In some embodiments, this tip is configured on a light pen, pointer or similar handheld device so as to allow the user to manually target a particular nerve fiber or series of fibers. In some embodiments, this optical tip is encased in or affixed to a disposable plastic sheath (e.g., a sterile sheath that is used once for an operation and then discarded), whereas in other embodiments it is encased in an end of the aforementioned light pen, pointer or similar device. In some embodiments, a sterile disposable sheath is applied to the handpiece before each use, and is discarded afterwards. In other embodiments, the handpiece, light pen, pointer or the light-delivery device itself is provided in a sterile condition, and is inexpensive enough to be disposable.
  • In some embodiments, the optical path is selectively interruptible by a mechanical shutter and/or variable aperture that allows the user to control the passage of laser light (i.e., the visible signal, optical-stimulation signal, optical surgical signal or the like) through the optical tip. In some embodiments, the shutter is used to start and stop the light passing through the optical tip. In some embodiments, as with the other components that form the delivery end of the device, this shutter and/or aperture is made from a non-metallic material such as a plastic, ceramic or similar material. In some embodiments, the variable aperture is adjustable to control the amount of light (e.g., the power and/or size of the spot), which, in some embodiments, also includes the start and stop of the light signal to the target tissue. In some embodiments, an iris diaphragm is provided to regulate the variable aperture through which light passes. In some embodiments, a non-metallic material such as a plastic, ceramic or similar material is used to construct the iris diaphragm. In some embodiments, the optical tip is secured to, or with, a ferrule or similar.
  • In some embodiments, the flow of stimulation and/or pointer light, be it IR or visible, is controlled via a mechanical linkage incorporated into the above-described handpiece, light pen or pointer. In such an embodiment, the linkage includes a trigger-like device that, when depressed or otherwise manually controlled, controls the flow of the above-described light.
  • In some embodiments, a sterile, disposable covering or sheath constructed from plastic, polymer or some other substance is placed over the above-described handpiece, light pen or pointer. This disposable covering is then discarded after use of the handpiece, light pen or pointer. In some embodiments, this disposable covering includes one of a plurality of different beam-shaping optics that allow for different beam characteristics for different applications.
  • In some embodiments, IR light in a higher or lower wavelength range may be more or less efficacious. For example, near-IR light (e.g., in the 700-1400 nm wavelength range) may be better for nerve-damage repair (or for cutting, ablating or cauterizing), while short-wavelength IR light (e.g., in the 1400-3000 nm range) may be better for vagus nerve stimulation, etc. The efficacy of a particular IR wavelength can be determined through empirical testing and/or modeling.
  • In some embodiments, a power controller is implemented that is operable to provide programmable pulse shapes (e.g., pulse width, repetition rate, etc. that can be varied in a programmable manner). In some embodiments, a laser light source is operatively coupled to a timer or pulse-regulating device that controls the shape, magnitude, cycles or other features of a light pulse. In some embodiments, this pulse-regulating device is used in conjunction with the above-described shutter, while in other embodiments it is used alone. In some embodiments, the pulse-regulating device is a remote control that is used from outside of the magnetic field generated by an MRI device, so as to not present a danger to an individual using an MRI device, while the hand-held device generating the stimulation light includes a receiver to obtain control information from the remote control but is made of materials that are compatible with use in the field of the MIR machine.
  • In some embodiments, a thumb/finger control mechanism includes a non-magnetic (e.g., plastic) component mechanism that is optically assessed in order to control the light source to drive a particular pulse shape (e.g., an optical assessment signal (e.g., an unmodulated laser or LED light signal) is sent to the component mechanism that is part of the thumb/finger control mechanism and the state of the component mechanism, which is a function of the position of the thumb/finger control mechanism, changes a characteristic of the light and returns it as an optical control signal). Specifically, whereas in some embodiments programmable pulses are automatically generated, in at least one embodiment, pulse shapes can be modified using a thumb/finger control that can modify the pulse width, repetition rate and the like. In some embodiments, a knob, toggle or other switch is used that allows a user to modify the pulse width by turning, for example, a knob to a particular position. The use of a knob, toggle or the like to modify the various pulse shapes can be determined through assessing the ergonomic benefits of a particular switch and switch location on the above- described handpiece or light pen.
  • In at least one embodiment, a laser-wavelength-selective device is implemented to couple the visible light and provide power control or laser-safety monitoring or output-power measurement. In some embodiments, this is done with a beamsplitter (e.g., a 10%-90%) to couple 10% of the visible laser signal into the optical beam having the stimulation-wavelength signal.
  • In some embodiments, the visible-light pointer includes a point-to-line or point-to-area beam spreader (e.g., a hologram) that generates a centered pattern (e.g., a cross-hair pattern with perpendicular lines that intersect where the stimulation will occur) that shows where the IR nerve-stimulation light will be (or is) directed, while providing better usability for the surgeon or technician by allowing the user to align one of the lines with the nerve.
  • In the discussions of the present invention, for brevity many embodiments describe laser diodes that are battery-powered. In any of the embodiments of the present invention, the battery can be replaced by another suitable self-contained energy-storage device (e.g., battery-like devices or other power source, such as capacitors, chemical energy, rotational flywheel energy, spring energy and the like that power the laser directly (e.g., chemical lasers) or are used to generate electricity (e.g., flywheel or spring-driven electrical generators); and/or a self-contained power receiver such as a coil for receiving AC magnetic or RF energy, a photovoltaic cell for receiving optical energy, and the like). Many embodiments, for brevity, describe laser diodes as the sources of optical radiation (IR or visible) however other embodiments use LEDs or diode-pumped rare-earth-doped optical fiber sources of laser, super-luminescent, or other radiant energy for the stimulation optical beam, the pointer visible beam, or both. Further, the exemplary embodiments shown include some features in some embodiments and not in others. It is to be understood that other embodiments of the present invention use combinations of features selected from the various figures and descriptions to achieve identical or similar operations.
  • FIG. 1A is a block diagram of a battery-operated nerve-stimulation laser handpiece system 100A. In some embodiments, system 100A uses a battery-operated nerve-stimulation handpiece 140A. In some embodiments, laser-diode assembly 111 is operatively coupled to a tip 107 that contains one or more light-transmitting optics or lenses 115. Some embodiments further include one or more lenses 114 for beam focusing, collimating, and/or shaping. In some embodiments, control of this IR and/or visible light is via trigger 108A (which, in some embodiments, includes one or more internal separately activateable switches) being pressed or otherwise activated by user 89—typically by the finger or thumb of user 89. In some embodiments, trigger 108A includes a flexible membrane portion of housing 132 that covers an internal switch that is operatively coupled to a laser controller/power controller 152 (alternatively designated light-emitting-source controller 152) that together with laser/light-emitting-source assembly 111 form light source 151. In some embodiments, power source 150 (also called self-contained energy source 150, which includes, e.g., batteries, in some embodiments) is interruptably connected to light source 151 via on-off switch 112A. In some embodiments, tip 107, on-off switch 112A and handpiece housing or handle 132 are grouped together and protected via a disposable replaceable sheath 105 to form handpiece 140A. In some embodiments, tip 107 forms a part of handpiece housing 132, and these are together inserted into the disposable sheath 105 via an opening 113, which is then folded over and sealed (e.g., via pressure-sensitive adhesive). In other embodiments, tip 107 and its lens 115 form a part of the disposable sheath 105 (this allows the optics to be interchanged with other disposable sheaths 105 having different optics by swapping sheaths, in order to easily obtain the desired optical pattern uniquely suited for nerve, brain or other tissue stimulation and avoiding possible contamination from the lens if the lens were left in place). Such a sheath 105 is pulled over the length of handpiece housing 132 until the light-transmitting optics or lens 115 of the tip 107 is flush or engaged with the opening 124 of housing 132. In some embodiments, the pieces of handpiece 140A are all manufactured from substantially non-metallic, non-magnetic materials such as plastics, polymers, ceramics or the like. In some embodiments, the light pattern desired from the optics is empirically determined by testing various patterns on various tissues and observing the reaction obtained. In other embodiments, the sheath 105 provides a clear window that covers tip 107 and its lens 115. In some embodiments, tip 107 and its lens 115 are configured to be an interchangeable optics mechanism (e.g., a threaded or snap-in imaging adaptor configured to be easily swapped), several different ones of which are provided as a kit with handpiece 140A.
  • FIG. 1B is a block diagram of a battery-operated nerve-stimulation laser handpiece system 100B. In some embodiments, reference numbers of elements shown in FIG. 1B refer to like-numbered elements described above for FIG. 1A. In some embodiments, handpiece 140B has few if any switches (such as 112A and 108A described for FIG. 1A), but rather is activated wirelessly by remote-control device 141. This helps prevent movement of the handpiece when the light is activated (in contrast to the embodiment shown in FIG. 1A, which might move when the user's finger presses on switch 108A). Instead, remote controller 141 includes one or more switches 108B (e.g., activated by user 89's foot, or opposite hand, or otherwise (such as a microphone and voice-recognition software on a computer, activated by the user's voice commands)), a controller 104B that interprets the activation of the one or more switches 108B and sends commands through wireless transmitter 109B to wireless receiver/controller 112B, which then activates the light-emitting functions of light source 151. Other aspects of system 100B are similar to those described for FIG. 1A.
  • FIG. 1C is a block diagram of a battery-operated nerve-stimulation laser handpiece system 100C. In some embodiments, system 100C uses a battery-operated nerve-stimulation handpiece 140C. In some embodiments, emission of IR and/or visible light from light source 151 is controlled via a foot-trigger 108C being pressed by the foot of user 89, which is operatively coupled to switch 112C via mechanical linkage 106C that is within cable sheath 109 (e.g., a flexible plastic rod in a flexible plastic tube). In some embodiments, handpiece 140C from tip 107 to cable sheath 109 are together inserted into disposable sheath 105 though opening 113, which is then closed and sealed to cable sheath 109 (e.g., with a twist-tie or pressure-sensitive adhesive). In some embodiments, other options for sheath 105 are as described for FIG. 1A. Other aspects of system 100C are similar to those described for FIG. 1A.
  • FIG. 1D is a block diagram of a combined light source or laser assembly 111. In some embodiments, light source 111 includes an IR-laser-diode emitter 101 that emits a wavelength of light useful for tissue stimulation and a front lens 104. Some embodiments further include a visible laser or LED 102 and a beam-combiner optic or optics 103 (for example, a highly reflective mirror 119 and a beam combiner plate 118, such as a dichroic mirror that is highly reflective of one wavelength (e.g., the visible-light wavelength of emitter 102) and highly transmissive of another wavelength (e.g., the stimulation-light wavelength of emitter 101). Some embodiments further include a therapeutic (e.g., surgical) beam generated by a high-power laser 117 and combined using a beam-combiner optic or optics 116 (similar to beam combiner 103, except for the wavelengths for which the dichroic mirror is configured). In some embodiments, combining the two or more beams into a single beam makes the downstream optics simpler. In other embodiments such as described below for FIG. 3, light source 111 generates two or more beams (e.g., parallel beams, in some embodiments), wherein the handpiece is configured to deliver the light in the separate beams to the desired location using suitable optics (e.g., some embodiments include two or more visible pointer beams that form separate beams that form separated spots, and the optics is arranged to focus the two visible beams into a single spot only when the invisible (IR) stimulation beam is in focus).
  • In some embodiments, one or more visible-light sources 102 emit visible indicator light (i.e., light having one or more visible wavelengths suitable for indicating to a user where the stimulation light or therapeutic (e.g., surgical) light will be delivered), which is coupled by light-beam combiner and/or coupler 103 to combine with the optical beam from stimulation-wavelength laser 101. In some embodiments, visible-light sources 102 include one or more visible-light LEDs, incandescent lamps, and/or laser diodes emitting light at one or more different wavelengths (e.g., 0.45-micron blue light (e.g., gallium-indium nitride devices), 0.55-micron green light (e.g., gallium-indium nitride LED or laser-diode devices), 0.63-micron red light (e.g., gallium-arsenide LED or laser-diode devices), or other wavelengths useful for pointing and/or delivering to the user function-state information, such as different colors or pulsing characteristics to indicate which function has been selected) under control of light-emitting-source controller 152.
  • In some embodiments, one or more high-power laser sources 117 emit high-power laser light (or very-short-pulse laser light), which is coupled by light-beam combiner 116 and/or coupler 103 into the output beam In some embodiments, high-power laser sources 117 include one or more high-power lasers or laser diodes or optically-pumped-fiber lasers emitting light at one or more different wavelengths (e.g., 1.55 microns, or other wavelengths useful for surgical purposes) under control of light-emitting-source controller 152. In some embodiments, the high-power laser light effects a burning or cutting operation where heat results from the laser interaction with the tissue (i.e., absorbing photon energy from the laser light and converting it to heat). This can result in cauterizing the surrounding tissue and reducing bleeding. In other embodiments, the very-short-pulse laser light (e.g., from one or more femtosecond-pulse lasers that concentrate power into a very short time period, such as are described in U.S. Patent Application Publication US 2004 0243111 A1 by Mark Bendett et al. and U.S. Patent Application Publication US 2004 0243112 A1 by Mark Bendett et al., both of which are incorporated by reference) effects an ablation or tiny explosion that removes tissue with substantially no heating of surrounding or underlying tissue.
  • FIG. 1E is a block diagram of a battery-operated nerve-stimulation laser handpiece system 100E. In some embodiments, system 100E includes a handpiece 140E having a programming and/or recharging port 160 (such as a USB port) that is removably connectable to a computer system 174 for recharging power system 150 (e.g., its batteries) and/or for programming the controller of light source 151. Such programming includes, in some embodiments, one or more predetermined characteristics of the light output such as the duration (e.g., the number of milliseconds the pulse is active), number (e.g., the number of pulses in one train, or the total number of pulses allowed in any one session), power (e.g., the total number of watts or the watts per area), shape (e.g., rising trapezoid, flat-top, or falling trapezoid or other shape of each pulse), envelope (e.g., the overall shape of the pulse train, for example, rising trapezoid, flat-top, or falling trapezoid or other shape of the envelope of a series of pulses) or like characteristics of the single pulse or pulse train that is initiated by user activation of trigger 108A (which, in some embodiments, includes one or more internal separately activateable switches). In other embodiments, the programming and/or rechargeability functions described here are combined into any of the other handpieces 140 (with any letter suffix) of the present invention described herein. In some embodiments, a computer-readable medium stores programs and/or computer-executed instructions that are loaded into PC 174 and/or into handpiece 140E that control the method performed in handpiece 140E and/or the user interface to handpiece 140E. In some embodiments, computer system 174 includes a user-input device such as keyboard 175 that communicates with the computer-processing unit of computer system 174 through connecting link 176, which may be a hardware-connecting link 176 or a wireless connecting link 176.
  • FIG. 1F is a block functional diagram of battery-operated nerve-stimulation laser handpiece system 100E as shown in FIG. 1E described above. Box 108F shows various input indications received from a user-manipulating trigger 108A of FIG. 1E described above. For example, in some embodiments, an array of one or more buttons and/or a rotateable thumbwheel are activated by the user to initiate one or more functions (e.g., turning on the pointer laser, the nerve-activation laser, or the therapeutic laser, or changing their function). In some embodiments, a single click on a button will cause one function to be performed, while two clicks in short succession produce a different function. In some embodiments, the USB interface 160 allows the program in programmable controller 177 to be changed, and/or provides a charging mechanism for batteries 150, which are later used to power programmable controller 177 for functionality and power controller 159 that is used to drive the laser and/or LED light source(s) (e.g., 101 and 102). In some embodiments, a display 117 is provided (e.g., and LCD screen or one or more LEDs of one or more colors) that displays text and/or graphics to show the activation state of the lasers, and their characteristics such as power, pulse length, repetition rate and the like.
  • FIG. 1G is a block diagram of battery-operated nerve-stimulation laser handpiece system 100G having a mister 195 and/or focus plate 194. Handpiece 140G is similar to handpiece 140C of FIG. 1C, but with the addition of a spring-loaded-tip light controller 167. In some embodiments, focus plate 194 provides a predetermined optical distance between handpiece 140G and the nerve 69 that is being stimulated. In some embodiments, focus plate 194 includes wetter 195 having a squeeze bulb 193 containing a sterile saline solution and/or index-of-refraction-matching liquid that is applied by squeezing drops through nozzle 196, either directly onto nerve 69 in tissue 68, and/or under (i.e., providing a clean gap-free interface between plate 194 and nerve 69) and/or on top of, focus plate 194 (i.e., providing a clean gap-free interface between plate 194 and handpiece 140G). In some embodiments, lens 115 is mounted on a spring-loaded selector-activation rod 167, such that when the tip of handpiece 140G is pressed onto a nerve or onto focus plate 194, the visible pointer-light source and/or the stimulation-light source is activated and pointer and/or stimulation light is emitted. In some such embodiments, selector buttons 127 and 117 are omitted, such that the handpiece 140G is selectively activated only when tip 167 is pressed against the subject or other object. In other embodiments, one or more of the activation signals to the various light sources is activated by switches 117 and/or 127, and/or by a remote activation switch as described elsewhere herein. In some embodiments, a mechanical shutter replaces selector 161, and is activated (e.g., opened) to allow light to be emitted only when the tip 167 is pressed (in some embodiments, other activation signals are also required, but the light is not emitted until the tip is also pressed). In some embodiments, such a spring-loaded tip helps to ensure that the correct focal distance is obtained before the laser is activated. In some embodiments, focus plate 194 (made of glass, plastic, or other material transparent to the light wavelengths of interest) is of a thickness such that when lens 115 is pressed on one face of focus plate 194 with stimulation light being emitted, and the other face of focus plate 194 is pressed onto nerve 69, the light is focussed to a spot size that is desired. In some embodiments, use of focus plate 194 also keeps the nerve moist and alive by preventing evaporation. In some embodiments, wetter 195 can be used to apply a moistening liquid or gel onto nerve 69 or onto the nerve-side face and/or outside face of focus plate 194 (besides keeping the nerve moist and alive, this provides an index-of-refraction matching, which reduces reflections; drying can cause tissue damage and changes the reflectivity to the stimulation light signal).
  • FIG. 1H is a block diagram of battery-operated diode-laser-pumped rare-earth-doped fiber emitter nerve-stimulation handpiece system 100H. In some embodiments, the invention uses fibers and pump-diode lasers such as described in U.S. patent application Ser. No. 11/426,302, filed Jun. 23, 2006 and titled “APPARATUS AND METHOD FOR A HIGH-GAIN DOUBLE-CLAD AMPLIFIER,” U.S. patent application Ser. No. 11/488,910, filed Jul. 17, 2006 and titled “APPARATUS AND METHOD FOR GENERATING CONTROLLED-LINEWIDTH LASER-SEED-SIGNALS FOR HIGH-POWERED FIBER-LASER AMPLIFIER SYSTEMS,” U.S. Provisional Patent Application Ser. No. 60/748,379, filed Dec. 7, 2005 and titled “APPARATUS AND METHOD FOR AN ERBIUM-DOPED FIBER FOR HIGH-PEAK-POWER APPLICATION,” and U.S. Provisional Application Ser. No. 60/733,977, filed Nov. 3, 2005 and titled “APPARATUS AND METHOD FOR A WAVEGUIDE WITH AN INDEX PROFILE MANIFESTING A CENTRAL DIP FOR BETTER ENERGY EXTRACTION,” each of which is incorporated herein by reference. In some embodiments, a pump laser diode emits pump light at about 960-micron wavelength, the doping species of the fiber is chosen (using a table of such elements that are well known to persons of skill in the art) to obtain a wavelength suitable for nerve or other tissue stimulation. In some embodiments, controller and laser device 158 includes electronics and light emitters. In some embodiments, one or more of the light emitters operate with visible wavelengths for pointer use, and one or more light emitters in wavelengths suitable for pumping the fiber emitters 159 (i.e., the pump lasers emit a wavelength suitable for pumping the fiber laser segment(s) 159). In some embodiments, fiber emitters 159 include feedback devices such as mirrors, gratings or the like, and operate as lasers. In other embodiments, the fibers serve as superluminescent emitters, wherein spontaneous emission of the fibers is amplified in the fibers. Other aspects of system 100H are as described in the above figure descriptions.
  • FIG. 2 is a block circuit diagram of battery-operated nerve-stimulation laser handpiece system 200. In some embodiments, power source 150 is connected to circuit 210, which provides drive current to stimulation-wavelength laser 101. In some embodiments, circuit 210 includes a one-shot circuit 283 that outputs macro pulse envelope waveform 284 of a suitable shape (flat, rising, or falling or other shape), repetition and duration, which signal is then optionally modulated with micro-pulse modulator 285 to obtain a suitable train of one or more shorter-duration pulses, such as waveform 286 or 287, and laser diode 101 outputs stimulation light having a corresponding amplitude light output (some embodiments switch the order of components, placing the micro-pulse circuit 283 first and use the one-shot 283 as an envelope modulator, other embodiments use other orders of components or substitute circuit functions (e.g., software or microcode control of a power transistor driven by a microcontroller)). In other embodiments, circuit 210 is simply a direct drive of an infrared laser diode 101 from switch 108.
  • FIG. 3 is a block diagram of focus-indicating nerve-stimulation laser handpiece system 300. In some embodiments, one, two, or more visible laser diodes 102 are arranged around (e.g., in some embodiments, one on either side and parallel with) the beam of the tissue-stimulating laser diode 101. A single lens 115 or a series of two or more lenses (e.g., 104, 114, and 115) are used to collimate and focus the nerve-stimulation beam to a point, or a suitable shape of a desired size. This optical path causes the two pointer beams (e.g., a red pointer beam from the top laser 102 and a blue beam from the bottom laser 102) to cross at the optimal focus depth to obtain the desired focus of the non-visible IR nerve-stimulation beam. If the lens 115 at the tip of the handpiece 140 is too close, the blue-beam's spot will be below the red-beam's spot, or if the lens 115 at the tip of the handpiece 140 is too far from the nerve, the blue-beam's spot will be above the red-beam's spot. When at the correct focus, the red spot and blue spot will coincide—be on top of one other.
  • One way to perform a surgical or therapeutic operation is to use a laser to ablate, cut, and/or cauterize tissue. In particular, very-short-pulse laser light (e.g., from one or more lasers that emit pulses shorter in duration than one nanosecond (typically called femtosecond pulses) concentrate power into a very short time period, such as are described in U.S. Patent Application Publications US 2004 0243111 A1 and US 2004 0243112 A1 by Mark Bendett et al., both of which are incorporated by reference) effects an ablation or tiny explosion that removes tissue with substantially no heating of surrounding or underlying tissue since the laser is turned off immediately after the extremely short pulse. In other embodiments, somewhat longer pulses and/or higher laser powers are used, and some heating and/or cauterization results. When a pulse train or series of such pulses are successively directed at a point, along a line or within an area, the tissue at that point, along that line or within that area is removed to a given depth. Further repetitions of pulses at the point, line, or area remove tissue to successively greater depths. The tissue-removing laser pulses act as an optical scalpel.
  • In some embodiments, it is desirable that the surgical or therapeutic operation be suppressed (inhibited or sufficiently reduced) to avoid damaging a nerve (e.g., to avoid damaging a facial nerve during an operation to remove a tumor). As used herein, “suppressed” includes both “inhibited” (meaning substantially stopped altogether) and “reduced” (meaning that the depth and/or lateral extent is reduced but not entirely inhibited). Using conventional methods, it is often difficult or cumbersome to locate particular nerves and/or to suppress the surgical or therapeutic operation when a nerve is located. Various embodiments of the present invention address these issues by sensing a result of stimulating a nerve (either a nerve action potential along the nerve at a short distance from the stimulation, or some other result such as a muscle twitch, or the like, caused by the nerve stimulation; still other embodiments directly stimulate a non-nerve tissue such as a muscle and sense that result), and then enabling the surgical operation (if it is desired to remove the tissue that reacted to the stimulation) or suppressing the surgical operation (if it is desired to preserve the tissue that reacted to the stimulation).
  • In some embodiments, the present invention provides an optical-electrical mechanism to stop the surgical laser pulses and/or reduce their power when the stimulation laser(s) and nerve sensor(s) detect a nerve, in order to preserve the nerve (if possible) while still removing other tissue as needed. In other embodiments, the surgery is performed by a mechanical scalpel (e.g., one that is robotically assisted or controlled, and the optical nerve stimulation and sensing is used to control movement and/or cutting of the mechanical scalpel to prevent or minimize nerve damage.
  • In some embodiments, a local anesthetic and/or analgesic 404 (e.g., such as novacaine or acupuncture; see FIG. 4A) can be administered “upstream” (e.g., between the surgical site and the brain) along a sensory nerve to prevent pain and discomfort during the operation, while the nerve stimulation and sensing of the present invention is still functional to locate and preserve the nerve at the site of the operation.
  • In some embodiments, the nerve simulation and sensing and the control of the optical scalpel is performed in “real time” in that the surgeon activates the cutting function and the stimulation/sensing functions, and manually moves the optical scalpel along a line, with a visible pointer laser indicating the location of where both stimulation and cutting would occur. As the optical scalpel is moved across or along a nerve that is stimulated by the stimulation laser, the sensing apparatus (e.g., a hook probe attached along the nerve) senses when the nerve is stimulated, and inhibits the cutting function until the optical scalpel has been moved off the nerve, whereupon the inhibition ceases and cutting again commences. In some such embodiments, the stimulation and sensing functions are used alone to determine a suitable location (e.g., perhaps at the junction of the ophthalmic, maxillary and mandibular branches of the trigeminal sensory nerve of the face) on the patient for placing each of one or more sensing probes. After the sensing probes are in place, the cutting function can be activated, and the sensing of nerve response would inhibit the cutting function to protect the sensed nerve. In some embodiments, a combination of “upstream” sensing-nerve sensors and “downstream” motor-nerve sensors are used to protect both types of nerves within the surgical area. In some embodiments, one or more stimulation pulses are alternated with one or more cutting pulses, such that the stimulation and sensing is done immediately before cutting is attempted, and if a nerve response is sensed, the cutting operation is suppressed.
  • Again, as used herein, “suppressed” includes both “inhibited” (meaning substantially stopped altogether) and “reduced” (meaning that the depth and/or lateral extent is reduced but not entirely inhibited). Typically, if a single nerve is stimulated, the response is either all (an action potential is triggered since the stimulation reached a threshold) or nothing (either no stimulation or a failed initiation where threshold is not reached and no action potential is propagated), while if an entire nerve bundle is stimulated, the signal strength can vary between a weak signal and a strong signal depending on the number of neurons that reached threshold. In some embodiments, any sensed reaction to nerve stimulation will inhibit or very strongly reduce the cutting depth (and/or lateral extent). In other embodiments, a strong sensed reaction to nerve stimulation will inhibit or strongly reduce the cutting depth (and/or lateral extent of the tissue removal), while weaker sensed reaction to nerve stimulation will reduce the cutting depth based on the strength of the sensed signal, providing a variable cutting based on how far from the nerve the cutting will occur or how large is the nerve bundle (e.g., sometimes allowing cutting or damage to small nerves while preventing damage to larger nerves).
  • In some embodiments, the surgical area is defined by a mask or marked boundary outside of which the cutting function is inhibited. For example, in some embodiments, the area to be treated is delineated by a marked line or shading (e.g., ink or a fluorescent dye) that indicates where cutting is permitted, and only when the visible pointer beam is projected on the allowed area is the cutting beam activated, but when the pointer is outside the allowed area, the cutting is inhibited. This additional inhibition function provides an additional safeguard as to where cutting is performed.
  • In other embodiments, rather than real-time stimulation sensing and inhibition, these functions are temporally separated, such that the sensing function is used first to create a map of the nerve locations, and later the inhibition functions are controlled by that map. For example, in some embodiments, the optical stimulation and the sensing are used to locate points along the various nerves within the planned surgical area. In some embodiments, these nerves are delineated by marked lines or shading (e.g., ink or a fluorescent dye) that indicate where cutting is or is not permitted. In other embodiments, one or more video cameras are connected to a computer and used to provide the location of the pointer laser when a response is sensed, and these locations are recorded into the computer's memory (e.g., optionally using fiducial marks or facial features as references for the map), and a computer-generated light map defining the nerve locations is projected (e.g., by a computer-projector display) onto the patient's tissue (e.g., the face). This map is then used to guide the cutting operation, both showing the surgeon where the nerves are located and/or as cut-inhibiting references that are sensed by the computer's video camera(s) such that when the pointer laser is on or next to a previously located nerve (as indicated by the proximity of the laser-pointer light to the projected nerve location), the cutting function is inhibited.
  • FIG. 4A is a block diagram of surgery-inhibiting nerve-stimulation system 400A. In some embodiments, system 400A stimulates a tissue of patient 88 using an optical signal 401 focussed to a suitably small tissue area and a suitable tissue depth. If a sensory nerve 87 (and/or a motor nerve) is stimulated by the optical stimulation signal 401 (e.g., a laser signal pulse having an IR wavelength of about 1.8 microns, in some embodiments) sufficiently to trigger an action potential (e.g., a CNAP), that nerve stimulation is sensed (e.g., by the nerve's electrical signal sensed by a needle-sized hook probe or other suitable probe along the stimulated nerve a short distance away (e.g., towards the brain if the nerve is a sensory nerve, or towards the muscle if the nerve is a motor nerve), or by a mechanical sensor such as a small piezo sensor or strain gauge that outputs an electrical signal if the muscle twitches due to the nerve being stimulated) and if sense signal 402 indicates the nerve was stimulated, then surgical or therapeutic operation 403 is suppressed (inhibited or sufficiently reduced) to avoid damaging the stimulated nerve 87.
  • For example, in some embodiments, the stimulation signal is formed and/or focussed onto the patient's tissue to a stimulation spot diameter of 0.1 mm or smaller to a spot diameter of 2 mm or larger, although various embodiments use spot diameters of about 0.1 mm, about 0.2 mm, about 0.3 mm, about 0.4 mm, about 0.5 mm, about 0.6 mm, about 0.7 mm, about 0.8 mm, about 0.9 mm, about 1.0 mm, about 1.1 mm, about 1.2 mm, about 1.3 mm, about 1.4 mm, about 1.5 mm, about 1.6 mm, about 1.7 mm, about 1.8 mm, about 1.9 mm, about 2.0 mm, about 2.2 mm, about 2.4 mm, about 2.6 mm, about 2.8 mm, about 3.0 mm, about 3.2 mm, about 3.4 mm, about 3.6 mm, about 3.8 mm, about 4.0 mm, about 4.2 mm, about 4.4 mm, about 5.6 mm, about 4.8 mm, or about 5.0 mm, or over about 5 mm; in some embodiments, the spot is circular while in other embodiments, the spot is elongated to an oval, a rectangle or a short line and a suitable tissue depth (e.g., in some embodiments, to a stimulation depth of about 0.6 to 0.7 mm; in other embodiments, to a stimulation depth 0.1 mm or shallower to a stimulation depth of 2 mm or deeper, although various embodiments use stimulation depth of about 0.1 mm, about 0.2 mm, about 0.3 mm, about 0.4 mm, about 0.5 mm, about 0.6 mm, about 0.7 mm, about 0.8 mm, about 0.9 mm, about 1.0 mm, about 1.1 mm, about 1.2 mm, about 1.3 mm, about 1.4 mm, about 1.5 mm, about 1.6 mm, about 1.7 mm, about 1.8 mm, about 1.9 mm, about 2.0 mm, or deeper than 2 mm).
  • Referring again to FIG. 4A, in some embodiments, system 400A includes a stimulation unit 410 that outputs an optical signal that is effective at stimulating a nerve 87 of patient 88. In some embodiments, stimulation unit 410 includes block 412 (e.g., a trigger such as 108A of FIG. 1A described above) that activates an optical stimulation source, block 414 (e.g., an IR laser diode such as device 151 of FIG. 1A described above) that generates an optical stimulation signal, and unit 416 (such as an optical fiber and/or lens system that directs and/or focuses optical signal 401 onto a particular location with desired characteristics (such as size, power, shape, and the like) to stimulate nerve 87). In some embodiments, a suitable probe (such as a needle hook adapted to attach to an empirically determined location on nerve 87 to detect whether an action potential has been triggered) generates a relatively small signal that is amplified and/or conditioned by block 422 (e.g., a sensitive low-current differential operational amplifier circuit) and block 424 (e.g., an analog and/or digital logic circuit that examines the output signal from block 422 in relationship to the stimulation trigger from block 412 to determine whether to reduce or inhibit the surgical signal and/or by how much to reduce the cutting signal) that generates control signal 425. In some embodiments, control signal 425 controls one or more aspects of block 430, which is what generates and/or controls the surgical optical pulses 403. In some embodiments, stimulation optical signals 401 and/or surgical optical signals 403 also include a visible pointer signal to show the user where the stimulation and/or surgery is taking or is soon to be taking place, and optionally the stimulation signal, the visible pointer, and the cutting optical signal are all generated from a single unit (e.g., an optical unit such as unit 111 of FIG. 1D) and/or are all combined and delivered through a single output lens and/or optical fiber. In some embodiments, block 430 is implemented as a separate laser and controller (e.g., such as a LASIK opthalmic surgical optical source (Laser-Assisted In Situ Keratomileusis, using an excimer laser)) whose output is controlled and/or inhibited by control signal 425, and delivered by an optical fiber or combined into a single optical fiber with the stimulation signal 401 for delivery and placement onto the surgical site on patient 88. In other embodiments, a single hand-held self-powered (e.g., via internal batteries or other power source 150, as shown in the figures above) stimulation and surgical laser handpiece is implemented and the cutting operation is controlled and/or inhibited by control signal 425 generated by an integrated or by a separate sensing and inhibition unit 420 (e.g., in some embodiments, system 400A is implemented and contained in a single handpiece such as 140E of FIG. 1E described above).
  • In various embodiments, the sensing, inhibition and/or control functions of sensing and inhibition unit 420 are used in combination with or integrated into any of the nerve-simulation systems described herein or described in U.S. patent application Ser. No. 11/420,729 filed on May 26, 2006 entitled “APPARATUS AND METHOD FOR OPTICAL STIMULATION OF NERVES AND OTHER ANIMAL TISSUE” (which is incorporated herein by reference).
  • FIG. 4B is a block diagram of surgery-inhibiting optical-signal nerve-stimulation system 400B. In some embodiments, the sensing, inhibition and/or control functions of sensing and inhibition unit 420 are used in combination with or integrated into a conventional electrical nerve stimulation unit 460 such as a conventional electrical-based electromyography (EMG) machine as is commonly used for nerve-conduction studies. In some embodiments, block 462 (e.g., a trigger corresponding to block 412 of FIG. 4A described above) activates an electrical stimulation source, block 464 (e.g., corresponding to block 414 of FIG. 4A described above) that generates an electrical stimulation signal, and unit 466 (such as a wire or needle along a side of the optical fiber, or an electrical conductor or sheath on the optical fiber that directs and/or focuses optical signal 403 onto a particular location with desired electrical characteristics (such as voltage, current, temporal shape, and the like) to stimulate nerve 87), wherein an electrical signal 406 is delivered by the electrical conductor (e.g., wire) to stimulate tissue next to the delivery end of the optical fiber that delivers optical surgical laser pulses 403, and the sensing and inhibition unit 420, when a nerve signal is sensed (a nerve signal initiated by electrical stimulation from the needle above), inhibits or reduces the power to the optical pulses 403 used for cutting/ablation.
  • FIG. 4C is a block diagram of surgery-inhibiting optical-signal nerve-stimulation system 400C. In some embodiments, system 400C is the same as system 400A of FIG. 4A described above, but with the addition of a camera and projector mapping system 440 that detects the locations of one or more nerves, optionally projects a map of the located nerves, and suppresses output from the cutting laser when in the vicinity of the detected and mapped nerves. In some embodiments, camera and projector mapping system 440 includes a camera 442 that gathers light 441 from the patient 88 and forms a digital image 443. In some embodiments, fiducial marks 84 (e.g., crosses drawn by an ink pen) are placed on the patient 88 and are detected on digital image 443 by image processor 444 (e.g., a combination of hardware and software, in some embodiments). The location 85 of the visible pointer laser (part of signal 401) from optical pointer/optical stimulation unit 410 is also located by image processor 444 from image 443. By correlating the location 85 on image 443 relative to fiducials 84 (or relative to other features of the image) at the moment that a nerve reaction is sensed in signal 402 by sensing circuit 412 and transmitted to image processor 444, a map 445 of the location(s) of nerve(s) on the patient is generated by image processor 444. In some embodiments, map 445 is also projected onto patient 88 as a projected pattern 447 from projector 446 that is visible as projected map 448 of the one or more nerves. The map that results can be used a short time later (e.g., a matter of seconds or minutes later, or even hours later) in combination with the detected location cutting signal 403 (either by camera 442 being sensitive to the wavelength of the cutting signal 403, or by including a visible laser signal that is coincident with cutting signal 403 and which is thus detectable by camera 442) to activate the inhibiting/control circuit 426 (similar in output to circuit 424 described above for FIG. 4A), which then suppresses the cutting portion of signal 403. This configuration of FIG. 4C is particularly useful when the nerve reaction time to stimulation is slow relative to the movement speed of the cutting optical implement 430, such that real-time sensing and inhibition is impractical. System 400C can be used to map the location of the nerves at a speed compatible with the nerve reaction and conduction times, and the map 445 can then be used to suppress (inhibit or reduce, as desired) the cutting beam. Note that in some embodiments, the map 445 need not be projected onto the patient (i.e., projector 446 can be omitted), but its data on the nerve locations can still be used to inhibit cutting in the locations of the mapped nerves.
  • FIG. 4D is a block diagram of surgery-inhibiting nerve-stimulation system 400D. System 400D is similar to system 400A described above for FIG. 4A, except that the handheld self-contained stimulation unit 140B (such as unit 140B of FIG. 1B described above) is physically separate from handheld self-contained surgical unit 480B (similar to unit 140B of FIG. 1B described above, except that a surgical-ablation laser (one that outputs femtosecond-type pulses capable of ablating very small pieces of tissue) replaces the stimulation laser). In some embodiments, a wireless transceiver-controller 109B (e.g., part of a unit such as unit 141 of FIG. 1B) transmits control signals to handpiece 140B and also indicates the timing of those pulses to inhibiting/control logic 424. If the differential sensing amplifiers (op amps) 422 detect a nerve-action-potential caused reaction (e.g., a nerve twitch sensed by skin-mounted motion sensors (as are well known in the art) or galvanic skin response sensors (e.g., such as are used in polygraph truth detectors, also well known in the art)), the resulting signal to response-sensing, surgery-inhibiting logic 424 sends a control signal 425 to wireless transceiver-controller 409B, which transmits an inhibit signal via its wireless linkage to handpiece 480B, and the cutting signal is reduced and/or inhibited based on the sensed signal. In other embodiments, the functions of both handpieces 140B and 480B are combined into a single handpiece having a combination of some or all of the above- described functions. In some embodiments, the wireless transceiver-controller 409B and/or wireless transceiver-controller 109B also have trigger signal inputs so a user can use a remote control (such as one or more foot-activated switches to activate their respective functions.
  • FIG. 5A is a perspective cut-away diagram of a surgery-inhibiting nerve-stimulation system 500 at the initiation of a surgical procedure. In some embodiments, hand-held laser stimulation/surgical device 540 includes a plurality of light-emitting functions including emitting an optical nerve-stimulation signal, a visible optical pointer signal, and/or an optical surgical ablation signal, and also includes a surgical suppression function as described above for FIGS. 4A-4D. In some embodiments, hand-held laser stimulation/surgical device 540 is scanned back and forth (e.g., in a raster pattern) and projects optical stimulation light onto the skin of patient 88, with any nerve- reaction signal (i.e., as a result of the optical stimulation) that is detected sending a signal along wire 402 to inhibit the surgical function of stimulation/surgical device 540. If no nerve-reaction signal is detected, the surgical function of laser stimulation/surgical device 540 is activated, with a resulting surgical operation being performed (e.g., ablation of the thin layer of tissue that has been stimulated with no ensuing nerve-reaction signal being detected). In some embodiments, the nerve-stimulation signal is one or more pulses that are projected, and if no suppression signal is generated, one or more ablation light-signal pulses are emitted, and the process of this sentence is iteratively repeated as the handpiece is moved across the tissue surface.
  • In some embodiments, the stimulation function of laser stimulation/surgical device 540 penetrates about 0.6 mm, and is not sufficiently intense to stimulate nerve 87 that lies below that depth in patient 88's tissue. In some embodiments, laser stimulation/surgical device 540 is configured to be moved back and forth across patient 88's skin manually. In other embodiments, laser stimulation/surgical device 540 is moved back and forth across patient 88's skin automatically (e.g., being controlled by a programmed computer-control system). In some embodiments, the surgeon marks the patient's skin (e.g., with a pen line 544 on the patient's skin or with white tape that masks the area outside line 544, or the like) to delineate the area where surgery is allowed, and surgery-area boundary marking 544 is used as a predetermined boundary marking that limits the travel excursion of laser stimulation/surgical device 540 (or inhibits its surgical light output) in computer-controlled embodiments. Surgery-area boundary marking 544 may also be a predetermined boundary marking that serves as a guide to limit the manual travel excursion of laser stimulation/surgical device 540 (or inhibits its surgical light output) in manually controlled embodiments.
  • FIG. 5B is a diagram of a first stimulation/surgical pattern 542 at an operation site sight at which a surgery-inhibiting nerve-stimulation system is employed, at a first time subsequent to the initiation of a surgical procedure. Laser stimulation/surgical device 540 (see FIG. 5A) passes back and forth across patient 88's skin, along pattern 542 that is limited by surgery-boundary marking 544. In some embodiments, the surgical light output from handpiece 540 ablates to a small depth on each pass, and deeper tissue removal is accomplished by repeated passes. Since no nerve stimulation was detected in this embodiment so far (since the nerves are located deeper than the stimulation penetration), the cutting/tissue ablation signal is not inhibited (note the continuous dark lines for pattern 542), and a uniform tissue removal is accomplished within boundary 544.
  • FIG. 5C is a diagram of a surgical sight at which a surgery-inhibiting nerve-stimulation system is employed, at a time when the stimulation/surgical pattern shown in FIG. 5B has been completed. Tissue has been surgically removed by laser stimulation/surgical device 540 to a shallow depth 546 and to lateral boundary 544.
  • FIG. 5D is a diagram of a second stimulation/surgical pattern at an operation site sight at which a surgery-inhibiting nerve-stimulation system is employed, at a second, later time subsequent to the initiation of a surgical procedure, and showing the surgical site at a time when the second stimulation/surgical pattern has been completed. Manual or computer-controlled passing of laser stimulation/surgical device 540 across patient 88's body within boundary 544 ablates-away further tissue to a depth 547 where no nerve has been stimulated. However, where the stimulation function of laser stimulation/surgical device 540 has resulted in stimulation of a nerve and a nerve reaction has been detected (e.g., by hook probe 402, in some embodiments) as the stimulation signal hits and triggers a nerve response with a resulting action-potential signal being detected and directed along wire 402 (see FIG. 5A), the surgical function of laser stimulation/surgical device 540 is suppressed (note the light dotted lines above the nerves where ablation is suppressed, but the dark lines in other areas where ablation is not suppressed), resulting in non-ablation of nerve 87; the top of non-ablated nerve 87 is at depth 541.
  • FIG. 5E is a diagram of a third stimulation/surgical pattern at an operation site sight at which a surgery-inhibiting nerve-stimulation system is employed, at a third, later time subsequent to initiation of a surgical procedure, and showing the surgical site at a time when the third stimulation/surgical pattern has been completed. Further non-nerve tissue has been ablated away to a depth 548 within boundary 544, however, nerve 87 is again not ablated by laser stimulation/ surgical device 540—the nerve having been stimulated by the stimulation function, with a signal resulting from detection of a nerve reaction passing up wire 402 and inhibiting the surgical function. The top of non-ablated nerve 87 remains at depth 541.
  • FIG. 5F is a diagram of an operation site sight at which a surgery-inhibiting nerve-stimulation system is employed, when the operation has been completed. Non-nerve tissue has been ablated or otherwise surgically removed to a depth 549 within boundary 544. But again, nerve 87 has not been ablated by laser stimulation/surgical device 540—the nerve having been stimulated by the stimulation function, with a signal resulting from detection of a nerve reaction passing up wire 402 and inhibiting the surgical function. The top of non-ablated nerve 87 remains at depth 541. In this way, unwanted tissue (e.g., a tumor) can be removed while preserving at least some of the nerves passing through the surgical site.
  • In some embodiments, an imaging optics turret (such as described in U.S. patent application Ser. No. 11/420,729 filed on May 26, 2006 entitled “APPARATUS AND METHOD FOR OPTICAL STIMULATION OF NERVES AND OTHER ANIMAL TISSUE” which is incorporated herein by reference) is provided at the operative end of handpiece 140 (with any letter suffix following the “140”) of the present invention, such that different optical patterns, spot sizes, and/or focal lengths can be provided by selecting one of a plurality of different lenses or holographic imagers (e.g., a turret that can be rotated to select one imaging optical element of the plurality of imaging optics). In other embodiments, a zoom-type lens is provided such that spot size and/or shape and focal length can be independently changed.
  • In some embodiments, a plurality of manually or foot-activateable trigger buttons and corresponding wireless connections, mechanical linkages, electrical connections, or other connectivities, are provided to select and/or activate one or more of a plurality of different functions of the handpiece, as described below. In other embodiments a voice-activated switch or other activation means is used instead of or in addition to manually activated or foot-activated buttons.
  • In other embodiments, the mechanical linkage(s) and trigger(s) are omitted and replaced with a non-magnetic optical-fiber-connected controller-selector that is manually operable to select and/or activate one or more functions. In still other embodiments, a foot-operated control is used instead.
  • In some embodiments of the mechanically-linked or optical-fiber-connected manual or foot controls (or a similarly functional foot control), three buttons are provided: a first button that when pushed a first time starts a series of one or more optical pulses, which series of one or more optical pulses optionally can automatically stop after a period of time determined by the function selected, or optionally can stop only after the user presses this first button a second time; a second button that, when pressed, advances a function-selecting state machine to the next one of a plurality of different optical-stimulation functions (e.g., no stimulation function is selected, or selecting the duration, intensity, pulse rate, pulse shape, pulse-train shape or pattern, and/or wavelength(s), and the like, for the IR stimulation light), wherein these functions are activated and/or deactivated by pressing the first button; and a third button that, when pressed, advances a state machine to the next one of a plurality of different optical-surgery functions (e.g., no surgical function is selected, or ablation, cutting, cauterizing, and the like functions for the high-powered laser light) that are activated and/or deactivated by pressing the first button. In some embodiments, successive presses of the stimulation or surgery function-selection buttons cycle through each of the items on the menu(s) of functions available.
  • In some embodiments, a single actuation/control button 108 is used both to select a stimulation function (e.g., by successive single long-duration presses of button 108 to select different functions as shown, e.g., in FIG. 1F) and to control triggering or timing of the stimulation light (e.g., by a quick double-click of button 108).
  • In some embodiments, upon changing the stimulation and/or surgery function by pressing of the respective function-selection buttons, the color of the visible light being sent down the optical fiber changes to a different color (e.g., hue, saturation, and/or intensity) and/or pulse (brightness pulsations) pattern, wherein the visible light color and/or pulsing of the light intensity is indicative of the function selected, thus providing instant feedback to the user concerning which function is currently active. For example, in some embodiments, a steady light of one of a plurality of different colors indicates that a stimulation function has been selected, wherein the color indicates which of the stimulation functions has been selected; whereas a quickly pulsating light of one of a plurality of different colors (also different than the stimulation-indicating colors) indicates that a surgery function has been selected, wherein the color of the pulsing light indicates which of the surgery functions has been selected. In some embodiments, audio feedback is also provided as the selection buttons cycle through the menus of functions available (such as a synthesized or recorded voice or a set of distinctive tones that announces which function has been selected).
  • in some embodiments, handpiece 140 is controlled using a manually controlled selector implementing a finger or thumb control (such as described in copending U.S. patent application Ser. No. 11/420,729 (Attorney Docket 5032.009US1) filed on May 26, 2006 entitled “APPARATUS AND METHOD FOR OPTICAL STIMULATION OF NERVES AND OTHER ANIMAL TISSUE”, incorporated herein by reference) for local mechanical control of the stimulation light. In some embodiments, a shutter is operated by button (in other embodiments, a user-controlled variable iris is provided instead of or in addition to shutter). In some embodiments, a turret having a plurality of different lenses (e.g., having different focal lengths, spot sizes, and/or cylinder/astigmatism (to focus to a long narrow spot or line on the nerve), neutral-density filters, holographic imagers or other optics) is rotatable using ratchet-pawl operated by button.
  • In some embodiments of any of the Figures and descriptions herein, a thin transparent membrane (such as plastic surgical tape or sterilized Saran Wrap™) is placed over and/or in contact with the nerve to keep it from drying out (again, drying can cause tissue dama ge and changes the reflectivity to the stimulation light signal). Some embodiments of the invention use a method of stimulating and/or treating nerves that includes covering the nerve with a transparent material (which is either flexible membrane or rigid substrate, or a combination of the two, depending on the embodiment), and delivering an efficacious amount of light through the transparent material. In some embodiments, the transparent material is configured to prevent drying. In some embodiments, the transparent material is configured to ensure a proper focus of the light. In some embodiments, the material is partially transparent, in order to reduce the intensity of the delivered light signal by a predetermined amount. In other embodiments, the material is substantially fully transparent, in order to deliver a maximum amount of light.
  • In some embodiments, the pattern and speed of scanning is predetermined by a computer program, while in other embodiments the pattern is manually controlled by operator 89. In some embodiments, the computer program controls the emission of stimulation laser light in some type of spatial and/or temporal pattern based upon an algorithm (e.g., a programmed binary search, sequential search, or the like) so as to determine which stimulation area delivered an efficacious dose of IR light to the nerve of interest.
  • The actual reaction or response of nerve tissue to IR-light stimulation would, in some embodiments, be determined through empirical observation (muscle twitches), subject reporting (of a touch sensation, taste sensation, or other sensation). In some embodiments, the user changes the position and/or function (e.g., changing the pulse length or intensity) of the handpiece based on the response. In other embodiments, the response is detected by the stimulation system, and the function of the stimulation system automatically adjusts the stimulation based on the response feedback (e.g., in some embodiments, a stimulation signal is repeated until the response is detected, and then the stimulation stops and/or an audio or visual indication of the response is output by the stimulation system). The manipulation of the array head itself is facilitated, in, at least one embodiment, through the use of an ergonomically designed handle, which is covered by a replaceable, disposable, sterile sheath, and by the feedback to the user provided by having visible light delivered to the area that would be stimulated by the IR stimulation signal and/or the other audio and/or visual indications.
  • In some embodiments, a high-power laser is also coupled to the optical fiber (or carried in its own separate fiber), in order to provide a capability for cutting or ablating tissue (e.g., nerve or brain tissue that has been located and identified by the light stimulation signals). This allows the surgeon to stimulate a brain area (or other nerve tissue) to more precisely locate specific regions that are to be saved versus other areas that are to be cut, cauterized or ablated. Thus, a surgeon wanting to excise a tumor or an epileptic focus can better locate and identify, e.g., borders of a lesion and surrounding functional portions of the brain using the optical-fiber-delivered optical stimulation according to the present invention, and then use the optical-fiber-delivered cutting or ablating function.
  • As used herein, the “launch end” on an optical fiber is not limited to just the fiber's first end, but can also be the point or length along the fiber to which light from a source (such as a laser diode) is coupled to insert the light into the fiber, and the “delivery end” is not limited to just the fiber's second end, but can also be the point or length along the fiber from which light from the fiber is ejected to illuminate and/or stimulate a nerve or neural tissue.
  • In some embodiments, action potentials are all-or-none, binary occurrences and therefore are not reinforceable—once an action potential is triggered, it goes to the end of the axon and causes neurotransmitter release into the synaptic cleft. However, if a nerve is cut or damaged by disease, it may be desirable to start an action potential and then restart the action potential beyond the damaged area.
  • In some embodiments, a set of machine control instructions (programmable control code to adjust, time, or otherwise control pulse shape, timing, intensity, and the like) is stored on computer-readable medium (for example, a compact FLASH memory fob, diskette, CDROM, or network connection (e.g., the internet)), which is connectable to control one or more operations or functions of the light-emitting-source controller.
  • In some embodiments, one or more of the items labeled herein as “plastic” are implemented using some other non-magnetic material such as ceramic or structured carbon nanotubes, or the like. In other embodiments, one or more of the items labeled herein as “laser diodes” are implemented instead as light-emitting diodes (LEDs) or as optically-pumped solid-state optical amplifiers (e.g., semiconductor laser-like devices that are pumped optically).
  • In some embodiments, a kit containing various components is included, this kit containing a first light-emitting source, a second light-emitting source, a light-beam combiner, a mechanical linkage with a trigger mechanism a light-emitting-source controller, and a disposable sheath. Also contained in this kit are the various materials needed to assemble the apparatus.
  • In some embodiments, a single pulse of light is emitted based on a manual user input (such as the press of a button or the rolling of a wheel) that is coupled mechanically, electrically or optically to the light-emitting-source controller (e.g., a unit that applies electrical power to a laser diode).
  • In some embodiments, a pulse train of light is emitted based on a manual user input (such as the press of a button or the rolling of a wheel) that is coupled mechanically, electrically or optically to the light-emitting-source controller (e.g., a unit that applies electrical power to a laser diode).
  • In some embodiments, a shaped, non-square pulse of light is emitted based on a manual user input (such as the press of a button or the rolling of a wheel) that is coupled mechanically, electrically or optically to the light-emitting-source controller (e.g., a unit that applies electrical power to a laser diode).
  • In some embodiments, a shaped pulse train of light is emitted based on a manual user input (such as the press of a button or the rolling of a wheel) that is coupled mechanically, electrically or optically to the light-emitting-source controller (e.g., a unit that applies electrical power to a laser diode).
  • Some embodiments of the present invention include an implantable apparatus that has an optical-light stimulator operable to generate a light signal that will stimulate a nerve, a first optical fiber operatively coupled to receive light from the stimulator and deliver the light to the nerve, a power source operatively coupled to power the stimulator, and a receiver configured to receive programming commands from a wireless remote programmer, in order to selectively control operation of the stimulator based on a set of data that was wirelessly received.
  • In some embodiments, the apparatus is configured to be implanted in the body of a mammal. In some embodiments, the power source is a battery. In some embodiments, the stimulator further includes an RF recharger operable to receive RF energy and recharge the battery. In some embodiments, the stimulator further includes a first light-emitting source and a second light-emitting source operatively coupled to be controlled by the stimulator. In some embodiments, the stimulator further includes an optical combiner operatively coupled to combine light from the first light-emitting source and the second light-emitting source into an optical fiber.
  • Some embodiments of the present invention include a method that includes charging a battery using RF energy, powering a controller from the battery, remotely programming the controller, selectively emitting light from a first light source under control of the controller, selectively emitting light from a second light source under control of the controller, combining the light from the first and second light sources, and transmitting the combined light to a nerve.
  • In some embodiments of this method, the selectively emitting light from the first light source includes emitting IR laser light from a laser diode. In some embodiments, the selectively emitting light from the second light source includes emitting visible light.
  • Some embodiments of the present invention include a kit that includes a first light-emitting source, a second light-emitting source, a light-beam combiner, a mechanical linkage with a trigger mechanism a light-emitting-source controller, and a disposable sheath.
  • Some embodiments of the present invention include an apparatus that includes an optical fiber, an optical-fiber holder operable to optically couple the optical fiber to a nerve, and an optical sensor operable to distinguish nerve tissue from other tissue based on a sensed optical color.
  • Some embodiments further include one or more additional optical fibers, wherein an illumination light is delivered to the nerve tissue using one or more of the plurality of optical fibers and the sensed optical color is sensed through one or more of the optical fibers.
  • Some embodiments of the present invention include a method that includes generating light from a first laser-diode device, the light having a wavelength between about 1.8 microns and about 2.2 microns, and stimulating a nerve with the light. In some embodiments, the light from the first laser-diode device is in a range of between about 1.80 microns and about 1.85 microns, or in a range of between about 1.81 microns and about 1.86 microns, or in a range of between about 1.82 microns and about 1.87 microns, or in a range of between about 1.83 microns and about 1.88 microns, or in a range of between about 1.84 microns and about 1.89 microns, or in a range of between about 1.85 microns and about 1.90 microns, or in a range of between about 1.86 microns and about 1.91 microns, or in a range of between about 1.87 microns and about 1.92 microns, or in a range of between about 1.88 microns and about 1.93 microns, or in a range of between about 1.89 microns and about 1.94 microns, or in a range of between about 1.90 microns and about 1.95 microns, or in a range of between about 1.91 microns and about 1.96 microns, or in a range of between about 1.92 microns and about 1.97 microns, or in a range of between about 1.93 microns and about 1.98 microns, or in a range of between about 1.94 microns and about 1.99 microns, or in a range of between about 1.95 microns and about 2.00 microns, or in a range of between about 1.96 microns and about 2.01 microns, or in a range of between about 1.97 microns and about 2.02 microns, or in a range of between about 1.98 microns and about 2.03 microns, or in a range of between about 1.99 microns and about 2.04 microns, or in a range of between about 2.00 microns and about 2.05 microns, or in a range of between about 2.01 microns and about 2.06 microns, or in a range of between about 2.02 microns and about 2.07 microns, or in a range of between about 2.03 microns and about 2.08 microns, or in a range of between about 2.04 microns and about 2.09 microns, or in a range of between about 2.05 microns and about 2.10 microns, or in a range of between about 2.06 microns and about 2.11 microns, or in a range of between about 2.07 microns and about 2.12 microns, or in a range of between about 2.08 microns and about 2.13 microns, or in a range of between about 2.09 microns and about 2.14 microns, or in a range of between about 2.10 microns and about 2.15 microns, or in a range of between about 2.11 microns and about 2.16 microns, or in a range of between about 2.12 microns and about 2.17 microns, or in a range of between about 2.13 microns and about 2.18 microns, or in a range of between about 2.14 microns and about 2.19 microns, or in a range of between about 2.15 microns and about 2.20 microns, or in a range of between about 2.16 microns and about 2.21 microns, or in a range of between about 2.17 microns and about 2.22 microns, or in a range of between about 2.18 microns and about 2.23 microns, or in a range of between about 2.19 microns and about 2.24 microns, or in a range of between about 2.20 microns and about 2.25 microns.
  • Some embodiments of the method further include conveying the light from the laser-diode device to the nerve using an optical fiber. In some embodiments, the laser-diode device includes a plurality of emitters, and the method further includes combining the light from at least two of the plurality of emitters into the optical fiber.
  • Some embodiments of the method further include affixing the optical fiber to a frame fixed in positional relationship relative to a patient. Some embodiments of the method further include remotely controlling a positioning of the light relative to the nerve.
  • Some embodiments of the present invention include an apparatus that includes a first disposable sheath that includes a first optical system configured to focus light into a first predetermined pattern that is efficacious to optically stimulate a nerve.
  • Some embodiments are supplied as a kit that further includes a second disposable sheath that includes a second optical system configured to focus light into a second predetermined pattern, different than the first, which is efficacious to optically stimulate a nerve.
  • Some embodiments of the present invention include an apparatus that includes a first light-emitting source operative to emit an optical signal at a first wavelength that is capable of directly stimulating a nerve of a patient; an optical-fiber structure having a first end and a second end; a light-beam coupler that is configured to direct light from the first light-emitting source into the first end of the optical-fiber structure; a light-emitting-source controller operatively coupled to the first light-emitting source and the second light-emitting source to selectively control light output thereof; and a light-delivery unit operatively coupled to the second end of the optical-fiber structure, wherein the light-delivery unit, the optical-fiber structure or both the light-delivery unit and the optical-fiber structure are configured to direct the optical signal onto neural tissue.
  • In some embodiments, the first light-emitting source emits infrared (IR) light from a laser diode.
  • Some embodiments further include a second light-emitting source operative to emit an optical signal at a second wavelength that is capable of directly stimulating a nerve, wherein the second wavelength is different than the first wavelength and has a different penetration depth into a given tissue, and wherein light at the first wavelength is applied to achieve a first tissue-penetration depth, and light at the second wavelength is applied to achieve a second tissue-penetration depth.
  • Some embodiments further include a second light-emitting source operative to emit an optical signal at a second wavelength that is capable of directly stimulating a nerve, wherein the second wavelength is different than the first wavelength and has a different penetration depth into a given tissue, and variable amounts of the first and second different wavelengths are applied simultaneously to achieve a tissue-penetration depth that is variable based on the intensities of the first and second wavelengths of light.
  • Some embodiments further include a third light-emitting source, wherein the third light-emitting source emits visible light, and wherein the light-beam combiner is operatively coupled to direct light from the third light-emitting source into the optical-fiber structure.
  • In some embodiments, the light-delivery unit includes a handpiece configured to be held by hand during delivery of the nerve stimulation, and the apparatus further includes a disposable sheath configured to cover at least a portion of the handpiece to provide a sterile covering.
  • Some embodiments further include a user-operable control mechanism operatively coupled to the controller to control a function of the controller, the control mechanism being configured to be operated in conjunction with the handpiece.
  • In some embodiments, the user-operable control mechanism is mounted on the handpiece, and configured to be hand operated by a user.
  • In some embodiments, the user-operable control mechanism is mechanically linked to the light-emitting-source controller.
  • In some embodiments, the light-delivery unit includes a frame configured to be affixed to the patient, and a moveable light-delivery head connected to the frame and configured to be changeably positioned to deliver light to one of a plurality of locations on the patient.
  • Some embodiments of the present invention include a method that includes obtaining, from a first laser diode, a first laser beam having a first wavelength that is capable of directly stimulating neural tissue; transmitting the first laser beam in an optical-fiber structure; imaging the first laser beam from the optical-fiber structure onto a location on the neural tissue for stimulation of the neural tissue; and obtaining user input and based on the user input, controlling the first laser beam. In some embodiments, the first laser beam has an infrared (IR) wavelength.
  • Some embodiments of the method further include obtaining a second laser beam having a second wavelength that is capable of directly stimulating a nerve, wherein the second wavelength is different than the first wavelength and has a different penetration depth into a given tissue; transmitting the second laser beam in the optical-fiber structure; applying light at the first wavelength to achieve a first tissue-penetration depth; and applying light at the second wavelength to achieve a second tissue-penetration depth.
  • Some embodiments further include obtaining a second laser beam having a second wavelength that is capable of directly stimulating a nerve, wherein the second wavelength is different than the first wavelength and has a different penetration depth into a given tissue; transmitting the second laser beam in the optical-fiber structure; and applying variable amounts of the first and second different wavelengths simultaneously to achieve a tissue-penetration depth that is variable based on the intensities of the first and second wavelengths of light.
  • Some embodiments further include obtaining a third light beam having a visible-light wavelength; transmitting the third light beam in the optical-fiber structure; and imaging the third light beam from the optical-fiber structure as an indication of where the first laser beam is directed.
  • Some embodiments further include providing a handpiece for manually directing the location of the imaged stimulation light; and covering at least a portion of the handpiece with a sterile cover.
  • In some embodiments, the obtaining user input includes coupling a control mechanism to a laser controller to control a function of the controller, wherein the control mechanism is configured to be operated in conjunction with the handpiece.
  • In some embodiments, the control mechanism is mounted on the handpiece, and the obtaining user input includes coupling a manual operation of the control mechanism by a user to control the first laser beam.
  • Some embodiments further include providing a handpiece for manually directing the location of the imaged stimulation light, wherein the obtaining user input includes coupling a user-operated control mechanism to a laser controller to control a function of the controller, wherein the control mechanism is separate from the handpiece and is configured to be operated such that operation of the control mechanism is independent of movement of the handpiece.
  • Some embodiments further include providing a light-delivery unit for directing the location of the imaged stimulation light, wherein the light-delivery unit includes a frame configured to be affixed to the patient, and a moveable light-delivery head connected to the frame; and positioning the light-delivery head to deliver light to one of a plurality of locations on the patient.
  • Some embodiments of the present invention include an apparatus that includes means for generating a first laser beam having a first wavelength that is capable of directly stimulating neural tissue of a patient, wherein light of the first wavelength has a first tissue-penetration profile; means for transmitting the first laser beam; means for imaging the transmitted first laser beam onto a location on the neural tissue for stimulation of the neural tissue; and means for obtaining user input and based on the user input, controlling the first laser beam.
  • In some embodiments, the means for generating the first laser beam includes a laser diode and means for controlling electrical power to the laser diode to control timing and intensity of the first laser beam.
  • Some embodiments further include means for visibly indicating a location on the patient at which nerve stimulation is to be obtained by application of the first laser beam.
  • Some embodiments further include means for generating a second laser beam having a second wavelength that is capable of directly stimulating neural tissue of a patient, wherein light of the second wavelength has a second tissue-penetration profile different than the first tissue-penetration profile, and wherein the means for generating the second laser beam is optically coupled to the means for imaging.
  • Some embodiments further include means for generating a third laser beam that is capable of optically cutting tissue, wherein the means for generating the third laser beam is optically coupled to the means for imaging.
  • In some embodiments, the apparatus is made of materials compatible with use within a magnetic field of an operating magnetic resonance machine.
  • Some embodiments of the present invention include an apparatus that includes an elongated endoscope structure having an image-obtaining end configured to be inserted into a small opening in a patient to enable viewing of an interior tissue of the patient; a first laser diode operable to output a laser beam having a first wavelength, and that is capable of directly stimulating neural tissue of a patient, wherein light of the first wavelength has a first tissue-penetration profile; a fiber holder operable to hold an optical fiber having a first end optically coupled to receive the laser beam from the first laser diode and configured to deliver the laser beam to a second end to stimulate neural tissue of the viewed interior tissue of the patient; and a user-input interface operable to obtain user input and based on the user input, to control application of the first laser beam.
  • Some embodiments further include the optical fiber.
  • In some embodiments, the fiber holder is further configured to implant and release the optical fiber in the patient.
  • Some embodiments include combinations of elements from different ones of the above-described Figures and specifications. Some embodiments of the invention include a computer-readable medium that has instructions stored thereon for causing a suitably programmed information processor to perform methods that include one or more of the functions or subfunctions described herein.
  • Some embodiments of the present invention include an apparatus that includes a first light-emitting source operative to emit an optical signal at a first wavelength that is capable of directly stimulating muscle tissue of a subject; an optical-fiber structure having a first end and a second end; a light-beam coupler that is configured to direct light from the first light-emitting source into the first end of the optical fiber structure; a light-emitting-source controller operatively coupled to the first light-emitting source to selectively control light output thereof, and a light-delivery unit operatively coupled to the second end of the optical-fiber structure, wherein the light-delivery unit, the optical fiber structure or both the light-delivery unit and the optical-fiber structure are configured to direct the optical signal onto muscle tissue. In some embodiments, the first light-emitting source emits infrared (IR) light from a laser diode.
  • Some embodiments of the muscle stimulator further include a second light-emitting source operative to emit an optical signal at a second wavelength that is capable of directly stimulating muscle tissue, wherein the second wavelength is different than the first wavelength and has a different penetration depth into a given tissue, and wherein light at the first wavelength is applied to achieve a first tissue-penetration depth, and light at the second wavelength is applied to achieve a second tissue-penetration depth.
  • Some embodiments of the muscle stimulator further include a second light-emitting source operative to emit an optical signal at a second wavelength that is capable of directly stimulating muscle tissue, wherein the first wavelength is different than the second wavelength and has a different penetration depth into a given tissue, and variable amounts of the first and second different wavelengths are applied simultaneously to achieve a tissue-penetration depth that is variable based on the intensities of the first and second wavelengths of light.
  • Some embodiments of the muscle stimulator further include a third light-emitting source, wherein the third light-emitting source emits visible light, and wherein the light-beam combiner is operatively coupled to direct light from the third light-emitting source into the optical-fiber structure.
  • In some embodiments of the muscle stimulator, the light-delivery unit includes a handpiece configured to be held by hand during delivery of the muscle tissue stimulation, and the apparatus further includes a disposable sheath configured to cover at least a portion of the handpiece to provide a sterile covering.
  • Some embodiments of the muscle stimulator further include a user-operable control mechanism operatively coupled to the controller to control a function of the controller, the control mechanism being configured to be operated in conjunction with the handpiece.
  • In some embodiments of the muscle stimulator, the user-operable control mechanism is mounted on the handpiece, and configured to be hand operated by a user. In some embodiments, the user-operable control mechanism is mechanically linked to the light-emitting-source controller. In some embodiments, the light-delivery unit includes a frame configured to be affixed to the subject, and a moveable light-delivery head connected to the frame and configured to be changeably positioned to deliver light to one of a plurality of locations on the subject.
  • Another aspect of some embodiments of the invention include a method that includes obtaining, from a first laser diode, a first laser beam having a first wavelength that is capable of directly optically stimulating an action potential in a tissue of an animal; transmitting the first laser beam in an optical-fiber structure; applying the first laser beam from the optical-fiber structure onto a location on the tissue for stimulation of the tissue; and obtaining user input and based on the user input, controlling the first laser beam.
  • In some embodiments, the first laser beam has an infrared (IR) wavelength.
  • In some embodiments, the tissue is muscle tissue, and the action potential is a muscle action potential.
  • In some embodiments, the tissue is neural tissue, and the action potential is a nerve action potential.
  • Some embodiments further include obtaining a second laser beam having a second wavelength that is capable of directly stimulating muscle tissue, wherein the second wavelength is different than the first wavelength and has a different penetration depth into a given tissue; transmitting the second laser beam in the optical-fiber structure; applying light at the first wavelength to achieve a first tissue-penetration depth; and applying light at the second wavelength to achieve a second tissue-penetration depth.
  • Some embodiments further include obtaining a second laser beam having a second wavelength that is capable of directly stimulating muscle tissue, wherein the second wavelength is different than the first wavelength and has a different penetration depth into a given tissue; transmitting the second laser beam in the optical-fiber structure; and applying variable amounts of the first and second different wavelengths simultaneously to achieve a tissue-penetration depth that is variable based on the intensities of the first and second wavelengths of light.
  • Some embodiments further include obtaining a third light beam having a visible-light wavelength; transmitting the third light beam in the optical-fiber structure; and imaging the third light beam from the optical-fiber structure as an indication of where the first laser beam is directed.
  • Some embodiments further include providing a handpiece for manually directing the location of the imaged stimulation light; and covering at least a portion of the handpiece with a sterile cover.
  • In some embodiments, the obtaining user input includes coupling a control mechanism to a laser controller controlling the first laser diode in order to control a function of the controller, wherein the control mechanism is configured to be operated in conjunction with the handpiece.
  • In some embodiments, the control mechanism is mounted on the handpiece, and the obtaining user input includes coupling a manual operation of the control mechanism by a user to control the first laser beam.
  • Some embodiments further include providing a handpiece for manually directing the location of imaged stimulation light, wherein the obtaining user input includes coupling a user-operated control mechanism to a laser controller to control a function of the controller, wherein the control mechanism is separate from the handpiece and is configured to be operated such that operation of the control mechanism is independent of movement of the handpiece.
  • Some embodiments further include providing a light-delivery unit for directing the location of the imaged stimulation light, wherein the light-delivery unit includes a frame configured to be affixed to the subject, and a moveable light-delivery head connected to the frame; and positioning the light-delivery head to deliver light to one of a plurality of locations on the subject.
  • Some embodiments of the present invention include an apparatus that includes means for generating a first laser beam having a first wavelength that is capable of directly stimulating an action potential in muscle tissue of a subject, wherein light of the first wavelength has a first tissue-penetration profile; means for transmitting the first laser beam; means for imaging the transmitted first laser beam onto a location on the muscle tissue for stimulation of the action potential in the muscle tissue; and means for obtaining user input and based on the user input, controlling the first laser beam.
  • In some embodiments, the means for generating the first laser beam includes a laser diode and means for controlling electrical power to the laser diode to control timing and intensity of the first laser beam.
  • Some embodiments further include means for visibly indicating a location on the subject to which optical muscle stimulation is to be obtained by application of the first laser beam.
  • Some embodiments further include means for generating a second laser beam having a second wavelength that is capable of directly stimulating muscle tissue of a subject, wherein light of the second wavelength has a second tissue-penetration profile different than the first tissue-penetration profile, and wherein the means for generating the second laser beam is optically coupled to the means for imaging.
  • Some embodiments further include means for generating a third laser beam that is capable of optically cutting tissue, wherein the means for generating the third laser beam is optically coupled to the means for imaging.
  • In some embodiments, the means are compatible with use within a magnetic field of an operating magnetic resonance imaging (MRI) apparatus.
  • Some embodiments of the present invention include an apparatus that includes an elongated endoscope structure having an image-obtaining end configured to be inserted into a small opening in a subject to enable viewing of an interior tissue of the subject; a first laser diode operable to output a laser beam having a first wavelength, and that is capable of directly stimulating muscle tissue of a subject, wherein light of the first wavelength has a first tissue-penetration profile; a fiber holder operable to hold an optical fiber, the optical fiber having a first end configured to be optically coupled to receive the laser beam from the first laser diode and configured to deliver the laser beam to a second end to stimulate neural tissue of the viewed interior tissue of the subject; and a user-input interface operable to obtain user input and based on the user input, to control application of the first laser beam. Some embodiments further include the optical fiber.
  • In some embodiments, the fiber holder is further configured to implant and release the optical fiber in the subject.
  • In some embodiments, a high-power diode laser array is used for one or more of the light sources used in the above-described embodiments. For example, some embodiments use high-power MQW (multiple quantum well) multiple-emitter laser arrays available from Princeton Lightwave Inc., 2555 Route 130 South Suite 1, Cranbury, N.J. 08512, whose laser arrays output laser light with up to 30 watts or more power at 1.45 to 1.55 microns and up to 12 watts or more power at 1.85 microns. In some embodiments, the present invention uses lasers such as described in “218 W quasi-CW operation of 1.83 microns (i.e., micrometers) two-dimensional laser diode array” by M. Maiorov et al., Electronics Letters, Vol.35 No.8, 15 Apr. 1999. Some embodiments use the structures described for such lasers modified to produce other IR wavelengths. In some embodiments, the present invention uses light sources such as described in U.S. Pat. Nos. 6,639,930 titled “Multi-level closed loop resonators and method for fabricating same” which issued 2003 Oct. 28; U.S. Pat. No. 6,556,611 titled “Wide stripe distributed Bragg reflector lasers with improved angular and spectral characteristics” which issued 2003 Apr. 29; U.S. Pat. No. 6,459,715 titled “Master-oscillator grating coupled power amplifier with angled amplifier section” which issued 2002 Oct. 01; U.S. Pat. No. 6,417,524 titled “Light emitting semiconductor device” which issued 2002 Jul. 09; U.S. Pat. No. 6,363,188 titled “Mode expander with co-directional grating” which issued 2002 Mar. 26; U.S. Pat. No. 6,339,606 titled “High power semiconductor light source” which issued 2002 Jan. 15; U.S. Pat. No. 6,301,279 titled “Semiconductor diode lasers with thermal sensor control of the active region temperature” which issued 2001 Oct. 09; and U.S. Pat. No. 6, 184,542 titled “Superluminescent diode and optical amplifier with extended bandwidth ” which issued 2001 Feb. 06; each of which is incorporated by reference.
  • It is to be understood that the above description is intended to be illustrative, and not restrictive. Although numerous characteristics and advantages of various embodiments as described herein have been set forth in the foregoing description, together with details of the structure and function of various embodiments, many other embodiments and changes to details will be apparent to those of skill in the art upon reviewing the above description. The scope of the invention should, therefore, be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled. In the appended claims, the terms “including” and “in which” are used as the plain-English equivalents of the respective terms “comprising” and “wherein,” respectively. Moreover, the terms “first,” “second,” and “third,” etc., are used merely as labels, and are not intended to impose numerical requirements on their objects.

Claims (16)

1. An apparatus comprising:
a nerve-stimulation unit operable to stimulate a nerve in an animal;
a sensor operatively coupled to tissue of the animal and operable to sense a physiological result of the nerve stimulation and that generates a sense signal based on the sensed physiological result; and
a controller operatively coupled to receive the sense signal, and that generates a control signal that controls a surgical instrument based on the sense signal.
2. The apparatus of claim 1, wherein the nerve-stimulation unit having a first light-emitting source that generates an optical stimulation signal capable of stimulating a nerve, the nerve-stimulation unit further comprising a light-delivery unit, operatively coupled to the first light-emitting source, that focuses the optical stimulation signal.
3. The apparatus of claim 2, the nerve-stimulation unit further comprising:
a second light-emitting source operative to emit a first optical pointer signal at a second wavelength that is visible to a human and which is configured to indicate a location of the optical stimulation signal.
4. The apparatus of claim 2, the nerve-stimulation unit further comprising:
a third light-emitting source that forms at least part of the surgical instrument and emits laser pulses capable of ablating animal tissue, wherein the laser pulses from the third light-emitting source are inhibited based on the sense signal.
5. The apparatus of claim 2, the nerve-stimulation unit further comprising:
a third light-emitting source that forms at least part of the surgical instrument and emits laser pulses capable of ablating animal tissue, wherein the laser pulses from the third light-emitting source are variably reduced based on the sense signal.
6. The apparatus of claim 2 wherein the first light-emitting source emits infrared (IR) light from a laser diode as at least a portion of the optical-stimulation signal.
7. The apparatus of claim 6, further comprising:
a second light-emitting source operative to emit a first optical pointer signal configured to indicate a location of the optical-stimulation signal;
an imaging device that captures an image of a patient and couples information including the location of the optical-stimulation signal from the image to the controller, wherein the physiological result sensor is a nerve-response sensor, and wherein the controller correlates the location of the optical-stimulation signal to generate a map representation of a nerve location and stores the map representation in a computer storage device.
8. The apparatus of claim 7, further comprising:
a projector coupled to the computer storage device and operable to project a light pattern based on the map representation onto the tissue of the animal to indicate the nerve location.
9. A method comprising:
stimulating a tissue in an animal, the tissue including a nerve that is stimulated when stimulation is close enough to trigger the nerve;
sensing a physiological result of the nerve stimulation and generating a sense signal based on the sensed physiological result; and
controlling a surgical instrument based on the sense signal.
10. The method of claim 9, wherein the stimulating of the nerve includes
emitting an optical stimulation signal capable of stimulating a nerve, and
focusing the optical stimulation signal onto a nerve.
11. The method of claim 10, the tissue stimulating further comprising:
emitting a first optical pointer signal at a second wavelength that is visible to a human and which is configured to indicate a location of the optical stimulation signal.
12. The method of claim 10, the tissue stimulating further comprising:
emitting laser pulses capable of ablating animal tissue, wherein the laser pulses are inhibited based on the sense signal.
13. The method of claim 10, the nerve-stimulation unit further comprising:
a third light-emitting source that forms at least part of the surgical instrument and emits laser pulses capable of ablating animal tissue, wherein the laser pulses from the third light-emitting source are variably reduced based on the sense signal.
14. The method of claim 10, wherein the emitting of stimulation light includes infrared (IR) light from a laser diode as at least a portion of the optical-stimulation signal.
15. An apparatus comprising:
means for stimulating a tissue in an animal, the tissue including a nerve that is stimulated when stimulation is close enough to trigger the nerve;
means for sensing a physiological result of the nerve stimulation and generating a sense signal based on the sensed physiological result; and
means for controlling a surgical instrument based on the sense signal.
16. The apparatus of claim 15, further comprising:
means for removing tissue to effect optical-beam surgery; and
means for suppressing operation of the means for removing tissue.
US11/536,642 2005-10-24 2006-09-28 Apparatus and method for stimulation of nerves and automated control of surgical instruments Abandoned US20080077200A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US11/536,642 US20080077200A1 (en) 2006-09-21 2006-09-28 Apparatus and method for stimulation of nerves and automated control of surgical instruments
US11/948,912 US8929973B1 (en) 2005-10-24 2007-11-30 Apparatus and method for characterizing optical sources used with human and animal tissues
US13/217,197 US8996131B1 (en) 2006-09-28 2011-08-24 Apparatus and method for managing chronic pain with infrared light sources and heat
US13/234,102 US9061135B1 (en) 2006-09-28 2011-09-15 Apparatus and method for managing chronic pain with infrared and low-level light sources
US13/525,268 US8945197B1 (en) 2005-10-24 2012-06-15 Sight-restoring visual prosthetic and method using infrared nerve-stimulation light
US13/525,270 US8956396B1 (en) 2005-10-24 2012-06-15 Eye-tracking visual prosthetic and method
US14/295,919 US9653872B2 (en) 2005-10-24 2014-06-04 System and method for high-power, pulsed ring fiber oscillator

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82653806P 2006-09-21 2006-09-21
US11/536,642 US20080077200A1 (en) 2006-09-21 2006-09-28 Apparatus and method for stimulation of nerves and automated control of surgical instruments

Publications (1)

Publication Number Publication Date
US20080077200A1 true US20080077200A1 (en) 2008-03-27

Family

ID=39226051

Family Applications (4)

Application Number Title Priority Date Filing Date
US11/536,639 Expired - Fee Related US7988688B2 (en) 2005-10-24 2006-09-28 Miniature apparatus and method for optical stimulation of nerves and other animal tissue
US11/536,642 Abandoned US20080077200A1 (en) 2005-10-24 2006-09-28 Apparatus and method for stimulation of nerves and automated control of surgical instruments
US13/157,217 Active US8506613B2 (en) 2006-09-21 2011-06-09 Miniature method and apparatus for optical stimulation of nerves and other animal tissue
US13/966,134 Active US8784461B2 (en) 2006-09-21 2013-08-13 Method and apparatus for optical stimulation of nerves and other animal tissue

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US11/536,639 Expired - Fee Related US7988688B2 (en) 2005-10-24 2006-09-28 Miniature apparatus and method for optical stimulation of nerves and other animal tissue

Family Applications After (2)

Application Number Title Priority Date Filing Date
US13/157,217 Active US8506613B2 (en) 2006-09-21 2011-06-09 Miniature method and apparatus for optical stimulation of nerves and other animal tissue
US13/966,134 Active US8784461B2 (en) 2006-09-21 2013-08-13 Method and apparatus for optical stimulation of nerves and other animal tissue

Country Status (1)

Country Link
US (4) US7988688B2 (en)

Cited By (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060280212A1 (en) * 2005-06-08 2006-12-14 Jianhong Lu Laser level with selectable constant or pulsed beam output
US20070054319A1 (en) * 2005-07-22 2007-03-08 Boyden Edward S Light-activated cation channel and uses thereof
US20070265609A1 (en) * 2006-05-12 2007-11-15 Thapliyal Hira V Method for Ablating Body Tissue
US20080077158A1 (en) * 2006-06-16 2008-03-27 Hani Haider Method and Apparatus for Computer Aided Surgery
US20080077198A1 (en) * 2006-09-21 2008-03-27 Aculight Corporation Miniature apparatus and method for optical stimulation of nerves and other animal tissue
US20080227139A1 (en) * 2007-02-14 2008-09-18 Karl Deisseroth System, method and applications involving identification of biological circuits such as neurological characteristics
US20080234670A1 (en) * 2007-03-15 2008-09-25 Rogers C Brian System and apparatus providing a controlled light source for medicinal applications
US20090088680A1 (en) * 2005-07-22 2009-04-02 Alexander Aravanis Optical tissue interface method and apparatus for stimulating cells
US20090112133A1 (en) * 2007-10-31 2009-04-30 Karl Deisseroth Device and method for non-invasive neuromodulation
US20090118800A1 (en) * 2007-10-31 2009-05-07 Karl Deisseroth Implantable optical stimulators
US20090131922A1 (en) * 2007-11-07 2009-05-21 Reliant Technologies, Inc. Reconnectable Handpieces for Optical Energy Based Devices and Methods for Adjusting Device Components
US20090251228A1 (en) * 2008-04-03 2009-10-08 Sony Corporation Voltage-controlled variable frequency oscillation circuit and signal processing circuit
US20090312755A1 (en) * 2008-06-13 2009-12-17 Vytronus, Inc. System and method for positioning an elongate member with respect to an anatomical structure
US20090312673A1 (en) * 2008-06-14 2009-12-17 Vytronus, Inc. System and method for delivering energy to tissue
WO2010009473A1 (en) * 2008-07-18 2010-01-21 Vytronus, Inc. Method and system for positioning an energy source
US20100016762A1 (en) * 2008-07-18 2010-01-21 Vytronus, Inc. System and method for delivering energy to tissue
US20100049180A1 (en) * 2007-10-19 2010-02-25 Lockheed Martin Corporation System and method for conditioning animal tissue using laser light
US20100113985A1 (en) * 2008-10-30 2010-05-06 Vytronus, Inc. System and method for energy delivery to tissue while monitoring position, lesion depth, and wall motion
US20100114094A1 (en) * 2008-10-30 2010-05-06 Vytronus, Inc. System and method for anatomical mapping of tissue and planning ablation paths therein
US20100114190A1 (en) * 2008-10-03 2010-05-06 Lockheed Martin Corporation Nerve stimulator and method using simultaneous electrical and optical signals
US20100113928A1 (en) * 2008-10-30 2010-05-06 Vytronus, Inc. System and method for delivery of energy to tissue while compensating for collateral tissue
US20100125198A1 (en) * 2008-11-17 2010-05-20 Vytronus, Inc. Systems and methods for ablating body tissue
US20100145418A1 (en) * 2007-01-10 2010-06-10 Feng Zhang System for optical stimulation of target cells
US20100152582A1 (en) * 2008-06-13 2010-06-17 Vytronus, Inc. Handheld system and method for delivering energy to tissue
US20100149794A1 (en) * 2008-12-16 2010-06-17 Shenzhen Futaihong Precision Industry Co., Ltd. Touch pen and portable electronic device using the same
US20100190229A1 (en) * 2005-07-22 2010-07-29 Feng Zhang System for optical stimulation of target cells
US20100234836A1 (en) * 2009-03-10 2010-09-16 Bwt Property, Inc. LED Based Light Surgery Apparatus
US7871175B1 (en) * 2007-12-17 2011-01-18 Natasha Dawn Bacca Apparatus and method of drawing with light
US7883536B1 (en) 2007-01-19 2011-02-08 Lockheed Martin Corporation Hybrid optical-electrical probes
US20110091155A1 (en) * 2009-10-19 2011-04-21 Lockheed Martin Corporation In-line forward/backward fiber-optic signal analyzer
US20110105998A1 (en) * 2008-04-23 2011-05-05 The Board Of Trustees Of The Leland Stanford Junio Systems, methods and compositions for optical stimulation of target cells
US20110112179A1 (en) * 2008-05-29 2011-05-12 Airan Raag D Cell line, system and method for optical control of secondary messengers
US20110159562A1 (en) * 2008-06-17 2011-06-30 Karl Deisseroth Apparatus and methods for controlling cellular development
US20110166632A1 (en) * 2008-07-08 2011-07-07 Delp Scott L Materials and approaches for optical stimulation of the peripheral nervous system
US20110172653A1 (en) * 2008-06-17 2011-07-14 Schneider M Bret Methods, systems and devices for optical stimulation of target cells using an optical transmission element
US8012189B1 (en) 2007-01-11 2011-09-06 Lockheed Martin Corporation Method and vestibular implant using optical stimulation of nerves
US20110235324A1 (en) * 2010-03-29 2011-09-29 Klaus-Martin Irion Light source device for endoscopic or exoscopic applications
WO2011150430A3 (en) * 2010-05-28 2012-02-23 Lockheed Martin Corporation Implantable infrared nerve stimulation devices for peripheral and cranial nerve interfaces
US20120053941A1 (en) * 2010-08-27 2012-03-01 Swick Michael D Wireless Voice Activation Apparatus for Surgical Lasers
US20120101356A1 (en) * 2010-10-26 2012-04-26 Korea Institute Of Science And Technology Optical Stimulus Probe with Reflecting Surface
US8179594B1 (en) 2007-06-29 2012-05-15 Lockheed Martin Corporation Method and apparatus for spectral-beam combining of fanned-in laser beams with chromatic-dispersion compensation using a plurality of diffractive gratings
US8202268B1 (en) 2007-03-18 2012-06-19 Lockheed Martin Corporation Method and multiple-mode device for high-power short-pulse laser ablation and CW cauterization of bodily tissues
US20120296323A1 (en) * 2011-05-16 2012-11-22 Tyco Healthcare Group Lp Optical Energy-Based Methods and Apparatus for Tissue Sealing
US20120296324A1 (en) * 2011-05-16 2012-11-22 Tyco Healthcare Group Lp Optical Energy-Based Methods and Apparatus for Tissue Sealing
US20120298871A1 (en) * 2009-10-26 2012-11-29 Morin Aurelie Method and device for slaving the activation of a set of infrared emitters of a sensor of venous networks to the presence of a living body
DE112011101288T5 (en) 2010-04-12 2013-02-07 Lockheed Martin Corporation Beam diagnostic and feedback system and methods for spectrally beam combined lasers
US20130090546A1 (en) * 2011-10-07 2013-04-11 Patrick W. STROMAN Spinal cord function assessment
US8475506B1 (en) 2007-08-13 2013-07-02 Lockheed Martin Corporation VCSEL array stimulator apparatus and method for light stimulation of bodily tissues
US8498699B2 (en) 2008-10-03 2013-07-30 Lockheed Martin Company Method and nerve stimulator using simultaneous electrical and optical signals
US8574280B2 (en) 2011-12-23 2013-11-05 Pine Development Corporation Systems and methods for eliciting cutaneous sensations by electromagnetic radiation
TWI425387B (en) * 2009-01-09 2014-02-01 Chi Mei Comm Systems Inc Touch pen
WO2014040014A1 (en) * 2012-09-10 2014-03-13 Dermal Photonics Corporation Systems and methods for usage replenishment
US8696722B2 (en) 2010-11-22 2014-04-15 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic magnetic resonance imaging
US8709078B1 (en) 2011-08-03 2014-04-29 Lockheed Martin Corporation Ocular implant with substantially constant retinal spacing for transmission of nerve-stimulation light
WO2013016350A3 (en) * 2011-07-25 2014-05-01 Diagnostic Biochips, Llc Integrated optical neural probe
US8715327B1 (en) 2009-04-13 2014-05-06 Cvrx, Inc. Baroreflex modulation using light-based stimulation
US8716447B2 (en) 2008-11-14 2014-05-06 The Board Of Trustees Of The Leland Stanford Junior University Optically-based stimulation of target cells and modifications thereto
US8747447B2 (en) 2011-07-22 2014-06-10 Lockheed Martin Corporation Cochlear implant and method enabling enhanced music perception
US8767286B2 (en) 2010-04-12 2014-07-01 Lockheed Martin Corporation Signal and pump mode-field adaptor for double-clad fibers and associated method
WO2014126558A1 (en) * 2013-02-13 2014-08-21 Biolitec Pharma Marketing Ltd. Enclosed laser medical device/system
US8843217B1 (en) 2013-09-13 2014-09-23 Lockheed Martin Corporation Combined vestibular and cochlear implant and method
US8926959B2 (en) 2005-07-22 2015-01-06 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
US8929973B1 (en) 2005-10-24 2015-01-06 Lockheed Martin Corporation Apparatus and method for characterizing optical sources used with human and animal tissues
US8932562B2 (en) 2010-11-05 2015-01-13 The Board Of Trustees Of The Leland Stanford Junior University Optically controlled CNS dysfunction
US8945197B1 (en) 2005-10-24 2015-02-03 Lockheed Martin Corporation Sight-restoring visual prosthetic and method using infrared nerve-stimulation light
US8956396B1 (en) 2005-10-24 2015-02-17 Lockheed Martin Corporation Eye-tracking visual prosthetic and method
US8985119B1 (en) 2005-09-09 2015-03-24 Lockheed Martin Corporation Method and apparatus for optical stimulation of nerves and other animal tissue
US8996131B1 (en) 2006-09-28 2015-03-31 Lockheed Martin Corporation Apparatus and method for managing chronic pain with infrared light sources and heat
US9023039B2 (en) 2012-07-19 2015-05-05 Covidien Lp Electrosurgical device including an optical sensor
US9079940B2 (en) 2010-03-17 2015-07-14 The Board Of Trustees Of The Leland Stanford Junior University Light-sensitive ion-passing molecules
US20150208934A1 (en) * 2014-01-24 2015-07-30 Genevieve Sztrubel Method And Apparatus For The Detection Of Neural Tissue
US9113904B2 (en) 2012-07-19 2015-08-25 Covidien Lp Surgical instrument with fiber bragg grating
US9161812B2 (en) 2012-07-19 2015-10-20 Covidien Lp Finger-mountable ablation device
US9175095B2 (en) 2010-11-05 2015-11-03 The Board Of Trustees Of The Leland Stanford Junior University Light-activated chimeric opsins and methods of using the same
US9192314B2 (en) * 2011-03-29 2015-11-24 The Charles Stark Draper Laboratory, Inc. Probe for neural recording and optical spectroscopic interrogation
US9220924B2 (en) 2008-10-30 2015-12-29 Vytronus, Inc. System and method for energy delivery to tissue while monitoring position, lesion depth, and wall motion
US9257021B2 (en) 2013-04-12 2016-02-09 Pine Development Corporation Systems and methods for optically induced cutaneous sensation
US9265573B2 (en) 2012-07-19 2016-02-23 Covidien Lp Ablation needle including fiber Bragg grating
US9274099B2 (en) 2005-07-22 2016-03-01 The Board Of Trustees Of The Leland Stanford Junior University Screening test drugs to identify their effects on cell membrane voltage-gated ion channel
US9271783B2 (en) 2012-07-17 2016-03-01 Covidien Lp End-effector assembly including a pressure-sensitive layer disposed on an electrode
US9284353B2 (en) 2007-03-01 2016-03-15 The Board Of Trustees Of The Leland Stanford Junior University Mammalian codon optimized nucleotide sequence that encodes a variant opsin polypeptide derived from Natromonas pharaonis (NpHR)
US9366872B2 (en) 2014-02-18 2016-06-14 Lockheed Martin Corporation Apparatus and method for fiber-laser output-beam shaping for spectral beam combination
US9365628B2 (en) 2011-12-16 2016-06-14 The Board Of Trustees Of The Leland Stanford Junior University Opsin polypeptides and methods of use thereof
US9429467B2 (en) 2014-04-11 2016-08-30 Lockheed Martin Corporation System for non-contact optical-power measurement
US9449477B2 (en) 2014-04-02 2016-09-20 Pine Development Corporation Applications of systems and methods for eliciting cutaneous sensations by electromagnetic radiation
US9498231B2 (en) 2011-06-27 2016-11-22 Board Of Regents Of The University Of Nebraska On-board tool tracking system and methods of computer assisted surgery
US9522288B2 (en) 2010-11-05 2016-12-20 The Board Of Trustees Of The Leland Stanford Junior University Upconversion of light for use in optogenetic methods
US9636380B2 (en) 2013-03-15 2017-05-02 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic control of inputs to the ventral tegmental area
US9696804B2 (en) 2011-12-23 2017-07-04 Pine Development Corporation Systems and methods for eliciting cutaneous sensations by electromagnetic radiation
US9737323B2 (en) 2008-11-17 2017-08-22 Vytronus, Inc. Systems and methods for imaging and ablating body tissue
US9833285B2 (en) 2012-07-17 2017-12-05 Covidien Lp Optical sealing device with cutting ability
US9992981B2 (en) 2010-11-05 2018-06-12 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic control of reward-related behaviors
US10086012B2 (en) 2010-11-05 2018-10-02 The Board Of Trustees Of The Leland Stanford Junior University Control and characterization of memory function
US10105149B2 (en) 2013-03-15 2018-10-23 Board Of Regents Of The University Of Nebraska On-board tool tracking system and methods of computer assisted surgery
US10219811B2 (en) 2011-06-27 2019-03-05 Board Of Regents Of The University Of Nebraska On-board tool tracking system and methods of computer assisted surgery
US10220092B2 (en) 2013-04-29 2019-03-05 The Board Of Trustees Of The Leland Stanford Junior University Devices, systems and methods for optogenetic modulation of action potentials in target cells
US10226297B2 (en) 2012-09-06 2019-03-12 Covidien Lp Medical devices and methods incorporating frustrated total internal reflection for energy-efficient sealing and cutting of tissue using light energy
US10231782B2 (en) 2012-09-06 2019-03-19 Covidien Lp Medical devices and methods incorporating frustrated total internal reflection for energy-efficient sealing and cutting of tissue using light energy
US10295823B2 (en) 2013-07-02 2019-05-21 Pine Development Corporation Systems and methods for eliciting cutaneous sensations using electromagnetic radiation
US10307609B2 (en) 2013-08-14 2019-06-04 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for controlling pain
US20200016425A1 (en) * 2017-03-24 2020-01-16 Covidien Lp Endoscopes and methods of treatment
US10568307B2 (en) 2010-11-05 2020-02-25 The Board Of Trustees Of The Leland Stanford Junior University Stabilized step function opsin proteins and methods of using the same
US10568516B2 (en) 2015-06-22 2020-02-25 The Board Of Trustees Of The Leland Stanford Junior University Methods and devices for imaging and/or optogenetic control of light-responsive neurons
US20200196882A1 (en) * 2008-07-03 2020-06-25 Masimo Corporation Noise shielding for a noninvasive device
US10694953B2 (en) * 2011-12-20 2020-06-30 Facebook Technologies, Llc Integrated medical device
US10974064B2 (en) 2013-03-15 2021-04-13 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic control of behavioral state
US11103723B2 (en) 2012-02-21 2021-08-31 The Board Of Trustees Of The Leland Stanford Junior University Methods for treating neurogenic disorders of the pelvic floor
US11122968B2 (en) 2019-06-20 2021-09-21 Cilag Gmbh International Optical fiber waveguide in an endoscopic system for hyperspectral imaging
US11213194B2 (en) * 2019-06-20 2022-01-04 Cilag Gmbh International Optical fiber waveguide in an endoscopic system for hyperspectral, fluorescence, and laser mapping imaging
US11294165B2 (en) 2017-03-30 2022-04-05 The Board Of Trustees Of The Leland Stanford Junior University Modular, electro-optical device for increasing the imaging field of view using time-sequential capture
US11298568B2 (en) 2008-10-30 2022-04-12 Auris Health, Inc. System and method for energy delivery to tissue while monitoring position, lesion depth, and wall motion
US20220126112A1 (en) * 2019-01-25 2022-04-28 Santen Pharmaceutical Co., Ltd. Optical probe
US11471697B2 (en) * 2015-02-10 2022-10-18 Andrew Hewitson Laser therapy device and method of use
WO2023283494A1 (en) * 2021-07-09 2023-01-12 Dignity Health Devices and methods for applying stimulation in the assessment of consciousness
US11911117B2 (en) 2011-06-27 2024-02-27 Board Of Regents Of The University Of Nebraska On-board tool tracking system and methods of computer assisted surgery
US11931010B2 (en) * 2017-03-24 2024-03-19 Covidien Lp Endoscopes and methods of treatment

Families Citing this family (152)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2604215B1 (en) * 2003-02-25 2017-10-11 Tria Beauty, Inc. Eye-safe dermatologic treatment apparatus and method
US8401212B2 (en) 2007-10-12 2013-03-19 Earlens Corporation Multifunction system and method for integrated hearing and communication with noise cancellation and feedback management
US8744570B2 (en) * 2009-01-23 2014-06-03 Lockheed Martin Corporation Optical stimulation of the brainstem and/or midbrain, including auditory areas
US7753549B2 (en) * 2006-02-02 2010-07-13 L-3 Insight Technology Incorporated Weapon aiming device
WO2007126999A2 (en) 2006-04-12 2007-11-08 Lumenis Ltd. System and method for microablation of tissue
US9078680B2 (en) * 2006-04-12 2015-07-14 Lumenis Ltd. System and method for microablation of tissue
US20080027520A1 (en) * 2006-07-25 2008-01-31 Zoom Therapeutics, Inc. Laser treatment of tissue
US7815630B2 (en) * 2007-01-25 2010-10-19 Biolase Technology, Inc. Target-close electromagnetic energy emitting device
US20080188914A1 (en) * 2007-02-01 2008-08-07 Candela Corporation Detachable handpiece
US20090093687A1 (en) * 2007-03-08 2009-04-09 Telfort Valery G Systems and methods for determining a physiological condition using an acoustic monitor
US8696655B2 (en) * 2007-04-10 2014-04-15 Intenzity Innovation Aps Self-contained handpiece and method for optical tissue surface treatment
WO2009042268A1 (en) * 2007-09-28 2009-04-02 Choi George Y Device and methods for treatment of tissue
US7605360B2 (en) * 2007-11-27 2009-10-20 Chung-Kai Yeh Power supply system for green laser indicating pen
US20090149797A1 (en) * 2007-12-05 2009-06-11 Searete Llc, A Limited Liability Corporation Of The State Of Delaware System for reversible chemical modulation of neural activity
US8160695B2 (en) * 2007-12-05 2012-04-17 The Invention Science Fund I, Llc System for chemical modulation of neural activity
US8180446B2 (en) * 2007-12-05 2012-05-15 The Invention Science Fund I, Llc Method and system for cyclical neural modulation based on activity state
US8180447B2 (en) 2007-12-05 2012-05-15 The Invention Science Fund I, Llc Method for reversible chemical modulation of neural activity
US8165669B2 (en) * 2007-12-05 2012-04-24 The Invention Science Fund I, Llc System for magnetic modulation of neural conduction
US8170660B2 (en) 2007-12-05 2012-05-01 The Invention Science Fund I, Llc System for thermal modulation of neural activity
US8195287B2 (en) * 2007-12-05 2012-06-05 The Invention Science Fund I, Llc Method for electrical modulation of neural conduction
US8165668B2 (en) * 2007-12-05 2012-04-24 The Invention Science Fund I, Llc Method for magnetic modulation of neural conduction
US8170658B2 (en) * 2007-12-05 2012-05-01 The Invention Science Fund I, Llc System for electrical modulation of neural conduction
WO2009072123A2 (en) * 2007-12-06 2009-06-11 Technion Research & Development Foundation Ltd. Method and system for optical stimulation of neurons
US20090153752A1 (en) * 2007-12-14 2009-06-18 Silverstein Barry D Projector using independent multiple wavelength light sources
WO2009111010A1 (en) * 2008-03-03 2009-09-11 Seminex Corp. Portable semiconductor diode laser for medical treatment
JP5628792B2 (en) 2008-04-25 2014-11-19 トリア ビューティ インコーポレイテッド Optical sensor and method for distinguishing skin presence and skin pigmentation
US8572876B2 (en) * 2008-05-02 2013-11-05 Taser International, Inc. Systems and methods for detecting use of an electronic control device
WO2009155358A1 (en) 2008-06-17 2009-12-23 Earlens Corporation Optical electro-mechanical hearing devices with separate power and signal components
WO2010033932A1 (en) 2008-09-22 2010-03-25 Earlens Corporation Transducer devices and methods for hearing
CA2740734C (en) * 2008-10-15 2017-04-11 Biolase Technology, Inc. Satellite-platformed electromagnetic energy treatment device
US20100123076A1 (en) * 2008-11-19 2010-05-20 Sevastyanov Victor V Method for experimentally optic transmitting information through an optic nerve
US9149647B2 (en) * 2008-12-14 2015-10-06 C Laser, Inc. Method for deep tissue laser treatments using low intensity laser therapy causing selective destruction of Nociceptive nerves
US9693825B2 (en) * 2008-12-14 2017-07-04 C Laser, Inc. Fiber embedded hollow needle for percutaneous delivery of laser energy
US8771204B2 (en) 2008-12-30 2014-07-08 Masimo Corporation Acoustic sensor assembly
IT1398510B1 (en) * 2009-06-11 2013-03-01 Touch Life Rehab S R L "THERAPEUTIC SYSTEM WITH LASER LIGHT"
US9544700B2 (en) 2009-06-15 2017-01-10 Earlens Corporation Optically coupled active ossicular replacement prosthesis
US10286215B2 (en) 2009-06-18 2019-05-14 Earlens Corporation Optically coupled cochlear implant systems and methods
CN102598713A (en) 2009-06-18 2012-07-18 音束有限责任公司 Eardrum implantable devices for hearing systems and methods
CN102598714A (en) 2009-06-22 2012-07-18 音束有限责任公司 Round window coupled hearing systems and methods
WO2010151629A2 (en) * 2009-06-24 2010-12-29 SoundBeam LLC Transdermal photonic energy transmission devices and methods
US8790382B2 (en) * 2009-08-04 2014-07-29 Yonatan Gerlitz Handheld low-level laser therapy apparatus
US9553422B2 (en) 2009-08-04 2017-01-24 Medical Coherence Llc Multiple aperture hand-held laser therapy apparatus
RU2558459C2 (en) * 2009-08-25 2015-08-10 АРГУС НЬЮРООПТИКС, ЭлЭлСи Systems and methods for stimulation of neuronal activity
US8845626B2 (en) * 2009-10-01 2014-09-30 Coherent, Inc. Lensed dual-chip fiber-coupler for providing an aiming beam in an infrared radiation delivery apparatus
US8821415B2 (en) * 2009-10-15 2014-09-02 Masimo Corporation Physiological acoustic monitoring system
WO2011047216A2 (en) 2009-10-15 2011-04-21 Masimo Corporation Physiological acoustic monitoring system
US8715206B2 (en) * 2009-10-15 2014-05-06 Masimo Corporation Acoustic patient sensor
US8523781B2 (en) 2009-10-15 2013-09-03 Masimo Corporation Bidirectional physiological information display
DE102009051276A1 (en) * 2009-10-29 2011-05-12 Life & Brain Gmbh In-vivo stimulation probe
DE112010004682T5 (en) 2009-12-04 2013-03-28 Masimo Corporation Calibration for multi-level physiological monitors
ITMI20100216A1 (en) * 2010-02-12 2011-08-13 Ths Therapeutic Solutions S R L NEUROLOGICAL MEDICAL INSTRUMENT
US10206742B2 (en) 2010-02-21 2019-02-19 C Laser, Inc. Fiber embedded hollow spikes for percutaneous delivery of laser energy
US9044594B2 (en) 2010-02-21 2015-06-02 C Laser, Inc. Laser generator for deep tissue laser treatments using low intensity laser therapy causing selective destruction of nociceptive nerves
US9265576B2 (en) 2010-02-21 2016-02-23 C Laser, Inc. Laser generator for medical treatment
US8518094B2 (en) * 2010-03-02 2013-08-27 Bwt Property, Inc. Precisely guided phototherapy apparatus
EP2368513B1 (en) * 2010-03-23 2013-02-13 Ivoclar Vivadent AG Soft tissue laser
US9326712B1 (en) 2010-06-02 2016-05-03 Masimo Corporation Opticoustic sensor
IT1403091B1 (en) * 2010-12-01 2013-10-04 Touch Life Rehab S R L METHOD FOR THE MANAGEMENT OF LASER THERAPY PROTOCOLS.
EP3758394A1 (en) 2010-12-20 2020-12-30 Earlens Corporation Anatomically customized ear canal hearing apparatus
CN103402580A (en) * 2011-01-27 2013-11-20 Med-El电气医疗器械有限公司 Combined stimulation with controlled light distribution for electro-optical cochlear implants
US11406448B2 (en) 2011-02-03 2022-08-09 Channel Investments, Llc Devices and methods for radiation-based dermatological treatments
US9789332B2 (en) 2011-02-03 2017-10-17 Tria Beauty, Inc. Devices and methods for radiation-based dermatological treatments
WO2012106689A1 (en) * 2011-02-03 2012-08-09 Tria Beauty, Inc. Radiation-based dermatological devices and methods
US8685008B2 (en) 2011-02-03 2014-04-01 Tria Beauty, Inc. Devices and methods for radiation-based dermatological treatments
US9220915B2 (en) 2011-02-03 2015-12-29 Tria Beauty, Inc. Devices and methods for radiation-based dermatological treatments
US8679102B2 (en) 2011-02-03 2014-03-25 Tria Beauty, Inc. Devices and methods for radiation-based dermatological treatments
US9173708B2 (en) 2011-03-30 2015-11-03 Tria Beauty, Inc. Dermatological treatment device with one or more laser diode bar
US9072533B2 (en) 2011-03-30 2015-07-07 Tria Beauty, Inc. Dermatological treatment device with one or more multi-emitter laser diode
US9044596B2 (en) * 2011-05-24 2015-06-02 Vanderbilt University Method and apparatus of pulsed infrared light for central nervous system neurons
US20130166001A1 (en) * 2011-06-23 2013-06-27 University Of North Carolina At Charlotte Continuous-wave optical stimulation of nerve tissue
US9950190B2 (en) * 2011-07-03 2018-04-24 Medical Quant Ltd Device and method of treating fungal nail infections
US20130023910A1 (en) * 2011-07-21 2013-01-24 Solomon Clifford T Tissue-identifying surgical instrument
US9192351B1 (en) 2011-07-22 2015-11-24 Masimo Corporation Acoustic respiratory monitoring sensor with probe-off detection
JP5684083B2 (en) * 2011-09-29 2015-03-11 ジーイー・メディカル・システムズ・グローバル・テクノロジー・カンパニー・エルエルシー Probe cover, ultrasonic probe, and ultrasonic image display device
EP2765909B1 (en) 2011-10-13 2019-06-26 Masimo Corporation Physiological acoustic monitoring system
JP2013122443A (en) 2011-11-11 2013-06-20 Hideo Ando Biological activity measuring method, biological activity measuring device, method for transfer of biological activity detection signal and method for provision of service using biological activity information
US8858929B2 (en) * 2012-01-04 2014-10-14 Technion Research & Development Foundation Limited Optically sensitive cell network
WO2013116603A1 (en) * 2012-02-02 2013-08-08 Tria Beauty, Inc. Dermatological treatment device with one or more multi-emitter laser diode
DE102012005030B4 (en) * 2012-03-12 2016-06-16 Forschungszentrum Jülich GmbH Apparatus and method for stimulating with thermo-stimuli
US9606003B2 (en) 2012-03-28 2017-03-28 Yonatan Gerlitz Clinical hand-held infrared thermometer with special optical configuration
US10531908B2 (en) * 2012-05-25 2020-01-14 Ojai Retinal Technology, Llc Method for heat treating biological tissues using pulsed energy sources
US9950188B2 (en) * 2012-05-31 2018-04-24 Color Seven Co., Ltd. Apparatus for relaxing smooth muscles of human body
US9480529B2 (en) * 2012-06-22 2016-11-01 S & Y Enterprises Llc Aesthetic treatment device and method
US9364684B2 (en) * 2012-06-22 2016-06-14 S & Y Enterprises Llc Aesthetic treatment device and method
US10463361B2 (en) * 2012-07-13 2019-11-05 The University Of North Carolina At Charlotte Selective laser vaporization of materials
US9955937B2 (en) 2012-09-20 2018-05-01 Masimo Corporation Acoustic patient sensor coupler
KR102296172B1 (en) 2012-10-24 2021-09-01 바이오레이즈, 인크. Handpiece assembly for laser treatment device
US10098585B2 (en) 2013-03-15 2018-10-16 Cadwell Laboratories, Inc. Neuromonitoring systems and methods
US9946082B2 (en) 2013-04-30 2018-04-17 Medical Coherence Llc Handheld, low-level laser apparatuses and methods for low-level laser beam production
JP2014239871A (en) * 2013-05-07 2014-12-25 安東 秀夫 Biological activity detection method, biological activity measuring apparatus, biological activity detection signal transfer method, and providing method of service using biological activity information
US11229789B2 (en) 2013-05-30 2022-01-25 Neurostim Oab, Inc. Neuro activator with controller
KR102363552B1 (en) 2013-05-30 2022-02-15 그라함 에이치. 크리시 Topical neurological stimulation
PL2823785T3 (en) * 2013-07-10 2018-08-31 Fotona D.O.O. Handheld laser device for medical purposes
WO2015042138A1 (en) 2013-09-17 2015-03-26 The Board Of Trustees Of The Leland Stanford Junior University Apparatus for obtaining high-quality optical images in a magnetic resonance imaging system
US10828007B1 (en) 2013-10-11 2020-11-10 Masimo Corporation Acoustic sensor with attachment portion
US11166672B2 (en) 2013-10-18 2021-11-09 Atlantic Health System, Inc. Nerve protecting dissection device
US10022090B2 (en) * 2013-10-18 2018-07-17 Atlantic Health System, Inc. Nerve protecting dissection device
US10644476B2 (en) * 2013-11-28 2020-05-05 Candela Corporation Laser systems and related methods
CN106415950B (en) * 2013-12-31 2019-06-11 宝镭适有限公司 Dual-wavelength laser therapeutic equipment
CN106456045A (en) 2014-02-03 2017-02-22 小利兰·斯坦福大学托管委员会 Contact-free physiological monitoring during simultaneous magnetic resonance imaging
DE102015101880A1 (en) * 2014-02-11 2015-08-13 Andrew Mark Hewitson Laser irradiation apparatus
WO2015123100A1 (en) * 2014-02-11 2015-08-20 Rush University Medical Center Self-contained, handheld bipolar cortical stimulator
US20150238259A1 (en) * 2014-02-27 2015-08-27 Dan David Albeck Nerve sparing treatment systems and methods
US9629749B2 (en) 2014-02-27 2017-04-25 Iridex Corporation Illuminated treatment probe for delivering laser energy
KR102586010B1 (en) * 2014-02-28 2023-10-11 삼성전자주식회사 Cleaning robot and remote controller therein
US10034103B2 (en) 2014-03-18 2018-07-24 Earlens Corporation High fidelity and reduced feedback contact hearing apparatus and methods
US10281534B2 (en) 2014-03-20 2019-05-07 Life Services, LLC Tissue-slice MRI coil and rotation mechanism
JP6254907B2 (en) * 2014-05-30 2017-12-27 株式会社モリタ製作所 Laser light guide system
WO2016011044A1 (en) 2014-07-14 2016-01-21 Earlens Corporation Sliding bias and peak limiting for optical hearing devices
US10398369B2 (en) 2014-08-08 2019-09-03 Medtronic Xomed, Inc. Wireless stimulation probe device for wireless nerve integrity monitoring systems
US10734943B2 (en) * 2014-09-12 2020-08-04 The Government Of The United States Of America, As Represented By The Secretary Of The Navy Photovoltaics optimized for laser remote power applications at eye-safer wavelengths
US9924276B2 (en) 2014-11-26 2018-03-20 Earlens Corporation Adjustable venting for hearing instruments
WO2016094712A1 (en) * 2014-12-10 2016-06-16 Medical Coherence Llc Handheld, low-level laser apparatuses and methods for low-level laser beam production
US9220563B1 (en) * 2014-12-29 2015-12-29 InnovaQuartz LLC Multiwavelength surgical laser
US11077301B2 (en) 2015-02-21 2021-08-03 NeurostimOAB, Inc. Topical nerve stimulator and sensor for bladder control
US10039915B2 (en) 2015-04-03 2018-08-07 Medtronic Xomed, Inc. System and method for omni-directional bipolar stimulation of nerve tissue of a patient via a surgical tool
WO2017025423A1 (en) * 2015-08-13 2017-02-16 Koninklijke Philips N.V. Radial illumination system
WO2017059240A1 (en) 2015-10-02 2017-04-06 Earlens Corporation Drug delivery customized ear canal apparatus
US11350226B2 (en) 2015-12-30 2022-05-31 Earlens Corporation Charging protocol for rechargeable hearing systems
US10178483B2 (en) 2015-12-30 2019-01-08 Earlens Corporation Light based hearing systems, apparatus, and methods
US10492010B2 (en) 2015-12-30 2019-11-26 Earlens Corporations Damping in contact hearing systems
US10335607B2 (en) 2016-02-05 2019-07-02 Boston Scientific Neuromodulation Corporation Implantable optical stimulation lead and methods of making and using
RU2731863C2 (en) * 2016-04-21 2020-09-08 Конинклейке Филипс Н.В. Manual appliance to perform action depending on angular position of appliance
WO2018005796A1 (en) 2016-06-30 2018-01-04 Iridex Corporation Handheld ophthalmic laser system with replaceable contact tips and treatment guide
CN109952771A (en) 2016-09-09 2019-06-28 伊尔兰斯公司 Contact hearing system, device and method
US10849517B2 (en) 2016-09-19 2020-12-01 Medtronic Xomed, Inc. Remote control module for instruments
US10625072B2 (en) 2016-10-21 2020-04-21 Boston Scientific Neuromodulation Corporation Electrical stimulation methods with optical observation and devices therefor
WO2018093733A1 (en) 2016-11-15 2018-05-24 Earlens Corporation Improved impression procedure
US11517373B2 (en) * 2016-12-27 2022-12-06 Alma Lasers Ltd. Switched lasers for dermal treatment
US9935395B1 (en) 2017-01-23 2018-04-03 Cadwell Laboratories, Inc. Mass connection plate for electrical connectors
WO2019005774A1 (en) * 2017-06-26 2019-01-03 Vorso Corp. Peripheral nerve stimulation device for affecting parasympathetic and sympathetic activity to achieve therapeutic effects
EP3645110B1 (en) 2017-06-26 2022-07-13 Boston Scientific Neuromodulation Corporation Systems for visualizing and controlling optogenetic stimulation using optical stimulation systems
US11439839B2 (en) * 2017-08-09 2022-09-13 Acuity Innovation And Design, Llc Hand-held treatment device using LED light sources with interchangeable emitters
CN111601636A (en) 2017-11-07 2020-08-28 Oab神经电疗科技公司 Non-invasive neural activator with adaptive circuit
EP3737464A1 (en) 2018-01-11 2020-11-18 Boston Scientific Neuromodulation Corporation Methods and systems for stimulation for glial modulation
WO2019173470A1 (en) 2018-03-07 2019-09-12 Earlens Corporation Contact hearing device and retention structure materials
EP3536235A1 (en) 2018-03-08 2019-09-11 Inomed Medizintechnik GmbH Device system for intraoperative location of a nerve
US11565131B2 (en) 2018-03-23 2023-01-31 Boston Scientific Neuromodulation Corporation Optical stimulation systems with calibration and methods of making and using
WO2019183068A1 (en) 2018-03-23 2019-09-26 Boston Scientific Neuromodulation Corporation An optical stimulation system with on-demand monitoring and methods of making and using
WO2019199680A1 (en) 2018-04-09 2019-10-17 Earlens Corporation Dynamic filter
US11253182B2 (en) 2018-05-04 2022-02-22 Cadwell Laboratories, Inc. Apparatus and method for polyphasic multi-output constant-current and constant-voltage neurophysiological stimulation
US11443649B2 (en) 2018-06-29 2022-09-13 Cadwell Laboratories, Inc. Neurophysiological monitoring training simulator
KR102160857B1 (en) * 2018-07-23 2020-09-29 이화여자대학교 산학협력단 Optical probe
US11224743B2 (en) 2018-09-21 2022-01-18 Boston Scientific Neuromodulation Corporation Systems and methods for making and using modular leads for electrical stimulation systems
CN113711623A (en) 2018-09-24 2021-11-26 Nesos公司 Neural stimulation of the ear for treating a patient's disease, and related systems and methods
US11426595B2 (en) 2018-11-16 2022-08-30 Boston Scientific Neuromodulation Corporation Optical stimulation system with on-demand monitoring and methods of making and using
KR102627205B1 (en) 2018-11-20 2024-01-18 뉴에너치 인크 Electrical stimulation device that applies frequency and peak voltage that have an inverse relationship
WO2020214743A1 (en) 2019-04-15 2020-10-22 Cornell University Optical relay station-based implantable sensor modules
US11458311B2 (en) 2019-06-26 2022-10-04 Neurostim Technologies Llc Non-invasive nerve activator patch with adaptive circuit
US11819644B2 (en) 2019-10-16 2023-11-21 Cjmi, Llc Method and apparatus for treating genitourinary problems
KR20220115802A (en) 2019-12-16 2022-08-18 뉴로스팀 테크놀로지스 엘엘씨 Non-invasive neural activator with boost charge transfer function
WO2022051295A1 (en) 2020-09-04 2022-03-10 Boston Scientific Neuromodulation Corporation Stimulation systems with a lens arrangement for light coupling and methods of making and using

Citations (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4566935A (en) * 1984-07-31 1986-01-28 Texas Instruments Incorporated Spatial light modulator and method
US4596992A (en) * 1984-08-31 1986-06-24 Texas Instruments Incorporated Linear spatial light modulator and printer
US4671285A (en) * 1984-04-20 1987-06-09 Judith Walker Treatment of human neurological problems by laser photo simulation
US4681791A (en) * 1985-01-30 1987-07-21 Pilot Ink Co., Ltd. Thermochromic textile material
US4724835A (en) * 1984-03-06 1988-02-16 Pain Suppression Labs, Inc. Laser therapeutic device
US4757515A (en) * 1984-05-14 1988-07-12 Hughes Technology Pty Ltd. Laser tube casing
US4813418A (en) * 1987-02-02 1989-03-21 Staodynamics, Inc. Nerve fiber stimulation using symmetrical biphasic waveform applied through plural equally active electrodes
US4840485A (en) * 1986-12-17 1989-06-20 I.S.S. (U.S.A.) Inc. Frequency domain cross-correlation fluorometry with phase-locked loop frequency synthesizers
US4928695A (en) * 1989-02-17 1990-05-29 Leon Goldman Laser diagnostic and treatment device
US4930504A (en) * 1987-11-13 1990-06-05 Diamantopoulos Costas A Device for biostimulation of tissue and method for treatment of tissue
US4989605A (en) * 1989-03-31 1991-02-05 Joel Rossen Transcutaneous electrical nerve stimulation (TENS) device
US5088493A (en) * 1984-08-07 1992-02-18 Sclavo, S.P.A. Multiple wavelength light photometer for non-invasive monitoring
US5122974A (en) * 1989-02-06 1992-06-16 Nim, Inc. Phase modulated spectrophotometry
US5187672A (en) * 1989-02-06 1993-02-16 Nim Incorporated Phase modulation spectroscopic system
US5192278A (en) * 1985-03-22 1993-03-09 Massachusetts Institute Of Technology Multi-fiber plug for a laser catheter
US5212386A (en) * 1991-12-13 1993-05-18 I.S.S. (U.S.A.) Inc. High speed cross-correlation frequency domain fluorometry-phosphorimetry
US5213093A (en) * 1991-05-29 1993-05-25 Applied Vascular Devices, Inc. Endoscope with non-circular probe and method of making same
US5213105A (en) * 1990-12-04 1993-05-25 Research Corporation Technologies, Inc. Frequency domain optical imaging using diffusion of intensity modulated radiation
US5323010A (en) * 1992-12-01 1994-06-21 I.S.S. (Usa) Inc. Time resolved optical array detectors and CCD cameras for frequency domain fluorometry and/or phosphorimetry
US5327902A (en) * 1993-05-14 1994-07-12 Lemmen Roger D Apparatus for use in nerve conduction studies
US5386827A (en) * 1993-03-30 1995-02-07 Nim Incorporated Quantitative and qualitative in vivo tissue examination using time resolved spectroscopy
US5402778A (en) * 1993-01-19 1995-04-04 Nim Incorporated Spectrophotometric examination of tissue of small dimension
US5419312A (en) * 1993-04-20 1995-05-30 Wildflower Communications, Inc. Multi-function endoscope apparatus
US5430175A (en) * 1993-11-30 1995-07-04 Cornell Research Foundation, Inc. Caged carboxyl compounds and use thereof
US5480482A (en) * 1991-11-04 1996-01-02 The United States Of America As Represented By The Secretary Of The Navy Reversible thermochromic pigments
US5484432A (en) * 1985-09-27 1996-01-16 Laser Biotech, Inc. Collagen treatment apparatus
US5704899A (en) * 1995-10-10 1998-01-06 Conceptus, Inc. Protective sheath for a fiberoptic image guide within an articulated endoscope
US5754578A (en) * 1996-06-24 1998-05-19 W. L. Gore & Associates, Inc. 1250-1650 nm vertical cavity surface emitting laser pumped by a 700-1050 nm vertical cavity surface emitting laser
US5755752A (en) * 1992-04-24 1998-05-26 Segal; Kim Robin Diode laser irradiation system for biological tissue stimulation
US5791231A (en) * 1993-05-17 1998-08-11 Endorobotics Corporation Surgical robotic system and hydraulic actuator therefor
US5823192A (en) * 1996-07-31 1998-10-20 University Of Pittsburgh Of The Commonwealth System Of Higher Education Apparatus for automatically positioning a patient for treatment/diagnoses
US5827265A (en) * 1996-02-07 1998-10-27 Regents Of The University Of California Intraluminal tissue welding for anastomosis
US5899865A (en) * 1988-12-21 1999-05-04 Non-Invasive Technology, Inc. Localization of abnormal breast tissue using time-resolved spectroscopy
US5913884A (en) * 1996-09-19 1999-06-22 The General Hospital Corporation Inhibition of fibrosis by photodynamic therapy
US6066127A (en) * 1997-09-30 2000-05-23 Nidek Co., Ltd. Laser treatment apparatus
US6074411A (en) * 1998-04-04 2000-06-13 Lai; Ming Multiple diode laser apparatus and method for laser acupuncture therapy
US6171239B1 (en) * 1998-08-17 2001-01-09 Emory University Systems, methods, and devices for controlling external devices by signals derived directly from the nervous system
US6184542B1 (en) * 1998-06-16 2001-02-06 Princeton Lightwave Superluminescent diode and optical amplifier with extended bandwidth
US6224969B1 (en) * 1997-09-01 2001-05-01 Stichting Voor De Technische Wetenschappen Optical phantom suitable for stimulating the optical properties of biological material and a method of producing said phantom
US6240308B1 (en) * 1988-12-23 2001-05-29 Tyrone L. Hardy Method and apparatus for archiving and displaying anatomico-physiological data in a normalized whole brain mapping and imaging system
US6246892B1 (en) * 1991-01-24 2001-06-12 Non-Invasive Technology Phase modulation spectroscopy
US6257759B1 (en) * 1998-06-26 2001-07-10 Medical Indicators, Inc. Liquid crystal thermometer
US6258082B1 (en) * 1999-05-03 2001-07-10 J. T. Lin Refractive surgery and presbyopia correction using infrared and ultraviolet lasers
US6263221B1 (en) * 1991-01-24 2001-07-17 Non-Invasive Technology Quantitative analyses of biological tissue using phase modulation spectroscopy
US6339606B1 (en) * 1998-06-16 2002-01-15 Princeton Lightwave, Inc. High power semiconductor light source
US6353226B1 (en) * 1998-11-23 2002-03-05 Abbott Laboratories Non-invasive sensor capable of determining optical parameters in a sample having multiple layers
US6358272B1 (en) * 1995-05-16 2002-03-19 Lutz Wilden Therapy apparatus with laser irradiation device
US6363188B1 (en) * 1999-10-22 2002-03-26 Princeton Lightwave, Inc. Mode expander with co-directional grating
US6505075B1 (en) * 1999-05-29 2003-01-07 Richard L. Weiner Peripheral nerve stimulation method
US6542530B1 (en) * 2000-10-27 2003-04-01 Chan-Long Shieh Electrically pumped long-wavelength VCSEL and methods of fabrication
US6542772B1 (en) * 1994-12-02 2003-04-01 Non-Invasive Technology, Inc. Examination and imaging of biological tissue
US6546291B2 (en) * 2000-02-16 2003-04-08 Massachusetts Eye & Ear Infirmary Balance prosthesis
US6556611B1 (en) * 1999-05-10 2003-04-29 Princeton Lightwave, Inc. Wide stripe distributed bragg reflector lasers with improved angular and spectral characteristics
US6564076B1 (en) * 1988-12-21 2003-05-13 Non-Invasive Technology, Inc. Time-resolved spectroscopic apparatus and method using streak camera
US6585722B1 (en) * 1999-08-05 2003-07-01 Nidek Co., Ltd. Photocoagulation apparatus
US6690873B2 (en) * 1999-01-27 2004-02-10 Teem Photonics Method and apparatus for waveguide optics and devices
US6688783B2 (en) * 2002-03-25 2004-02-10 Princeton Lightwave, Inc. Method of fabricating an optical module including a lens attached to a platform of the optical module
US6735475B1 (en) * 2001-01-30 2004-05-11 Advanced Bionics Corporation Fully implantable miniature neurostimulator for stimulation as a therapy for headache and/or facial pain
US6735474B1 (en) * 1998-07-06 2004-05-11 Advanced Bionics Corporation Implantable stimulator system and method for treatment of incontinence and pain
US6744548B2 (en) * 2000-01-20 2004-06-01 Princeton Lightwave, Inc. Resonant enhanced modulator (REM)
US6748275B2 (en) * 1999-05-05 2004-06-08 Respironics, Inc. Vestibular stimulation system and method
US20050065531A1 (en) * 2003-03-28 2005-03-24 Cohen Donald M. Vascular occlusion systems and methods
US20050096720A1 (en) * 2003-11-04 2005-05-05 Medtronic, Inc. Implantable medical device having optical fiber for sensing electrical activity
US20050099824A1 (en) * 2000-08-04 2005-05-12 Color Kinetics, Inc. Methods and systems for medical lighting
US6902528B1 (en) * 1999-04-14 2005-06-07 Stereotaxis, Inc. Method and apparatus for magnetically controlling endoscopes in body lumens and cavities
US6909826B2 (en) * 1999-10-28 2005-06-21 Princeton Lightwave, Inc. Multiple grating optical waveguide monitor
US20050143789A1 (en) * 2001-01-30 2005-06-30 Whitehurst Todd K. Methods and systems for stimulating a peripheral nerve to treat chronic pain
US20050142344A1 (en) * 2003-12-24 2005-06-30 Zap-It Corp., Inc. Laser test card
US6921413B2 (en) * 2000-08-16 2005-07-26 Vanderbilt University Methods and devices for optical stimulation of neural tissues
US6989023B2 (en) * 2003-07-08 2006-01-24 Oralum, Llc Hygienic treatments of body structures
US7003353B1 (en) * 2002-12-10 2006-02-21 Quallion Llc Photovoltaic powered charging apparatus for implanted rechargeable batteries
US7004645B2 (en) * 2003-04-30 2006-02-28 Agilent Technologies, Inc. VCSEL array configuration for a parallel WDM transmitter
US7006749B2 (en) * 2002-08-07 2006-02-28 Dornier Medtech Laser Gmbh Laser system with fiber-bound communication
US7031363B2 (en) * 2003-10-29 2006-04-18 Finisar Corporation Long wavelength VCSEL device processing
US20060095105A1 (en) * 2001-10-31 2006-05-04 London Health Sciences Center Multichannel electrode and methods of using same
US7040805B1 (en) * 2004-05-24 2006-05-09 The United States Of America As Represented By The Secretary Of The Air Force Method of infrared thermography
US20060122509A1 (en) * 2004-11-24 2006-06-08 Liposonix, Inc. System and methods for destroying adipose tissue
US20060129210A1 (en) * 2004-11-09 2006-06-15 Institut National D'optique Device and method for transmitting multiple optically-encoded stimulation signals to multiple cell locations
US7069083B2 (en) * 2002-12-13 2006-06-27 Advanced Neuromodulation Systems, Inc. System and method for electrical stimulation of the intervertebral disc
US20060141633A1 (en) * 2000-03-28 2006-06-29 The Foundation Of Research And Technology Hellas Method and system for characterization and mapping of tissue lesions
US7156866B1 (en) * 2003-10-15 2007-01-02 Riggs Jeffrey M Holistic method of treating injured or pathologic tissue with a laser
US7177081B2 (en) * 2001-03-08 2007-02-13 Silicon Light Machines Corporation High contrast grating light valve type device
US20070054319A1 (en) * 2005-07-22 2007-03-08 Boyden Edward S Light-activated cation channel and uses thereof
US20070060984A1 (en) * 2005-09-09 2007-03-15 Webb James S Apparatus and method for optical stimulation of nerves and other animal tissue
US7194063B2 (en) * 2005-02-10 2007-03-20 Brookhaven Science Associates, Llc Methods for implementing microbeam radiation therapy
US20070106306A1 (en) * 2005-09-30 2007-05-10 Restoration Robotics, Inc. Automated system for harvesting or implanting follicular units
US7231256B2 (en) * 2005-03-11 2007-06-12 Medtronic, Inc. Neurostimulation site screening
US20080009748A1 (en) * 2006-05-16 2008-01-10 The Regents Of The University Of California method and apparatus for the determination of intrinsic spectroscopic tumor markers by broadband-frequency domain technology
US7324852B2 (en) * 2004-02-25 2008-01-29 Giancarlo Barolat System and method for neurological stimulation of peripheral nerves to treat low back pain
US7329251B2 (en) * 2003-12-25 2008-02-12 Nidek Co., Ltd. Laser treatment apparatus
US7337004B2 (en) * 2004-02-09 2008-02-26 Classen Ashley M Method and apparatus for veterinary RF pain management
US20090076115A1 (en) * 2005-02-28 2009-03-19 The General Hospital Corporation Photosensitizers for Targeted Photodynamic Therapy
US20090163982A1 (en) * 2004-11-15 2009-06-25 Decharms R Christopher Applications of the stimulation of neural tissue using light
US7554578B2 (en) * 2000-07-11 2009-06-30 Phase One A/S Digital camera with integrated accelerometers
US7647112B2 (en) * 2004-02-11 2010-01-12 Ethicon, Inc. System and method for selectively stimulating different body parts
US7654750B2 (en) * 2005-08-10 2010-02-02 Brenner Mary K Bidirectional optical fiber link systems component couplers
US20100162109A1 (en) * 2008-12-22 2010-06-24 Shuvo Chatterjee User interface having changeable topography
US7865236B2 (en) * 2004-10-20 2011-01-04 Nervonix, Inc. Active electrode, bio-impedance based, tissue discrimination system and methods of use
US7883536B1 (en) * 2007-01-19 2011-02-08 Lockheed Martin Corporation Hybrid optical-electrical probes
US7909867B2 (en) * 2004-10-05 2011-03-22 The Board Of Trustees Of The Leland Stanford Junior University Interpenetrating polymer network hydrogel corneal prosthesis
US7914842B1 (en) * 2006-02-10 2011-03-29 Second Sight Medical Products, Inc Method of manufacturing a flexible circuit electrode array
US7988688B2 (en) * 2006-09-21 2011-08-02 Lockheed Martin Corporation Miniature apparatus and method for optical stimulation of nerves and other animal tissue

Family Cites Families (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064872A (en) 1976-09-02 1977-12-27 Ashley-Butler, Inc. Temperature measuring device of a liquid crystal laminate
FR2390968A1 (en) * 1977-05-16 1978-12-15 Skovajsa Joseph Local acupuncture treatment appts. - has oblong head with end aperture and contains laser diode unit (NL 20.11.78)
US4215694A (en) 1978-06-01 1980-08-05 Isakov Viktor L Laser therapy apparatus
US4296995A (en) * 1980-02-01 1981-10-27 International Telephone And Telegraph Corporation Optical fiber beam splitter couplers employing coatings with dichroic properties
US4558703A (en) * 1982-05-27 1985-12-17 Hermann Mark Vestibular stimulation method
US5139025A (en) 1983-10-14 1992-08-18 Somanetics Corporation Method and apparatus for in vivo optical spectroscopic examination
US4768516A (en) 1983-10-14 1988-09-06 Somanetics Corporation Method and apparatus for in vivo evaluation of tissue composition
JPS633873A (en) 1986-06-23 1988-01-08 富士電機株式会社 Laser remedy device
US5564417A (en) 1991-01-24 1996-10-15 Non-Invasive Technology, Inc. Pathlength corrected oximeter and the like
US4972331A (en) 1989-02-06 1990-11-20 Nim, Inc. Phase modulated spectrophotometry
US5792051A (en) 1988-12-21 1998-08-11 Non-Invasive Technology, Inc. Optical probe for non-invasive monitoring of neural activity
US5553614A (en) 1988-12-21 1996-09-10 Non-Invasive Technology, Inc. Examination of biological tissue using frequency domain spectroscopy
US5353799A (en) 1991-01-22 1994-10-11 Non Invasive Technology, Inc. Examination of subjects using photon migration with high directionality techniques
WO1990009637A1 (en) 1989-02-13 1990-08-23 Research Corporation Technologies, Inc. Method and means for parallel frequency acquisition in frequency domain fluorometry
US5062428A (en) 1990-06-04 1991-11-05 Nim Incorporated Method and device for in vivo diagnosis detecting IR emission by body organ
US5152278A (en) * 1990-08-28 1992-10-06 Applied Medical Resources, Inc. Surgical endoscope apparatus
US5151909A (en) 1990-10-16 1992-09-29 Laserscope Frequency doubled solid state laser having programmable pump power modes and method for controllable lasers
US5259382A (en) 1991-03-04 1993-11-09 Kronberg James W Optical transcutaneous bilirubin detector
US5851223A (en) 1991-05-21 1998-12-22 Medi Consultants, Inc. Combination non-intrusive analgesic neuroaugmentive system and method triple-modulated gigatens with optional bipolar spike
US5445146A (en) 1995-03-31 1995-08-29 Bellinger; Gary J. Biological tissue stimulation by low level optical energy
US5187972A (en) * 1992-01-17 1993-02-23 Clean Air Engineering, Inc. Gas monitor
US5464960A (en) 1993-01-12 1995-11-07 Iatrotech, Inc. Laser calibration device
US5261822A (en) 1993-01-12 1993-11-16 Iatrotech, Inc. Surgical refractive laser calibration device
US5548604A (en) * 1993-03-19 1996-08-20 Toepel; Michael P. Compact hand held medical device laser
US7776631B2 (en) 1994-05-05 2010-08-17 Qualcomm Mems Technologies, Inc. MEMS device and method of forming a MEMS device
US6284078B1 (en) 1994-11-22 2001-09-04 Medical Indicators, Inc. Method for preparing an improved liquid crystal clinical thermometer
EP0808124B1 (en) * 1995-01-03 2003-04-16 Non-Invasive Technology, Inc. Optical coupler for in vivo examination of biological tissue
US5608519A (en) 1995-03-20 1997-03-04 Gourley; Paul L. Laser apparatus and method for microscopic and spectroscopic analysis and processing of biological cells
US6294109B1 (en) 1995-06-13 2001-09-25 The United States Of America As Represented By The Secretary Of The Navy Ferroelectric and electroclinic liquid crystal materials with sub-ambient temperature stability, broad operation range, and fast dynamic response
US5796889A (en) * 1996-03-13 1998-08-18 E-Tek Dynamics, Inc. Integrated WDM coupler devices for fiberoptic networks
JP2002515181A (en) * 1996-06-05 2002-05-21 サーノフ コーポレイション Light emitting semiconductor device
US5799030A (en) 1996-07-26 1998-08-25 Honeywell Inc. Semiconductor device with a laser and a photodetector in a common container
JP3036232U (en) 1996-09-26 1997-04-15 ヤーマン株式会社 Optical hair removal device
US6048359A (en) 1997-08-25 2000-04-11 Advanced Photodynamic Technologies, Inc. Spatial orientation and light sources and method of using same for medical diagnosis and photodynamic therapy
WO2000053261A1 (en) * 1999-03-08 2000-09-14 Asah Medico A/S An apparatus for tissue treatment and having a monitor for display of tissue features
US6836685B1 (en) 1998-04-07 2004-12-28 William R. Fitz Nerve stimulation method and apparatus for pain relief
US6324429B1 (en) 1998-05-08 2001-11-27 Massachusetts Eye And Ear Infirmary Chronically implantable retinal prosthesis
US6110195A (en) * 1998-06-01 2000-08-29 Altralight, Inc. Method and apparatus for surgical and dermatological treatment by multi-wavelength laser light
US6104957A (en) 1998-08-21 2000-08-15 Alo; Kenneth M. Epidural nerve root stimulation with lead placement method
US6402739B1 (en) * 1998-12-08 2002-06-11 Y-Beam Technologies, Inc. Energy application with cooling
US7095770B2 (en) 2001-12-20 2006-08-22 Finisar Corporation Vertical cavity surface emitting laser including indium, antimony and nitrogen in the active region
US6310083B1 (en) 1998-12-21 2001-10-30 University Of Maryland Boitechnology Institute Caged amino acid derivatives bearing photolabile protective groups
US6152882A (en) * 1999-01-26 2000-11-28 Impulse Dynamics N.V. Apparatus and method for chronic measurement of monophasic action potentials
JP2000212489A (en) 1999-01-28 2000-08-02 Pilot Ink Co Ltd Thermally fugitive dry offset ink and printed matter by use thereof
US6214035B1 (en) 1999-03-23 2001-04-10 Jackson Streeter Method for improving cardiac microcirculation
US8180453B2 (en) 1999-03-24 2012-05-15 Second Sight Medical Products, Inc. Electrode array for neural stimulation
US6267779B1 (en) * 1999-03-29 2001-07-31 Medelaser, Llc Method and apparatus for therapeutic laser treatment
US6301279B1 (en) * 1999-04-16 2001-10-09 Princeton Lightwave Inc. Semiconductor diode lasers with thermal sensor control of the active region temperature
US6314324B1 (en) * 1999-05-05 2001-11-06 Respironics, Inc. Vestibular stimulation system and method
US6459715B1 (en) * 1999-05-10 2002-10-01 Princeton Lightwave, Inc. Master-oscillator grating coupled power amplifier with angled amplifier section
US6243508B1 (en) 1999-06-01 2001-06-05 Picolight Incorporated Electro-opto-mechanical assembly for coupling a light source or receiver to an optical waveguide
US7302296B1 (en) * 1999-07-06 2007-11-27 Neurostream Technologies, Inc. Electrical stimulation system and methods for treating phantom limb pain and for providing sensory feedback to an amputee from a prosthetic limb
US6475800B1 (en) 1999-07-22 2002-11-05 Instrumentation Metrics, Inc. Intra-serum and intra-gel for modeling human skin tissue
WO2001008552A1 (en) * 1999-08-03 2001-02-08 Biophysica, Llc Spectroscopic systems and methods for detecting tissue properties
US6456866B1 (en) 1999-09-28 2002-09-24 Dustin Tyler Flat interface nerve electrode and a method for use
JP3188437B2 (en) 1999-12-08 2001-07-16 ヤーマン株式会社 Laser irradiation probe
US8078263B2 (en) * 2000-01-19 2011-12-13 Christie Medical Holdings, Inc. Projection of subsurface structure onto an object's surface
JP2001242339A (en) 2000-03-01 2001-09-07 Nippon Sheet Glass Co Ltd Optical fiber lens array
US6556607B1 (en) 2000-06-23 2003-04-29 Picolight, Incorporated Temperature compensated lasers
US6871084B1 (en) 2000-07-03 2005-03-22 Srico, Inc. High-impedance optical electrode
US6592611B1 (en) 2000-10-10 2003-07-15 Robert H. Zawada Violation of time reversal invariance in living tissue
US6493476B2 (en) 2000-11-27 2002-12-10 Teem Photonics Apparatus and method for integrated photonic devices having gain and wavelength-selectivity
US6444313B1 (en) 2001-01-05 2002-09-03 The Pilot Ink Co., Ltd. Thermochromic acrylic synthetic fiber, its processed article, and process for producing thermochromic acrylic synthetic fiber
US6639930B2 (en) * 2001-01-11 2003-10-28 Princeton, Lightwave, Inc. Multi-level closed loop resonators and method for fabricating same
US6956650B2 (en) * 2001-01-12 2005-10-18 General Hospital Corporation System and method for enabling simultaneous calibration and imaging of a medium
WO2002062420A1 (en) 2001-01-22 2002-08-15 SØRENSEN, Svein Photodynamic stimulation device and methods
US20050131499A1 (en) * 2001-03-02 2005-06-16 Shanks Steven C. Laser device to treat sympathetic and parasympathetic nervous systems
US6746473B2 (en) * 2001-03-02 2004-06-08 Erchonia Patent Holdings, Llc Therapeutic laser device
US6488704B1 (en) 2001-05-07 2002-12-03 Biomed Solutions, Llc Implantable particle measuring apparatus
AUPR851601A0 (en) 2001-10-26 2001-11-29 Cochlear Limited Auditory midbrain implant
US6585411B2 (en) 2001-11-02 2003-07-01 Illinois Tool Works Inc. Aerosol dispenser temperature indicator
EP1627662B1 (en) * 2004-06-10 2011-03-02 Candela Corporation Apparatus for vacuum-assisted light-based treatments of the skin
US7085300B2 (en) 2001-12-28 2006-08-01 Finisar Corporation Integral vertical cavity surface emitting laser and power monitor
US6669379B2 (en) 2002-04-01 2003-12-30 Princeton Lightwave, Inc. Method of attaching optical fiber in alignment with a light source in an optical module
US6874950B2 (en) * 2002-12-17 2005-04-05 International Business Machines Corporation Devices and methods for side-coupling optical fibers to optoelectronic components
WO2004058352A2 (en) * 2002-12-20 2004-07-15 Palomar Medical Technologies, Inc. Apparatus for light treatment of acne and other disorders of follicles
US7402167B2 (en) 2003-03-03 2008-07-22 Mikhail Nemenov Portable laser and process for producing controlled pain
US6953341B2 (en) * 2003-08-20 2005-10-11 Oralum, Llc Toothpick for light treatment of body structures
US7144247B2 (en) * 2003-04-25 2006-12-05 Oralum, Llc Hygienic treatments of structures in body cavities
US7351241B2 (en) * 2003-06-02 2008-04-01 Carl Zeiss Meditec Ag Method and apparatus for precision working of material
US7131968B2 (en) * 2003-06-02 2006-11-07 Carl Zeiss Meditec Ag Apparatus and method for opthalmologic surgical procedures using a femtosecond fiber laser
US20060161218A1 (en) * 2003-11-26 2006-07-20 Wicab, Inc. Systems and methods for treating traumatic brain injury
WO2005065565A1 (en) * 2003-12-31 2005-07-21 Palomar Medical Technologies, Inc. Dermatological treatment with vusualization
US7899512B2 (en) * 2004-03-22 2011-03-01 Vanderbilt University System and method for surgical instrument disablement via image-guided position feedback
US7225028B2 (en) * 2004-05-28 2007-05-29 Advanced Bionics Corporation Dual cochlear/vestibular stimulator with control signals derived from motion and speech signals
US7787170B2 (en) 2004-06-15 2010-08-31 Texas Instruments Incorporated Micromirror array assembly with in-array pillars
US20050283148A1 (en) * 2004-06-17 2005-12-22 Janssen William M Ablation apparatus and system to limit nerve conduction
US7833257B2 (en) * 2004-11-12 2010-11-16 Northwestern University Apparatus and methods for optical stimulation of the auditory nerve
US20060276861A1 (en) 2005-06-01 2006-12-07 Lin J T Non-invasive method and system for the treatment of snoring and nasal obstruction
US7391561B2 (en) * 2005-07-29 2008-06-24 Aculight Corporation Fiber- or rod-based optical source featuring a large-core, rare-earth-doped photonic-crystal device for generation of high-power pulsed radiation and method
US7488341B2 (en) * 2005-09-14 2009-02-10 Massachusetts Eye & Ear Infirmary Method for optical stimulation of the vestibular system
US7801601B2 (en) * 2006-01-27 2010-09-21 Cyberonics, Inc. Controlling neuromodulation using stimulus modalities
US20070191906A1 (en) 2006-02-13 2007-08-16 Anand Iyer Method and apparatus for selective nerve stimulation
US8197539B2 (en) * 2006-05-05 2012-06-12 University Of Southern California Intraocular camera for retinal prostheses
US8136531B2 (en) 2006-05-08 2012-03-20 Chariff Mark D Device and method for treating musculo-skeletal injury and pain by application of laser light therapy
US7747318B2 (en) * 2006-12-07 2010-06-29 Neuropace, Inc. Functional ferrule
US7792588B2 (en) 2007-01-26 2010-09-07 Medtronic, Inc. Radio frequency transponder based implantable medical system
US20090210039A1 (en) 2007-05-09 2009-08-20 Boyden Edward S Prosthetic system for therapeutic optical activation and silencing of genetically-targeted neurons

Patent Citations (106)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724835A (en) * 1984-03-06 1988-02-16 Pain Suppression Labs, Inc. Laser therapeutic device
US4671285A (en) * 1984-04-20 1987-06-09 Judith Walker Treatment of human neurological problems by laser photo simulation
US4757515A (en) * 1984-05-14 1988-07-12 Hughes Technology Pty Ltd. Laser tube casing
US4566935A (en) * 1984-07-31 1986-01-28 Texas Instruments Incorporated Spatial light modulator and method
US5088493A (en) * 1984-08-07 1992-02-18 Sclavo, S.P.A. Multiple wavelength light photometer for non-invasive monitoring
US4596992A (en) * 1984-08-31 1986-06-24 Texas Instruments Incorporated Linear spatial light modulator and printer
US4681791A (en) * 1985-01-30 1987-07-21 Pilot Ink Co., Ltd. Thermochromic textile material
US5192278A (en) * 1985-03-22 1993-03-09 Massachusetts Institute Of Technology Multi-fiber plug for a laser catheter
US5484432A (en) * 1985-09-27 1996-01-16 Laser Biotech, Inc. Collagen treatment apparatus
US4840485A (en) * 1986-12-17 1989-06-20 I.S.S. (U.S.A.) Inc. Frequency domain cross-correlation fluorometry with phase-locked loop frequency synthesizers
US4813418A (en) * 1987-02-02 1989-03-21 Staodynamics, Inc. Nerve fiber stimulation using symmetrical biphasic waveform applied through plural equally active electrodes
US4930504A (en) * 1987-11-13 1990-06-05 Diamantopoulos Costas A Device for biostimulation of tissue and method for treatment of tissue
US6564076B1 (en) * 1988-12-21 2003-05-13 Non-Invasive Technology, Inc. Time-resolved spectroscopic apparatus and method using streak camera
US5899865A (en) * 1988-12-21 1999-05-04 Non-Invasive Technology, Inc. Localization of abnormal breast tissue using time-resolved spectroscopy
US6240308B1 (en) * 1988-12-23 2001-05-29 Tyrone L. Hardy Method and apparatus for archiving and displaying anatomico-physiological data in a normalized whole brain mapping and imaging system
US5187672A (en) * 1989-02-06 1993-02-16 Nim Incorporated Phase modulation spectroscopic system
US5122974A (en) * 1989-02-06 1992-06-16 Nim, Inc. Phase modulated spectrophotometry
US4928695A (en) * 1989-02-17 1990-05-29 Leon Goldman Laser diagnostic and treatment device
US4989605A (en) * 1989-03-31 1991-02-05 Joel Rossen Transcutaneous electrical nerve stimulation (TENS) device
US5213105A (en) * 1990-12-04 1993-05-25 Research Corporation Technologies, Inc. Frequency domain optical imaging using diffusion of intensity modulated radiation
US6263221B1 (en) * 1991-01-24 2001-07-17 Non-Invasive Technology Quantitative analyses of biological tissue using phase modulation spectroscopy
US6246892B1 (en) * 1991-01-24 2001-06-12 Non-Invasive Technology Phase modulation spectroscopy
US5213093A (en) * 1991-05-29 1993-05-25 Applied Vascular Devices, Inc. Endoscope with non-circular probe and method of making same
US5480482A (en) * 1991-11-04 1996-01-02 The United States Of America As Represented By The Secretary Of The Navy Reversible thermochromic pigments
US5212386A (en) * 1991-12-13 1993-05-18 I.S.S. (U.S.A.) Inc. High speed cross-correlation frequency domain fluorometry-phosphorimetry
US6033431A (en) * 1992-04-24 2000-03-07 Segal; Kim Robin Diode laser irradiation system for biological tissue stimulation
US5755752A (en) * 1992-04-24 1998-05-26 Segal; Kim Robin Diode laser irradiation system for biological tissue stimulation
US5323010A (en) * 1992-12-01 1994-06-21 I.S.S. (Usa) Inc. Time resolved optical array detectors and CCD cameras for frequency domain fluorometry and/or phosphorimetry
US5402778A (en) * 1993-01-19 1995-04-04 Nim Incorporated Spectrophotometric examination of tissue of small dimension
US5386827A (en) * 1993-03-30 1995-02-07 Nim Incorporated Quantitative and qualitative in vivo tissue examination using time resolved spectroscopy
US5419312A (en) * 1993-04-20 1995-05-30 Wildflower Communications, Inc. Multi-function endoscope apparatus
US5327902A (en) * 1993-05-14 1994-07-12 Lemmen Roger D Apparatus for use in nerve conduction studies
US5791231A (en) * 1993-05-17 1998-08-11 Endorobotics Corporation Surgical robotic system and hydraulic actuator therefor
US5430175A (en) * 1993-11-30 1995-07-04 Cornell Research Foundation, Inc. Caged carboxyl compounds and use thereof
US6542772B1 (en) * 1994-12-02 2003-04-01 Non-Invasive Technology, Inc. Examination and imaging of biological tissue
US6358272B1 (en) * 1995-05-16 2002-03-19 Lutz Wilden Therapy apparatus with laser irradiation device
US5704899A (en) * 1995-10-10 1998-01-06 Conceptus, Inc. Protective sheath for a fiberoptic image guide within an articulated endoscope
US5827265A (en) * 1996-02-07 1998-10-27 Regents Of The University Of California Intraluminal tissue welding for anastomosis
US5754578A (en) * 1996-06-24 1998-05-19 W. L. Gore & Associates, Inc. 1250-1650 nm vertical cavity surface emitting laser pumped by a 700-1050 nm vertical cavity surface emitting laser
US5823192A (en) * 1996-07-31 1998-10-20 University Of Pittsburgh Of The Commonwealth System Of Higher Education Apparatus for automatically positioning a patient for treatment/diagnoses
US5913884A (en) * 1996-09-19 1999-06-22 The General Hospital Corporation Inhibition of fibrosis by photodynamic therapy
US6224969B1 (en) * 1997-09-01 2001-05-01 Stichting Voor De Technische Wetenschappen Optical phantom suitable for stimulating the optical properties of biological material and a method of producing said phantom
US6066127A (en) * 1997-09-30 2000-05-23 Nidek Co., Ltd. Laser treatment apparatus
US6074411A (en) * 1998-04-04 2000-06-13 Lai; Ming Multiple diode laser apparatus and method for laser acupuncture therapy
US6339606B1 (en) * 1998-06-16 2002-01-15 Princeton Lightwave, Inc. High power semiconductor light source
US6184542B1 (en) * 1998-06-16 2001-02-06 Princeton Lightwave Superluminescent diode and optical amplifier with extended bandwidth
US6257759B1 (en) * 1998-06-26 2001-07-10 Medical Indicators, Inc. Liquid crystal thermometer
US6735474B1 (en) * 1998-07-06 2004-05-11 Advanced Bionics Corporation Implantable stimulator system and method for treatment of incontinence and pain
US6171239B1 (en) * 1998-08-17 2001-01-09 Emory University Systems, methods, and devices for controlling external devices by signals derived directly from the nervous system
US6353226B1 (en) * 1998-11-23 2002-03-05 Abbott Laboratories Non-invasive sensor capable of determining optical parameters in a sample having multiple layers
US6690873B2 (en) * 1999-01-27 2004-02-10 Teem Photonics Method and apparatus for waveguide optics and devices
US6902528B1 (en) * 1999-04-14 2005-06-07 Stereotaxis, Inc. Method and apparatus for magnetically controlling endoscopes in body lumens and cavities
US6258082B1 (en) * 1999-05-03 2001-07-10 J. T. Lin Refractive surgery and presbyopia correction using infrared and ultraviolet lasers
US6748275B2 (en) * 1999-05-05 2004-06-08 Respironics, Inc. Vestibular stimulation system and method
US6556611B1 (en) * 1999-05-10 2003-04-29 Princeton Lightwave, Inc. Wide stripe distributed bragg reflector lasers with improved angular and spectral characteristics
US6505075B1 (en) * 1999-05-29 2003-01-07 Richard L. Weiner Peripheral nerve stimulation method
US6585722B1 (en) * 1999-08-05 2003-07-01 Nidek Co., Ltd. Photocoagulation apparatus
US6363188B1 (en) * 1999-10-22 2002-03-26 Princeton Lightwave, Inc. Mode expander with co-directional grating
US6909826B2 (en) * 1999-10-28 2005-06-21 Princeton Lightwave, Inc. Multiple grating optical waveguide monitor
US6744548B2 (en) * 2000-01-20 2004-06-01 Princeton Lightwave, Inc. Resonant enhanced modulator (REM)
US6546291B2 (en) * 2000-02-16 2003-04-08 Massachusetts Eye & Ear Infirmary Balance prosthesis
US20060141633A1 (en) * 2000-03-28 2006-06-29 The Foundation Of Research And Technology Hellas Method and system for characterization and mapping of tissue lesions
US7554578B2 (en) * 2000-07-11 2009-06-30 Phase One A/S Digital camera with integrated accelerometers
US20050099824A1 (en) * 2000-08-04 2005-05-12 Color Kinetics, Inc. Methods and systems for medical lighting
US6921413B2 (en) * 2000-08-16 2005-07-26 Vanderbilt University Methods and devices for optical stimulation of neural tissues
US7951181B2 (en) * 2000-08-16 2011-05-31 Vanderbilt University System and methods for optical stimulation of neural tissues
US6542530B1 (en) * 2000-10-27 2003-04-01 Chan-Long Shieh Electrically pumped long-wavelength VCSEL and methods of fabrication
US20050143789A1 (en) * 2001-01-30 2005-06-30 Whitehurst Todd K. Methods and systems for stimulating a peripheral nerve to treat chronic pain
US6735475B1 (en) * 2001-01-30 2004-05-11 Advanced Bionics Corporation Fully implantable miniature neurostimulator for stimulation as a therapy for headache and/or facial pain
US7177081B2 (en) * 2001-03-08 2007-02-13 Silicon Light Machines Corporation High contrast grating light valve type device
US20060095105A1 (en) * 2001-10-31 2006-05-04 London Health Sciences Center Multichannel electrode and methods of using same
US6688783B2 (en) * 2002-03-25 2004-02-10 Princeton Lightwave, Inc. Method of fabricating an optical module including a lens attached to a platform of the optical module
US7006749B2 (en) * 2002-08-07 2006-02-28 Dornier Medtech Laser Gmbh Laser system with fiber-bound communication
US7003353B1 (en) * 2002-12-10 2006-02-21 Quallion Llc Photovoltaic powered charging apparatus for implanted rechargeable batteries
US7069083B2 (en) * 2002-12-13 2006-06-27 Advanced Neuromodulation Systems, Inc. System and method for electrical stimulation of the intervertebral disc
US20050065531A1 (en) * 2003-03-28 2005-03-24 Cohen Donald M. Vascular occlusion systems and methods
US7004645B2 (en) * 2003-04-30 2006-02-28 Agilent Technologies, Inc. VCSEL array configuration for a parallel WDM transmitter
US6989023B2 (en) * 2003-07-08 2006-01-24 Oralum, Llc Hygienic treatments of body structures
US7156866B1 (en) * 2003-10-15 2007-01-02 Riggs Jeffrey M Holistic method of treating injured or pathologic tissue with a laser
US7031363B2 (en) * 2003-10-29 2006-04-18 Finisar Corporation Long wavelength VCSEL device processing
US20050096720A1 (en) * 2003-11-04 2005-05-05 Medtronic, Inc. Implantable medical device having optical fiber for sensing electrical activity
US20050142344A1 (en) * 2003-12-24 2005-06-30 Zap-It Corp., Inc. Laser test card
US7329251B2 (en) * 2003-12-25 2008-02-12 Nidek Co., Ltd. Laser treatment apparatus
US7337004B2 (en) * 2004-02-09 2008-02-26 Classen Ashley M Method and apparatus for veterinary RF pain management
US7647112B2 (en) * 2004-02-11 2010-01-12 Ethicon, Inc. System and method for selectively stimulating different body parts
US7324852B2 (en) * 2004-02-25 2008-01-29 Giancarlo Barolat System and method for neurological stimulation of peripheral nerves to treat low back pain
US7040805B1 (en) * 2004-05-24 2006-05-09 The United States Of America As Represented By The Secretary Of The Air Force Method of infrared thermography
US7909867B2 (en) * 2004-10-05 2011-03-22 The Board Of Trustees Of The Leland Stanford Junior University Interpenetrating polymer network hydrogel corneal prosthesis
US7865236B2 (en) * 2004-10-20 2011-01-04 Nervonix, Inc. Active electrode, bio-impedance based, tissue discrimination system and methods of use
US20060129210A1 (en) * 2004-11-09 2006-06-15 Institut National D'optique Device and method for transmitting multiple optically-encoded stimulation signals to multiple cell locations
US20090163982A1 (en) * 2004-11-15 2009-06-25 Decharms R Christopher Applications of the stimulation of neural tissue using light
US20060122509A1 (en) * 2004-11-24 2006-06-08 Liposonix, Inc. System and methods for destroying adipose tissue
US7194063B2 (en) * 2005-02-10 2007-03-20 Brookhaven Science Associates, Llc Methods for implementing microbeam radiation therapy
US20090076115A1 (en) * 2005-02-28 2009-03-19 The General Hospital Corporation Photosensitizers for Targeted Photodynamic Therapy
US7231256B2 (en) * 2005-03-11 2007-06-12 Medtronic, Inc. Neurostimulation site screening
US20070053996A1 (en) * 2005-07-22 2007-03-08 Boyden Edward S Light-activated cation channel and uses thereof
US20070054319A1 (en) * 2005-07-22 2007-03-08 Boyden Edward S Light-activated cation channel and uses thereof
US7654750B2 (en) * 2005-08-10 2010-02-02 Brenner Mary K Bidirectional optical fiber link systems component couplers
US7736382B2 (en) * 2005-09-09 2010-06-15 Lockheed Martin Corporation Apparatus for optical stimulation of nerves and other animal tissue
US20070060984A1 (en) * 2005-09-09 2007-03-15 Webb James S Apparatus and method for optical stimulation of nerves and other animal tissue
US20070106306A1 (en) * 2005-09-30 2007-05-10 Restoration Robotics, Inc. Automated system for harvesting or implanting follicular units
US7914842B1 (en) * 2006-02-10 2011-03-29 Second Sight Medical Products, Inc Method of manufacturing a flexible circuit electrode array
US20080009748A1 (en) * 2006-05-16 2008-01-10 The Regents Of The University Of California method and apparatus for the determination of intrinsic spectroscopic tumor markers by broadband-frequency domain technology
US7988688B2 (en) * 2006-09-21 2011-08-02 Lockheed Martin Corporation Miniature apparatus and method for optical stimulation of nerves and other animal tissue
US7883536B1 (en) * 2007-01-19 2011-02-08 Lockheed Martin Corporation Hybrid optical-electrical probes
US20100162109A1 (en) * 2008-12-22 2010-06-24 Shuvo Chatterjee User interface having changeable topography

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
Harner et al; "Improved Preservation of Facial Nerve Function With Use of Electrical Monitoring During Removal of Acoustic Neuromas"; Mao Clin. Proc.; Vol 62; February 1987; pp 92-102 *
Makeieff et al; "Continuous Facial Nerve Monitoring during Pleomorphic Adenoma Recurrence Surgery"; Laryngos.; Vol. 115; July 2005; pp 1310-1314. *
Matthies et al; "Direct Brainstem Recording of Auditrory Evoked Potentials During Vestibular Schwannoma Resection: Neuclear BAEP Recording"; J. Neurosrug.; Vol. 86; June 1997; pp1057-1062. *
Meier et al; "Continuous Intraoperative Facial Nerve Monitoring in Predicting Postoperative Injury During Parotidectomy"; Laryngos.; Vol 116, September 2006, 1569-1572. *
M�ller et al; "Intraoperative Neurophysiologic Monitoring";Am. J. Otol.; Vol. 16, No. 1; Januray 1995; pp 115-117. *
Tonn et al; "Acoustic Neuroma Surgery as an Interdisciplinary Appraoch: a Neurosurgical Series of n508 Patients"; J. Neurol. Neurosurg. Psychiatry Vol. 69, No. 2; Aug 2000; pp 161-166. *
Witt et al; "Facial Nerve Monitoring in Parotid Surgery: the Standard of Care?"; Otolaryng - Head and Neck Surg.; Vol. 119, No. 5; November 1998; pp 468-470. *

Cited By (272)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7412774B2 (en) * 2005-06-08 2008-08-19 Johnson Level & Tool Mfg. Co., Inc. Laser level with selectable constant or pulsed beam output
US20060280212A1 (en) * 2005-06-08 2006-12-14 Jianhong Lu Laser level with selectable constant or pulsed beam output
US9238150B2 (en) 2005-07-22 2016-01-19 The Board Of Trustees Of The Leland Stanford Junior University Optical tissue interface method and apparatus for stimulating cells
US20100190229A1 (en) * 2005-07-22 2010-07-29 Feng Zhang System for optical stimulation of target cells
US10569099B2 (en) 2005-07-22 2020-02-25 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
US10627410B2 (en) 2005-07-22 2020-04-21 The Board Of Trustees Of The Leland Stanford Junior University Light-activated cation channel and uses thereof
US10422803B2 (en) 2005-07-22 2019-09-24 The Board Of Trustees Of The Leland Stanford Junior University Light-activated cation channel and uses thereof
US10094840B2 (en) 2005-07-22 2018-10-09 The Board Of Trustees Of The Leland Stanford Junior University Light-activated cation channel and uses thereof
US9829492B2 (en) 2005-07-22 2017-11-28 The Board Of Trustees Of The Leland Stanford Junior University Implantable prosthetic device comprising a cell expressing a channelrhodopsin
US20090088680A1 (en) * 2005-07-22 2009-04-02 Alexander Aravanis Optical tissue interface method and apparatus for stimulating cells
US9101690B2 (en) 2005-07-22 2015-08-11 The Board Of Trustees Of The Leland Stanford Junior University Light-activated cation channel and uses thereof
US9278159B2 (en) 2005-07-22 2016-03-08 The Board Of Trustees Of The Leland Stanford Junior University Light-activated cation channel and uses thereof
US20100234273A1 (en) * 2005-07-22 2010-09-16 The Board Of Trustees Of The Leland Stanford Junior University Light-activated cation channel and uses thereof
US9360472B2 (en) 2005-07-22 2016-06-07 The Board Of Trustees Of The Leland Stanford Junior University Cell line, system and method for optical-based screening of ion-channel modulators
US10052497B2 (en) 2005-07-22 2018-08-21 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
US8906360B2 (en) 2005-07-22 2014-12-09 The Board Of Trustees Of The Leland Stanford Junior University Light-activated cation channel and uses thereof
US8926959B2 (en) 2005-07-22 2015-01-06 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
US20070054319A1 (en) * 2005-07-22 2007-03-08 Boyden Edward S Light-activated cation channel and uses thereof
US10451608B2 (en) 2005-07-22 2019-10-22 The Board Of Trustees Of The Leland Stanford Junior University Cell line, system and method for optical-based screening of ion-channel modulators
US10046174B2 (en) 2005-07-22 2018-08-14 The Board Of Trustees Of The Leland Stanford Junior University System for electrically stimulating target neuronal cells of a living animal in vivo
US10036758B2 (en) 2005-07-22 2018-07-31 The Board Of Trustees Of The Leland Stanford Junior University Delivery of a light-activated cation channel into the brain of a subject
US9274099B2 (en) 2005-07-22 2016-03-01 The Board Of Trustees Of The Leland Stanford Junior University Screening test drugs to identify their effects on cell membrane voltage-gated ion channel
US8985119B1 (en) 2005-09-09 2015-03-24 Lockheed Martin Corporation Method and apparatus for optical stimulation of nerves and other animal tissue
US8956396B1 (en) 2005-10-24 2015-02-17 Lockheed Martin Corporation Eye-tracking visual prosthetic and method
US8929973B1 (en) 2005-10-24 2015-01-06 Lockheed Martin Corporation Apparatus and method for characterizing optical sources used with human and animal tissues
US8945197B1 (en) 2005-10-24 2015-02-03 Lockheed Martin Corporation Sight-restoring visual prosthetic and method using infrared nerve-stimulation light
US10980565B2 (en) 2006-05-12 2021-04-20 Auris Health, Inc. Method for ablating body tissue
US7942871B2 (en) 2006-05-12 2011-05-17 Vytronus, Inc. Device for ablating body tissue
US9737325B2 (en) 2006-05-12 2017-08-22 Vytronus, Inc. Method for ablating body tissue
US20070265609A1 (en) * 2006-05-12 2007-11-15 Thapliyal Hira V Method for Ablating Body Tissue
US20070265610A1 (en) * 2006-05-12 2007-11-15 Thapliyal Hira V Device for Ablating Body Tissue
US10349966B2 (en) 2006-05-12 2019-07-16 Vytronus, Inc. Method for ablating body tissue
US8607800B2 (en) 2006-05-12 2013-12-17 Vytronus, Inc. Method for ablating body tissue
US8146603B2 (en) 2006-05-12 2012-04-03 Vytronus, Inc. Method for ablating body tissue
US8511317B2 (en) 2006-05-12 2013-08-20 Vytronus, Inc. Method for ablating body tissue
US10052121B2 (en) 2006-05-12 2018-08-21 Vytronus, Inc. Method for ablating body tissue
US20110230798A1 (en) * 2006-05-12 2011-09-22 Vytronus, Inc. Method for ablating body tissue
US7950397B2 (en) 2006-05-12 2011-05-31 Vytronus, Inc. Method for ablating body tissue
US20080077158A1 (en) * 2006-06-16 2008-03-27 Hani Haider Method and Apparatus for Computer Aided Surgery
US11857265B2 (en) 2006-06-16 2024-01-02 Board Of Regents Of The University Of Nebraska Method and apparatus for computer aided surgery
US11116574B2 (en) 2006-06-16 2021-09-14 Board Of Regents Of The University Of Nebraska Method and apparatus for computer aided surgery
US7988688B2 (en) 2006-09-21 2011-08-02 Lockheed Martin Corporation Miniature apparatus and method for optical stimulation of nerves and other animal tissue
US20110238141A1 (en) * 2006-09-21 2011-09-29 Lockheed Martin Corporation Miniature method and apparatus for optical stimulation of nerves and other animal tissue
US8506613B2 (en) 2006-09-21 2013-08-13 Lockheed Martin Corporation Miniature method and apparatus for optical stimulation of nerves and other animal tissue
US20080077198A1 (en) * 2006-09-21 2008-03-27 Aculight Corporation Miniature apparatus and method for optical stimulation of nerves and other animal tissue
US8996131B1 (en) 2006-09-28 2015-03-31 Lockheed Martin Corporation Apparatus and method for managing chronic pain with infrared light sources and heat
US9061135B1 (en) 2006-09-28 2015-06-23 Lockheed Martin Corporation Apparatus and method for managing chronic pain with infrared and low-level light sources
US10105551B2 (en) 2007-01-10 2018-10-23 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
US9187745B2 (en) 2007-01-10 2015-11-17 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
US11007374B2 (en) 2007-01-10 2021-05-18 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
US10369378B2 (en) 2007-01-10 2019-08-06 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
US8398692B2 (en) 2007-01-10 2013-03-19 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
US8864805B2 (en) 2007-01-10 2014-10-21 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
US20100145418A1 (en) * 2007-01-10 2010-06-10 Feng Zhang System for optical stimulation of target cells
US8551150B1 (en) 2007-01-11 2013-10-08 Lockheed Martin Corporation Method and system for optical stimulation of nerves
US8012189B1 (en) 2007-01-11 2011-09-06 Lockheed Martin Corporation Method and vestibular implant using optical stimulation of nerves
US8317848B1 (en) 2007-01-11 2012-11-27 Lockheed Martin Corporation Vestibular implant and method for optical stimulation of nerves
US8357187B1 (en) 2007-01-19 2013-01-22 Lockheed Martin Corporation Hybrid optical-electrical probes for stimulation of nerve or other animal tissue
US7883536B1 (en) 2007-01-19 2011-02-08 Lockheed Martin Corporation Hybrid optical-electrical probes
US8632577B1 (en) 2007-01-19 2014-01-21 Lockheed Martin Corporation Hybrid optical-electrical probes for stimulation of nerve or other animal tissue
US20080227139A1 (en) * 2007-02-14 2008-09-18 Karl Deisseroth System, method and applications involving identification of biological circuits such as neurological characteristics
US8401609B2 (en) 2007-02-14 2013-03-19 The Board Of Trustees Of The Leland Stanford Junior University System, method and applications involving identification of biological circuits such as neurological characteristics
US9693692B2 (en) 2007-02-14 2017-07-04 The Board Of Trustees Of The Leland Stanford Junior University System, method and applications involving identification of biological circuits such as neurological characteristics
US9757587B2 (en) 2007-03-01 2017-09-12 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic method for generating an inhibitory current in a mammalian neuron
US9855442B2 (en) 2007-03-01 2018-01-02 The Board Of Trustees Of The Leland Stanford Junior University Method for optically controlling a neuron with a mammalian codon optimized nucleotide sequence that encodes a variant opsin polypeptide derived from natromonas pharaonis (NpHR)
US10589123B2 (en) 2007-03-01 2020-03-17 The Board Of Trustees Of The Leland Stanford Junior University Systems, methods and compositions for optical stimulation of target cells
US9284353B2 (en) 2007-03-01 2016-03-15 The Board Of Trustees Of The Leland Stanford Junior University Mammalian codon optimized nucleotide sequence that encodes a variant opsin polypeptide derived from Natromonas pharaonis (NpHR)
US20080234670A1 (en) * 2007-03-15 2008-09-25 Rogers C Brian System and apparatus providing a controlled light source for medicinal applications
US8636726B1 (en) 2007-03-18 2014-01-28 Lockheed Martin Corporation Multiple-mode device for high-power short-pulse laser ablation and CW cauterization of bodily tissues
US8202268B1 (en) 2007-03-18 2012-06-19 Lockheed Martin Corporation Method and multiple-mode device for high-power short-pulse laser ablation and CW cauterization of bodily tissues
US8353899B1 (en) 2007-03-18 2013-01-15 Lockheed Martin Corporation Multiple-mode device for high-power short-pulse laser ablation and CW cauterization of bodily tissues
US8179594B1 (en) 2007-06-29 2012-05-15 Lockheed Martin Corporation Method and apparatus for spectral-beam combining of fanned-in laser beams with chromatic-dispersion compensation using a plurality of diffractive gratings
US8475506B1 (en) 2007-08-13 2013-07-02 Lockheed Martin Corporation VCSEL array stimulator apparatus and method for light stimulation of bodily tissues
US20100049180A1 (en) * 2007-10-19 2010-02-25 Lockheed Martin Corporation System and method for conditioning animal tissue using laser light
US20090112133A1 (en) * 2007-10-31 2009-04-30 Karl Deisseroth Device and method for non-invasive neuromodulation
US20090118800A1 (en) * 2007-10-31 2009-05-07 Karl Deisseroth Implantable optical stimulators
US10434327B2 (en) 2007-10-31 2019-10-08 The Board Of Trustees Of The Leland Stanford Junior University Implantable optical stimulators
US10035027B2 (en) 2007-10-31 2018-07-31 The Board Of Trustees Of The Leland Stanford Junior University Device and method for ultrasonic neuromodulation via stereotactic frame based technique
US10426970B2 (en) 2007-10-31 2019-10-01 The Board Of Trustees Of The Leland Stanford Junior University Implantable optical stimulators
US20090131922A1 (en) * 2007-11-07 2009-05-21 Reliant Technologies, Inc. Reconnectable Handpieces for Optical Energy Based Devices and Methods for Adjusting Device Components
US8523847B2 (en) * 2007-11-07 2013-09-03 Reliant Technologies, Inc. Reconnectable handpieces for optical energy based devices and methods for adjusting device components
US8998914B2 (en) 2007-11-30 2015-04-07 Lockheed Martin Corporation Optimized stimulation rate of an optically stimulating cochlear implant
US9011509B2 (en) 2007-11-30 2015-04-21 Lockheed Martin Corporation Individually optimized performance of optically stimulating cochlear implants
US9011508B2 (en) 2007-11-30 2015-04-21 Lockheed Martin Corporation Broad wavelength profile to homogenize the absorption profile in optical stimulation of nerves
US7871175B1 (en) * 2007-12-17 2011-01-18 Natasha Dawn Bacca Apparatus and method of drawing with light
US20090251228A1 (en) * 2008-04-03 2009-10-08 Sony Corporation Voltage-controlled variable frequency oscillation circuit and signal processing circuit
US8603790B2 (en) 2008-04-23 2013-12-10 The Board Of Trustees Of The Leland Stanford Junior University Systems, methods and compositions for optical stimulation of target cells
US9878176B2 (en) 2008-04-23 2018-01-30 The Board Of Trustees Of The Leland Stanford Junior University System utilizing Volvox carteri light-activated ion channel protein (VChR1) for optical stimulation of target cells
US10350430B2 (en) 2008-04-23 2019-07-16 The Board Of Trustees Of The Leland Stanford Junior University System comprising a nucleotide sequence encoding a volvox carteri light-activated ion channel protein (VCHR1)
US9249200B2 (en) 2008-04-23 2016-02-02 The Board Of Trustees Of The Leland Stanford Junior University Expression vector comprising a nucleotide sequence encoding a Volvox carteri light-activated ion channel protein (VChR1) and implantable device thereof
US20110105998A1 (en) * 2008-04-23 2011-05-05 The Board Of Trustees Of The Leland Stanford Junio Systems, methods and compositions for optical stimulation of target cells
US9394347B2 (en) 2008-04-23 2016-07-19 The Board Of Trustees Of The Leland Stanford Junior University Methods for treating parkinson's disease by optically stimulating target cells
US8815582B2 (en) 2008-04-23 2014-08-26 The Board Of Trustees Of The Leland Stanford Junior University Mammalian cell expressing Volvox carteri light-activated ion channel protein (VChR1)
US20110112179A1 (en) * 2008-05-29 2011-05-12 Airan Raag D Cell line, system and method for optical control of secondary messengers
US9453215B2 (en) 2008-05-29 2016-09-27 The Board Of Trustees Of The Leland Stanford Junior University Cell line, system and method for optical control of secondary messengers
US8729040B2 (en) 2008-05-29 2014-05-20 The Board Of Trustees Of The Leland Stanford Junior University Cell line, system and method for optical control of secondary messengers
US8962589B2 (en) 2008-05-29 2015-02-24 The Board Of Trustees Of The Leland Stanford Junior University Cell line, system and method for optical control of secondary messengers
US20100152582A1 (en) * 2008-06-13 2010-06-17 Vytronus, Inc. Handheld system and method for delivering energy to tissue
US20090312755A1 (en) * 2008-06-13 2009-12-17 Vytronus, Inc. System and method for positioning an elongate member with respect to an anatomical structure
US9155588B2 (en) 2008-06-13 2015-10-13 Vytronus, Inc. System and method for positioning an elongate member with respect to an anatomical structure
US20090312673A1 (en) * 2008-06-14 2009-12-17 Vytronus, Inc. System and method for delivering energy to tissue
US20110159562A1 (en) * 2008-06-17 2011-06-30 Karl Deisseroth Apparatus and methods for controlling cellular development
US9084885B2 (en) 2008-06-17 2015-07-21 The Board Of Trustees Of The Leland Stanford Junior University Methods, systems and devices for optical stimulation of target cells using an optical transmission element
US8956363B2 (en) 2008-06-17 2015-02-17 The Board Of Trustees Of The Leland Stanford Junior University Methods, systems and devices for optical stimulation of target cells using an optical transmission element
US10711242B2 (en) 2008-06-17 2020-07-14 The Board Of Trustees Of The Leland Stanford Junior University Apparatus and methods for controlling cellular development
US20110172653A1 (en) * 2008-06-17 2011-07-14 Schneider M Bret Methods, systems and devices for optical stimulation of target cells using an optical transmission element
US11751773B2 (en) * 2008-07-03 2023-09-12 Masimo Corporation Emitter arrangement for physiological measurements
US20200196882A1 (en) * 2008-07-03 2020-06-25 Masimo Corporation Noise shielding for a noninvasive device
US10583309B2 (en) 2008-07-08 2020-03-10 The Board Of Trustees Of The Leland Stanford Junior University Materials and approaches for optical stimulation of the peripheral nervous system
US9308392B2 (en) 2008-07-08 2016-04-12 The Board Of Trustees Of The Leland Stanford Junior University Materials and approaches for optical stimulation of the peripheral nervous system
US20110166632A1 (en) * 2008-07-08 2011-07-07 Delp Scott L Materials and approaches for optical stimulation of the peripheral nervous system
US9101759B2 (en) 2008-07-08 2015-08-11 The Board Of Trustees Of The Leland Stanford Junior University Materials and approaches for optical stimulation of the peripheral nervous system
US11207549B2 (en) 2008-07-18 2021-12-28 Auris Health, Inc. System and method for delivering energy to tissue
WO2010009473A1 (en) * 2008-07-18 2010-01-21 Vytronus, Inc. Method and system for positioning an energy source
US20100016762A1 (en) * 2008-07-18 2010-01-21 Vytronus, Inc. System and method for delivering energy to tissue
US20100049099A1 (en) * 2008-07-18 2010-02-25 Vytronus, Inc. Method and system for positioning an energy source
US10363057B2 (en) 2008-07-18 2019-07-30 Vytronus, Inc. System and method for delivering energy to tissue
US10368891B2 (en) 2008-07-18 2019-08-06 Vytronus, Inc. System and method for delivering energy to tissue
US8160696B2 (en) * 2008-10-03 2012-04-17 Lockheed Martin Corporation Nerve stimulator and method using simultaneous electrical and optical signals
US20100114190A1 (en) * 2008-10-03 2010-05-06 Lockheed Martin Corporation Nerve stimulator and method using simultaneous electrical and optical signals
US8498699B2 (en) 2008-10-03 2013-07-30 Lockheed Martin Company Method and nerve stimulator using simultaneous electrical and optical signals
US9192789B2 (en) 2008-10-30 2015-11-24 Vytronus, Inc. System and method for anatomical mapping of tissue and planning ablation paths therein
US9220924B2 (en) 2008-10-30 2015-12-29 Vytronus, Inc. System and method for energy delivery to tissue while monitoring position, lesion depth, and wall motion
US20100113985A1 (en) * 2008-10-30 2010-05-06 Vytronus, Inc. System and method for energy delivery to tissue while monitoring position, lesion depth, and wall motion
US8414508B2 (en) 2008-10-30 2013-04-09 Vytronus, Inc. System and method for delivery of energy to tissue while compensating for collateral tissue
US9033885B2 (en) 2008-10-30 2015-05-19 Vytronus, Inc. System and method for energy delivery to tissue while monitoring position, lesion depth, and wall motion
US20100114094A1 (en) * 2008-10-30 2010-05-06 Vytronus, Inc. System and method for anatomical mapping of tissue and planning ablation paths therein
US11298568B2 (en) 2008-10-30 2022-04-12 Auris Health, Inc. System and method for energy delivery to tissue while monitoring position, lesion depth, and wall motion
US9907983B2 (en) 2008-10-30 2018-03-06 Vytronus, Inc. System and method for ultrasound ablation of tissue while compensating for collateral tissue
US10850133B2 (en) 2008-10-30 2020-12-01 Auris Health, Inc. System and method for anatomical mapping of tissue and planning ablation paths therein
US20100113928A1 (en) * 2008-10-30 2010-05-06 Vytronus, Inc. System and method for delivery of energy to tissue while compensating for collateral tissue
US9833641B2 (en) 2008-10-30 2017-12-05 Vytronus, Inc. System and method for energy delivery to tissue while monitoring position, lesion depth, and wall motion
US10071132B2 (en) 2008-11-14 2018-09-11 The Board Of Trustees Of The Leland Stanford Junior University Optically-based stimulation of target cells and modifications thereto
US9458208B2 (en) 2008-11-14 2016-10-04 The Board Of Trustees Of The Leland Stanford Junior University Optically-based stimulation of target cells and modifications thereto
US9309296B2 (en) 2008-11-14 2016-04-12 The Board Of Trustees Of The Leland Stanford Junior University Optically-based stimulation of target cells and modifications thereto
US8716447B2 (en) 2008-11-14 2014-05-06 The Board Of Trustees Of The Leland Stanford Junior University Optically-based stimulation of target cells and modifications thereto
US10064912B2 (en) 2008-11-14 2018-09-04 The Board Of Trustees Of The Leland Stanford Junior University Optically-based stimulation of target cells and modifications thereto
US10154831B2 (en) 2008-11-17 2018-12-18 Vytronus, Inc. Methods for imaging and ablating body tissue
US8475379B2 (en) 2008-11-17 2013-07-02 Vytronus, Inc. Systems and methods for ablating body tissue
US9737323B2 (en) 2008-11-17 2017-08-22 Vytronus, Inc. Systems and methods for imaging and ablating body tissue
US20100125198A1 (en) * 2008-11-17 2010-05-20 Vytronus, Inc. Systems and methods for ablating body tissue
US8246192B2 (en) * 2008-12-16 2012-08-21 Shenzhen Futaihong Precision Industry Co., Ltd. Touch pen and portable electronic device using the same
US20100149794A1 (en) * 2008-12-16 2010-06-17 Shenzhen Futaihong Precision Industry Co., Ltd. Touch pen and portable electronic device using the same
TWI425387B (en) * 2009-01-09 2014-02-01 Chi Mei Comm Systems Inc Touch pen
US20100234836A1 (en) * 2009-03-10 2010-09-16 Bwt Property, Inc. LED Based Light Surgery Apparatus
US8715327B1 (en) 2009-04-13 2014-05-06 Cvrx, Inc. Baroreflex modulation using light-based stimulation
US8755649B2 (en) 2009-10-19 2014-06-17 Lockheed Martin Corporation In-line forward/backward fiber-optic signal analyzer
US20110091155A1 (en) * 2009-10-19 2011-04-21 Lockheed Martin Corporation In-line forward/backward fiber-optic signal analyzer
US20120298871A1 (en) * 2009-10-26 2012-11-29 Morin Aurelie Method and device for slaving the activation of a set of infrared emitters of a sensor of venous networks to the presence of a living body
US8957382B2 (en) * 2009-10-26 2015-02-17 Morpho Method and device for slaving the activation of a set of infrared emitters of a sensor of venous networks to the presence of a living body
US9604073B2 (en) 2010-03-17 2017-03-28 The Board Of Trustees Of The Leland Stanford Junior University Light-sensitive ion-passing molecules
US9249234B2 (en) 2010-03-17 2016-02-02 The Board Of Trustees Of The Leland Stanford Junior University Light-sensitive ion-passing molecules
US9079940B2 (en) 2010-03-17 2015-07-14 The Board Of Trustees Of The Leland Stanford Junior University Light-sensitive ion-passing molecules
US9359449B2 (en) 2010-03-17 2016-06-07 The Board Of Trustees Of The Leland Stanford Junior University Light-sensitive ion-passing molecules
US20110235324A1 (en) * 2010-03-29 2011-09-29 Klaus-Martin Irion Light source device for endoscopic or exoscopic applications
US9072454B2 (en) * 2010-03-29 2015-07-07 Karl Storz Gmbh & Co. Kg Light source device for endoscopic or exoscopic applications
DE112011101288T5 (en) 2010-04-12 2013-02-07 Lockheed Martin Corporation Beam diagnostic and feedback system and methods for spectrally beam combined lasers
US8630323B2 (en) 2010-04-12 2014-01-14 Lockheed Martin Corporation Beam diagnostics and feedback method and system for spectrally beam-combined lasers
US8830568B2 (en) 2010-04-12 2014-09-09 Lockheed Martin Corporation High beam quality and high average power from large-core-size optical-fiber amplifiers
US8767286B2 (en) 2010-04-12 2014-07-01 Lockheed Martin Corporation Signal and pump mode-field adaptor for double-clad fibers and associated method
US9431786B2 (en) 2010-04-12 2016-08-30 Lockheed Martin Corporation System and method for a delivery fiber for isolation against back reflections
US8736953B2 (en) 2010-04-12 2014-05-27 Lockheed Martin Corporation High-power laser system having delivery fiber with non-circular cross section for isolation against back reflections
US8864806B2 (en) 2010-05-28 2014-10-21 Lockheed Martin Corporation Optical bundle apparatus and method for optical and/or electrical nerve stimulation of peripheral nerves
US8792978B2 (en) 2010-05-28 2014-07-29 Lockheed Martin Corporation Laser-based nerve stimulators for, E.G., hearing restoration in cochlear prostheses and method
US8652187B2 (en) 2010-05-28 2014-02-18 Lockheed Martin Corporation Cuff apparatus and method for optical and/or electrical nerve stimulation of peripheral nerves
US8968376B2 (en) 2010-05-28 2015-03-03 Lockheed Martin Corporation Nerve-penetrating apparatus and method for optical and/or electrical nerve stimulation of peripheral nerves
WO2011150430A3 (en) * 2010-05-28 2012-02-23 Lockheed Martin Corporation Implantable infrared nerve stimulation devices for peripheral and cranial nerve interfaces
US20120053941A1 (en) * 2010-08-27 2012-03-01 Swick Michael D Wireless Voice Activation Apparatus for Surgical Lasers
US8886278B2 (en) * 2010-10-26 2014-11-11 Korea Institute Of Science And Technology Optical stimulus probe with reflecting surface
US20120101356A1 (en) * 2010-10-26 2012-04-26 Korea Institute Of Science And Technology Optical Stimulus Probe with Reflecting Surface
US9522288B2 (en) 2010-11-05 2016-12-20 The Board Of Trustees Of The Leland Stanford Junior University Upconversion of light for use in optogenetic methods
US9175095B2 (en) 2010-11-05 2015-11-03 The Board Of Trustees Of The Leland Stanford Junior University Light-activated chimeric opsins and methods of using the same
US10196431B2 (en) 2010-11-05 2019-02-05 The Board Of Trustees Of The Leland Stanford Junior University Light-activated chimeric opsins and methods of using the same
US10568307B2 (en) 2010-11-05 2020-02-25 The Board Of Trustees Of The Leland Stanford Junior University Stabilized step function opsin proteins and methods of using the same
US10252076B2 (en) 2010-11-05 2019-04-09 The Board Of Trustees Of The Leland Stanford Junior University Upconversion of light for use in optogenetic methods
US10086012B2 (en) 2010-11-05 2018-10-02 The Board Of Trustees Of The Leland Stanford Junior University Control and characterization of memory function
US9850290B2 (en) 2010-11-05 2017-12-26 The Board Of Trustees Of The Leland Stanford Junior University Light-activated chimeric opsins and methods of using the same
US9421258B2 (en) 2010-11-05 2016-08-23 The Board Of Trustees Of The Leland Stanford Junior University Optically controlled CNS dysfunction
US9340589B2 (en) 2010-11-05 2016-05-17 The Board Of Trustees Of The Leland Stanford Junior University Light-activated chimeric opsins and methods of using the same
US8932562B2 (en) 2010-11-05 2015-01-13 The Board Of Trustees Of The Leland Stanford Junior University Optically controlled CNS dysfunction
US9968652B2 (en) 2010-11-05 2018-05-15 The Board Of Trustees Of The Leland Stanford Junior University Optically-controlled CNS dysfunction
US9992981B2 (en) 2010-11-05 2018-06-12 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic control of reward-related behaviors
US9271674B2 (en) 2010-11-22 2016-03-01 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic magnetic resonance imaging
US10018695B2 (en) 2010-11-22 2018-07-10 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic magnetic resonance imaging
US10914803B2 (en) 2010-11-22 2021-02-09 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic magnetic resonance imaging
US8696722B2 (en) 2010-11-22 2014-04-15 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic magnetic resonance imaging
US9615789B2 (en) 2010-11-22 2017-04-11 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic magnetic resonance imaging
US8834546B2 (en) 2010-11-22 2014-09-16 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic magnetic resonance imaging
US10371776B2 (en) 2010-11-22 2019-08-06 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic magnetic resonance imaging
US9192314B2 (en) * 2011-03-29 2015-11-24 The Charles Stark Draper Laboratory, Inc. Probe for neural recording and optical spectroscopic interrogation
US9402685B2 (en) 2011-05-16 2016-08-02 Covidien Lp Optical energy-based methods and apparatus for tissue sealing
US9456870B2 (en) * 2011-05-16 2016-10-04 Covidien Lp Optical energy-based methods and apparatus for tissue sealing
US10925662B2 (en) 2011-05-16 2021-02-23 Covidien Lp Optical energy-based methods and apparatus for tissue sealing
US20120296324A1 (en) * 2011-05-16 2012-11-22 Tyco Healthcare Group Lp Optical Energy-Based Methods and Apparatus for Tissue Sealing
US9113933B2 (en) * 2011-05-16 2015-08-25 Covidien Lp Optical energy-based methods and apparatus for tissue sealing
US20120296323A1 (en) * 2011-05-16 2012-11-22 Tyco Healthcare Group Lp Optical Energy-Based Methods and Apparatus for Tissue Sealing
US9498231B2 (en) 2011-06-27 2016-11-22 Board Of Regents Of The University Of Nebraska On-board tool tracking system and methods of computer assisted surgery
US10080617B2 (en) 2011-06-27 2018-09-25 Board Of Regents Of The University Of Nebraska On-board tool tracking system and methods of computer assisted surgery
US11911117B2 (en) 2011-06-27 2024-02-27 Board Of Regents Of The University Of Nebraska On-board tool tracking system and methods of computer assisted surgery
US10219811B2 (en) 2011-06-27 2019-03-05 Board Of Regents Of The University Of Nebraska On-board tool tracking system and methods of computer assisted surgery
US8747447B2 (en) 2011-07-22 2014-06-10 Lockheed Martin Corporation Cochlear implant and method enabling enhanced music perception
US8840654B2 (en) 2011-07-22 2014-09-23 Lockheed Martin Corporation Cochlear implant using optical stimulation with encoded information designed to limit heating effects
US8834545B2 (en) 2011-07-22 2014-09-16 Lockheed Martin Corporation Optical-stimulation cochlear implant with electrode(s) at the apical end for electrical stimulation of apical spiral ganglion cells of the cochlea
US8894697B2 (en) 2011-07-22 2014-11-25 Lockheed Martin Corporation Optical pulse-width modulation used in an optical-stimulation cochlear implant
US10285605B2 (en) 2011-07-25 2019-05-14 Diagnostic Biochips, Inc. Integrated optical neural probe
US9801559B2 (en) 2011-07-25 2017-10-31 Diagnostic Biochips, Inc. Integrated optical neural probe
WO2013016350A3 (en) * 2011-07-25 2014-05-01 Diagnostic Biochips, Llc Integrated optical neural probe
US10188304B2 (en) 2011-07-25 2019-01-29 Diagnostic Biochips, Inc. Integrated optical neural probe
US8709078B1 (en) 2011-08-03 2014-04-29 Lockheed Martin Corporation Ocular implant with substantially constant retinal spacing for transmission of nerve-stimulation light
US20130090546A1 (en) * 2011-10-07 2013-04-11 Patrick W. STROMAN Spinal cord function assessment
US9969783B2 (en) 2011-12-16 2018-05-15 The Board Of Trustees Of The Leland Stanford Junior University Opsin polypeptides and methods of use thereof
US10538560B2 (en) 2011-12-16 2020-01-21 The Board Of Trustees Of The Leland Stanford Junior University Opsin polypeptides and methods of use thereof
US9365628B2 (en) 2011-12-16 2016-06-14 The Board Of Trustees Of The Leland Stanford Junior University Opsin polypeptides and methods of use thereof
US9505817B2 (en) 2011-12-16 2016-11-29 The Board Of Trustees Of The Leland Stanford Junior University Opsin polypeptides and methods of use thereof
US9840541B2 (en) 2011-12-16 2017-12-12 The Board Of Trustees Of The Leland Stanford Junior University Opsin polypeptides and methods of use thereof
US10087223B2 (en) 2011-12-16 2018-10-02 The Board Of Trustees Of The Leland Stanford Junior University Opsin polypeptides and methods of use thereof
US10694953B2 (en) * 2011-12-20 2020-06-30 Facebook Technologies, Llc Integrated medical device
US8574280B2 (en) 2011-12-23 2013-11-05 Pine Development Corporation Systems and methods for eliciting cutaneous sensations by electromagnetic radiation
US9696804B2 (en) 2011-12-23 2017-07-04 Pine Development Corporation Systems and methods for eliciting cutaneous sensations by electromagnetic radiation
US11103723B2 (en) 2012-02-21 2021-08-31 The Board Of Trustees Of The Leland Stanford Junior University Methods for treating neurogenic disorders of the pelvic floor
US9271783B2 (en) 2012-07-17 2016-03-01 Covidien Lp End-effector assembly including a pressure-sensitive layer disposed on an electrode
US9833285B2 (en) 2012-07-17 2017-12-05 Covidien Lp Optical sealing device with cutting ability
US10117708B2 (en) 2012-07-19 2018-11-06 Covidien Lp Ablation needle including fiber Bragg grating
US9265573B2 (en) 2012-07-19 2016-02-23 Covidien Lp Ablation needle including fiber Bragg grating
US9023039B2 (en) 2012-07-19 2015-05-05 Covidien Lp Electrosurgical device including an optical sensor
US9113904B2 (en) 2012-07-19 2015-08-25 Covidien Lp Surgical instrument with fiber bragg grating
US9987079B2 (en) 2012-07-19 2018-06-05 Covidien Lp Surgical instrument with fiber bragg grating
US9549776B2 (en) 2012-07-19 2017-01-24 Covidien Lp Ablation needle including fiber Bragg grating
US9707032B2 (en) 2012-07-19 2017-07-18 Covidien Lp Surgical instrument with fiber Bragg grating
US9161812B2 (en) 2012-07-19 2015-10-20 Covidien Lp Finger-mountable ablation device
US9375265B2 (en) 2012-07-19 2016-06-28 Covidien Lp Surgical instrument with fiber Bragg grating
US9681910B2 (en) 2012-07-19 2017-06-20 Covidien Lp Finger-mountable ablation device
US9730754B2 (en) 2012-07-19 2017-08-15 Covidien Lp Ablation needle including fiber Bragg grating
US10925670B2 (en) 2012-09-06 2021-02-23 Covidien Lp Medical devices and methods incorporating frustrated total internal reflection for energy-efficient sealing and cutting of tissue using light energy
US11793569B2 (en) 2012-09-06 2023-10-24 Covidien Lp Medical devices and methods incorporating frustrated total internal reflection for energy-efficient sealing and cutting of tissue using light energy
US11786304B2 (en) 2012-09-06 2023-10-17 Covidien Lp Medical devices and methods incorporating frustrated total internal reflection for energy-efficient sealing and cutting of tissue using light energy
US10226297B2 (en) 2012-09-06 2019-03-12 Covidien Lp Medical devices and methods incorporating frustrated total internal reflection for energy-efficient sealing and cutting of tissue using light energy
US10231782B2 (en) 2012-09-06 2019-03-19 Covidien Lp Medical devices and methods incorporating frustrated total internal reflection for energy-efficient sealing and cutting of tissue using light energy
US10893908B2 (en) 2012-09-06 2021-01-19 Covidien Lp Medical devices and methods incorporating frustrated total internal reflection for energy-efficient sealing and cutting of tissue using light energy
US8974443B2 (en) 2012-09-10 2015-03-10 Dermal Photonics Corporation Systems and methods for treating dermatological imperfections
WO2014040014A1 (en) * 2012-09-10 2014-03-13 Dermal Photonics Corporation Systems and methods for usage replenishment
US8888830B2 (en) 2012-09-10 2014-11-18 Dermal Photonics Corporation Systems and methods for usage replenishment
US10695582B2 (en) 2012-09-10 2020-06-30 Dermal Photonics Corporation Systems and methods for treating dermatological imperfections
WO2014099038A1 (en) * 2012-12-20 2014-06-26 Pine Development Corporation Systems and methods for eliciting cutaneous sensations by electromagnetic radiation
US20160000507A1 (en) * 2013-02-13 2016-01-07 Biolitec Pharma Marketing Ltd. Enclosed laser medical device/system
WO2014126558A1 (en) * 2013-02-13 2014-08-21 Biolitec Pharma Marketing Ltd. Enclosed laser medical device/system
US10105149B2 (en) 2013-03-15 2018-10-23 Board Of Regents Of The University Of Nebraska On-board tool tracking system and methods of computer assisted surgery
US10974064B2 (en) 2013-03-15 2021-04-13 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic control of behavioral state
US9636380B2 (en) 2013-03-15 2017-05-02 The Board Of Trustees Of The Leland Stanford Junior University Optogenetic control of inputs to the ventral tegmental area
US9257021B2 (en) 2013-04-12 2016-02-09 Pine Development Corporation Systems and methods for optically induced cutaneous sensation
US10220092B2 (en) 2013-04-29 2019-03-05 The Board Of Trustees Of The Leland Stanford Junior University Devices, systems and methods for optogenetic modulation of action potentials in target cells
US10295823B2 (en) 2013-07-02 2019-05-21 Pine Development Corporation Systems and methods for eliciting cutaneous sensations using electromagnetic radiation
US10307609B2 (en) 2013-08-14 2019-06-04 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for controlling pain
US8843217B1 (en) 2013-09-13 2014-09-23 Lockheed Martin Corporation Combined vestibular and cochlear implant and method
US20150208934A1 (en) * 2014-01-24 2015-07-30 Genevieve Sztrubel Method And Apparatus For The Detection Of Neural Tissue
US11679271B2 (en) * 2014-02-11 2023-06-20 Andrew Hewitson Laser therapy device and method of use
US9366872B2 (en) 2014-02-18 2016-06-14 Lockheed Martin Corporation Apparatus and method for fiber-laser output-beam shaping for spectral beam combination
US9927621B2 (en) 2014-02-18 2018-03-27 Lockheed Martin Corporation Method and apparatus for fiber-laser output-beam shaping for beam combination
US9449477B2 (en) 2014-04-02 2016-09-20 Pine Development Corporation Applications of systems and methods for eliciting cutaneous sensations by electromagnetic radiation
US10037661B2 (en) 2014-04-02 2018-07-31 Pine Development Corporation Applications of systems and methods for eliciting cutaneous sensations by electromagnetic radiation
US9791347B2 (en) 2014-04-11 2017-10-17 Lockheed Martin Corporation Method and system for non-contact optical-power measurement
US9429467B2 (en) 2014-04-11 2016-08-30 Lockheed Martin Corporation System for non-contact optical-power measurement
US11471697B2 (en) * 2015-02-10 2022-10-18 Andrew Hewitson Laser therapy device and method of use
US10568516B2 (en) 2015-06-22 2020-02-25 The Board Of Trustees Of The Leland Stanford Junior University Methods and devices for imaging and/or optogenetic control of light-responsive neurons
US20200016425A1 (en) * 2017-03-24 2020-01-16 Covidien Lp Endoscopes and methods of treatment
US11931010B2 (en) * 2017-03-24 2024-03-19 Covidien Lp Endoscopes and methods of treatment
US11294165B2 (en) 2017-03-30 2022-04-05 The Board Of Trustees Of The Leland Stanford Junior University Modular, electro-optical device for increasing the imaging field of view using time-sequential capture
US20220126112A1 (en) * 2019-01-25 2022-04-28 Santen Pharmaceutical Co., Ltd. Optical probe
US11617541B2 (en) 2019-06-20 2023-04-04 Cilag Gmbh International Optical fiber waveguide in an endoscopic system for fluorescence imaging
US11213194B2 (en) * 2019-06-20 2022-01-04 Cilag Gmbh International Optical fiber waveguide in an endoscopic system for hyperspectral, fluorescence, and laser mapping imaging
US11122968B2 (en) 2019-06-20 2021-09-21 Cilag Gmbh International Optical fiber waveguide in an endoscopic system for hyperspectral imaging
WO2023283494A1 (en) * 2021-07-09 2023-01-12 Dignity Health Devices and methods for applying stimulation in the assessment of consciousness

Also Published As

Publication number Publication date
US8784461B2 (en) 2014-07-22
US20140052221A1 (en) 2014-02-20
US7988688B2 (en) 2011-08-02
US20080077198A1 (en) 2008-03-27
US8506613B2 (en) 2013-08-13
US20110238141A1 (en) 2011-09-29

Similar Documents

Publication Publication Date Title
US8784461B2 (en) Method and apparatus for optical stimulation of nerves and other animal tissue
US7736382B2 (en) Apparatus for optical stimulation of nerves and other animal tissue
CN109414291B (en) Handheld ophthalmic laser system with replaceable contact tip and treatment guide
EP1896122B1 (en) Tissue treatment device
KR100971358B1 (en) Invasive Dual-wavelength Laser Acupuncture
JP2010505566A (en) Dermatological treatment device
KR20120105552A (en) Handpiece finger switch for actuation of handheld medical instrumentation
US20220117661A1 (en) Devices for image-guided light treatment of skin
JP2013027684A (en) Portable laser hair removal apparatus of multi purpose use
JP6076847B2 (en) Laser therapy device
US20090099559A1 (en) Coherent imaging fiber based hair removal device
US7160287B1 (en) Apparatus and method for performing radiation energy treatments
KR102276076B1 (en) Laser medical treatment device
JP6608806B2 (en) Multi-aperture handheld laser therapy device
US20100121198A1 (en) Multi-Purpose Illumination System And Method For Tissue Examination
JP6592223B1 (en) Surgical treatment system
US20170035506A1 (en) Laser Diode Package Arrangement with Interchangable Tip
US20190217119A1 (en) Interchangeable modular cap for laser light therapy
US20090052184A1 (en) Multi-Purpose Light Source
KR101381031B1 (en) Easy adjustable optical stimulation system
US11007373B1 (en) Photobiostimulation device and method of using same
TWI490008B (en) Hand held hair treatment device for the stimulation of hair growth on the scalp
WO2009075718A1 (en) Multi-purpose illumination system and method for tissue examination

Legal Events

Date Code Title Description
AS Assignment

Owner name: ACULIGHT CORPORATION, WASHINGTON

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BENDETT, MARK P.;WEBB, JAMES S.;MEAD, ROY D.;AND OTHERS;REEL/FRAME:018466/0711

Effective date: 20061031

AS Assignment

Owner name: LOCKHEED MARTIN CORPORATION, MARYLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ACULIGHT CORPORATION;REEL/FRAME:021763/0985

Effective date: 20080829

Owner name: LOCKHEED MARTIN CORPORATION,MARYLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ACULIGHT CORPORATION;REEL/FRAME:021763/0985

Effective date: 20080829

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: LOCKHEED MARTIN CORPORATION, MARYLAND

Free format text: CHAIN OF TITLE;ASSIGNOR:LOCKHEED MARTIN ACULIGHT CORPORATION;REEL/FRAME:045094/0491

Effective date: 20180110

Owner name: LOCKHEED MARTIN ACULIGHT CORPORATION, WASHINGTON

Free format text: CHANGE OF NAME;ASSIGNOR:ACULIGHT CORPORATION;REEL/FRAME:045102/0451

Effective date: 20080829

AS Assignment

Owner name: LOCKHEED MARTIN SONAR SYSTEMS CORPORATION, NEW YOR

Free format text: CHANGE OF NAME;ASSIGNOR:LORAL SONAR SYSTEMS CORPORATION;REEL/FRAME:045110/0316

Effective date: 19960429